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ZUSAMMENFASSUNG 
 
Die angeborene Immunantwort vermittelt die schnelle Abwehr einwandernder Pathogene 
und die Beseitigung von Pathogen-assoziiertem sowie wirtseigenem Material. Die 
Aktivierung von Makrophagen und dendritischen Zellen bestimmt die Immunantwort im 
Körper, während Mikroglia und Astrozyten durch die Produktion pro-inflammatorischer 
Zytokine entzündliche Prozesse im Gehirn induzieren, welche als Neuroinflammation 
bezeichnet werden. Neuroinflammation ist ein pathologisches Merkmal 
neurodegenerativer Erkrankungen und exzessive sowie anhaltende Immunaktivierung 
wurden als Risikofaktoren für die Alzheimer-Krankheit identifiziert.  
In dieser Arbeit habe ich langanhaltende Effekte einer systemischen Immunaktivierung mit 
verschiedenen endotoxischen Komponenten aus Bakterien auf neuronale Architektur, 
elektrophysiologische Funktionalität und räumliches Lernen von Mäusen untersucht. Auch 
der Einfluss des natürlichen Alterns wurde dabei analysiert. Zusätzlich wurden 
Veränderungen der Neurodegeneration im APP/PS1 Mausmodel für die Alzheimer-
Krankheit erforscht. 
Die Daten im ersten und zweiten Teil dieser Arbeit präsentieren eine altersabhängige 
Sensitivität gegenüber einer Immunaktivierung mit Lipopolysaccharid (LPS) aus 
Salmonella enterica serovar typhimurium (S.typhimurium) und mit Peptidoglycan (PGN) 
zusammen mit Lipoteichonsäure (LTA) aus Staphylococcus aureus. Alte Mäuse zeigen 
eine Reduktion der dendritischen Komplexität und der Dichte dendritischer spines 
hippokampaler und kortikaler Neurone. Zusätzlich wurden Beeinträchtigungen im 
räumlichen Lernen und der Langzeitpotenzierung (LTP), welche als zelluläre Grundlage 
von Lernen und Gedächtnis betrachtet wird, in alten Mäusen entdeckt. Des Weiteren 
weisen die gealterten Tiere eine erhöhte Mikroglia Aktivierung auf, welche durch die LPS 
Stimulation noch verstärkt wird. Die Behandlung mit LPS aus Escherichia coli zeigt diese 
negativen Auswirkungen nicht. Jedoch zeigen alte APP/PS1 Mäuse Einbußen der 
dendritischen Komplexität und dendritischer spines mit beiden LPS Sorten. Die LTP ist 
sowohl nach LPS als auch nach PGN/LTA Stimulation reduziert. Interessanterweise 
zeigen die jungen APP/PS1 Mäuse ebenfalls negative Auswirkungen der systemischen 
Immunaktivierung. Ferner konnte ich zeigen, dass das NLRP3 Inflammasom, welches die 
Reifung der proinflammatorischen Zytokine IL-1β and IL-18 vermittelt, essentiell für die 
Minderung neuronaler Komplexität und der LTP nach LPS S.typhimurium Aktivierung ist. 
Der letzte Teil der Dissertation verdeutlicht die Auswirkungen einer chronischen Infektion 
mit Toxoplasma gondii (T.gondii) auf neuronale Strukturen. Bereits junge Mäuse 
reagieren sensitiv auf eine Infektion des Zentralen Nervensystems mit T.gondii. Hier ist 
eine generalisierte Reduktion der dendritischen Komplexität in verschiedenen Zelltypen zu 
sehen ist. 
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ABSTRACT 
 
The innate immunity provides rapid and important protection against invading pathogens 
and obtains clearance of pathogen-associated as well as host-derived danger-associated 
material. The activation of macrophages and dendritic cells orchestrates the inflammatory 
response in the body, while microglia and astrocytes induce an inflammatory response by 
production of pro-inflammatory cytokines in the brain, termed neuroinflammation. 
Neuroinflammation is part of the pathogenesis of neurodegenerative diseases and 
excessive or prolonged innate immune activation has been identified as risk factor for 
Alzheimer´s disease.  
In this thesis, I investigated the long-term effects of a systemic immune activation on 
neuronal architecture, function and learning behavior of mice. Different inflammatory 
components as well as the influence of age were examined. Additionally the APP/PS1 
mouse model of Alzheimer´s disease was taken to determine changes in 
neurodegeneration upon peripheral immune stimulation.  
In the first and second part of the thesis the presented data provide evidence for an age-
dependent vulnerability towards an immune stimulation with lipopolysaccharide (LPS) of 
Salmonella enterica serovar typhimurium (S.typhimurium) as well as with peptidoglycan 
(PGN) and lipoteichoic acid (LTA) of Staphylococcus aureus. Aged mice exhibit 
decreased dendritic complexity and spine density of hippocampal and cortical excitatory 
neurons. Moreover, the long-term potentiation (LTP) as enduring enhanced synaptic 
transmission reflecting the cellular correlate of learning, and the formation of spatial 
memory, was impaired in aged wildtype mice. Moreover, aged mice showed a higher 
microglia activation under basal conditions and further activation upon LPS stimulation 
which was not detectable in adult mice. The treatment with LPS of Escherichia coli (E.coli) 
did not show these deleterious effects. However, in aged APP/PS1 mice, both E.coli and 
S.typhimurium LPS resulted in reduction of dendritic branches and spine density of 
hippocampal and cortical excitatory neurons. Moreover, synaptic plasticity was inhibited 
with both kinds of LPS and upon PGN/LTA treatment. Interestingly, also adult APP/PS1 
mice exhibited detrimental effects on neuronal morphology upon systemic immune 
activation. In addition, I could demonstrate that the impairment in neuronal structure and 
LTP after LPS S.typhimurium treatment can be rescued with genetic ablation of the 
NLRP3 inflammasome which is required for the maturation of the proinflammatory 
cytokines IL-1β and IL-18. 
The last part of this thesis demonstrates the impact of chronic Toxoplasma gondii 
(T.gondii) infection on neuronal architecture. I could provide evidence that even young 
adult mice are sensible towards a CNS infection with T.gondii as they show a generalized 
reduction in dendritic complexity in various different brain areas and cell types.  
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1. INTRODUCTION 
 
The modern human has come a long and successful way since its genesis about 200,000 
years ago in Africa. With rise of civilization and – much later – technology, humans 
conquered many problems, survived many crises. And still, microbes of about 1 µm and 
even smaller particles only 10 nm in size deprived of any kind of metabolism can serve as 
tremendous threat to the human being. It was thought that with the discovery of penicillin 
by Alexander Fleming in 1928 the battle against bacteria was won, but today infections 
are still among the leading causes of death worldwide. The overuse of antibiotics in 
agriculture and medicine, excessive hygiene and exorbitant travel going along with 
globalization are only some of the man-made factors helping microbes to everlasting 
world supremacy. And even when infections are overcome they can promote distinct 
types of cancer, heart failure, allergies and possibly also neurodegeneration. In an ever 
older growing society, neurodegenerative disease represents a major threat to the human 
well-being. The term neurodegeneration covers all conditions characterized by a 
progressive loss of neuronal function associated with neuronal death. Neurodegeneration 
can be caused by accumulation of small particles seen in prion diseases or misfolded 
proteins such as α-synuclein in Parkinson´s disease and huntingtin in Huntington´s 
disease. Also in Alzheimer´s disease as the most eminent neurodegenerative disease and 
the leading cause of dementia amongst the elderly, protein aggregation plays a crucial 
role. Even though genetic factors have been discovered accounting for a small subset of 
cases, answers are still missing to why the prevalence for Alzheimer´s disease doubles 
every 5 years once people reached an age of 65 (Qiu et al. 2009).  
The underlying mechanisms causing neurodegenerative diseases are not well understood 
yet, but the fact that diseases featuring inflammatory conditions as type 2 diabetes and 
obesity (Luchsinger and Gustafson 2009), systemic infection (Perry et al. 2007), sepsis 
(Holmes et al. 2009) and periodontitis (Cerajewska et al. 2015) are identified as 
environmental risk factors for Alzheimer´s disease, opens a whole new, interesting field of 
research into the origin and progression of neurodegenerative disease. And possibly, a 
fight against infectious diseases and immune activation within the body might serve as 
double strike against other human health threats. 
 
 
1.1. Innate immunity  
 
Although all individuals, humans and animals, are surrounded by numerous potentially 
harmful microorganisms, these organisms do rarely cause diseases. Physical as well as 
chemical barriers like epidermal or mucosal tissues provide protection against invasion of 
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bacteria, viruses or protozoa. But even when the attachment and invasion of a pathogen 
is successful, the majority of invaders are eliminated within minutes or hours by the host’s 
defense mechanisms underlying epithelial surfaces. 
Together with the adaptive or acquired immunity (only present in vertebrates), the innate 
immune response is part of the mammalian immune system. While the adaptive immunity 
plays a role in the late phase of infection and the formation of an immune memory, the 
innate immunity is the first and rapid response to invading pathogens or host-derived 
danger signals. Thereby pathogen associated molecular patterns (PAMPs) as well as 
danger associated molecular patterns (DAMPs) are recognized by germline-encoded 
pattern recognition receptors (PRRs). The different PRRs include membrane bound and 
cytoplasmic receptors. Membrane bound receptors are Toll like receptors (TLRs) and C-
type lectin receptors, cytoplasmic receptors are NOD like receptors (NLRs) and RIG-I- like 
receptors. The motives recognized by PRRs are usually highly conserved molecules 
within microbes which are essential for survival or pathogenicity and therefore unlikely to 
undergo mutation (Akira et al. 2006, Mogensen 2009).  
PRRs are constitutively expressed on various cell types like macrophages and dendritic 
cells but also on non-immune cells. The expression of PRRs is upregulated by the 
presence of pathogens. Dependent on the receptor and bound PAMP or DAMP, different 
signaling cascades are initiated which mediate the initiation, propagation and subsequent 
elimination of inflammation. Inflammation ensures the delivery of effector molecules, the 
killing of the infectious agent by phagocytes, mainly macrophages and polymorphonuclear 
neutrophilic leukocytes, the prevention of pathogen spreading and the subsequent tissue 
repair. Primary proinflammatory cytokines like IL-1β, IL-6 and TNF-α orchestrate those 
functions via various pathways comprising the mitogen activated protein kinases ERK, 
Jak/p54 and p38, and promote local and systemic reactions (Dinarello 1991). 
 
 
1.2. Lipopolysaccharide and peptidoglycan-mediated innate immune 
activation  
 
Different PRRs as mediators of the innate immunity show distinct expression patterns, 
they can recognize different pathogen associated ligands and activate specific as well as 
overlapping intracellular cascades. The binding of PAMPs or DAMPs via different Toll like 
receptors for example leads to activation of the same cytoplasmic domains like MyD88, 
interleukin 1 receptor (IL-1R) -associated protein kinase and tumor necrosis factor 
receptor-activated factor 6 (TRAF6), which overlap with the signaling of the IL-1 receptor 
(Bowie and O´Neill 2000). Toll, as the namesake and founding member of the TLR family, 
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was discovered in Drosophila melanogaster as a factor of embryonic dorsal-ventral 
polarity (Anderson and Nüsslein-Volhard 1986, Hashimoto et al. 1988). To date, 9 
different TLRs are known in insects, 13 in mammals of which 11 are expressed in humans 
(reviewed in Takeda et al. 2003). The Toll like receptors are type I integral membrane 
glycoproteins containing an extracellular domain comprised of varying numbers of leucine-
rich-repeat (LRR) motifs and the Toll/IL-1R homology (TIR) cytoplasmic signaling domain 
which shows homology to the IL-1R intracellular domain (Bowie and O’Neill, 2000). The 
usage of different TIR domain-containing adaptors like the mentioned MyD88, TIRAP (TIR 
domain-containing adapter protein or Mal = MyD88-adaptor like), TRIF and TRAM 
mediate the specificity of the TLR signaling. TLR 1, 2, 4, 5 and 6 are trafficked to the cell 
membrane, whereas TLR 3, 7, 8 and 9 are expressed on intracellular compartments. 
Therefore, the recognition of internalized viral dsRNA, ssRNA and prokaryotic DNA is 
mediated by the later group of TLRs. 
While some TLRs perceive only one group or a small number of ligands, others are able 
to recognize several microbial molecules. For example, TLR 5 only binds bacterial 
flagellin, TLR 1 recognizes soluble factors and triacylic lipopeptides of bacteria and 
mycobacteria. TLR 2 and TLR 4 can bind several molecules of different origin like 
bacteria, viruses, fungi and also host material. TLR 4 (as well as TLR 2 to some extend) 
recognizes bacterial lipopolysaccharide (LPS) as a very strong immune activator.  
LPS is a complex glycolipid of the outer membrane of Gram negative bacteria. The 
polysaccharide of the LPS contains a core region and the O-antigen. The O-antigen 
generates the high structural diversity of the LPS. Here, the composition and linkage of 
monosaccharides raises this high variation. The lipid A comprises the hydrophobic 
membrane anchor of the LPS and is connected to the inner core region via an unusual 2-
keto-3-deoxyoctonoic acid, L-glycero-D-manno-heptose, often together with phosphate or 
sulfate groups and ethanolamine. The lipid A fraction gives rise to the endotoxic function 
of the molecule. The recognition of LPS is realized via binding to the serum-protein LBP 
(LPS binding protein, Schumann et al. 1990), which subsequently binds to the membrane 
bound or soluble CD14 (Hailman et al. 1994). This ternary complex is able to activate the 
receptor complex of TLR 4 and MD-2.  
TLR 2 shows response to PAMPs like lipoteichoic acid, di- and triacylated cysteine-
containing lipopeptides and peptidoglycan. Lipoteichoic acid (LTA) is a component of 
Gram positive bacteria which is anchored to the up to 80 nm thick peptidoglycan (PGN) 
layer mounting the bacterial cell membrane. LTAs mediate the adhesion to host cells, 
autolysis and like LPS they also induce fever and septic shock in the host during a severe 
infection. The signaling of TLR 2 requires heterodimerization with TLR 1 or TLR 6 
(Ozinsky et al. 2000). In both cases, downstream of the MyD88-dependent signaling of 
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TLR 2 and TLR 4 lays the activation of different transcription factors like nuclear factor κB 
(NF-κB) or cyclic AMP-responsive element-binding protein (CREB) (Figure 1).  
 
 
Figure 1.1 | Mammalian TLR signaling pathways (O´Neill et al. 2013). While Toll like receptor (TLR) 5, TLR 
11, TLR 4 and the heterodimers of TLR 1–TLR 2 and TLR2–TLR6 are localized on the cell surface, TLR 3, the 
heterodimer TLR 7–TLR 8, TLR 9 and TLR 13 bind their ligands at endosomes. There, they recognize 
microbial and host-derived nucleic acids. TLR 4 is found plasma membrane and endosome associated. Upon 
ligand binding, the receptors form dimers; which induces linking to the Toll/IL-1-resistence (TIR) domains of 
the TLRs to TIR domain-containing adaptor proteins. These are either myeloid differentiation primary-
response protein 88 (MyD88) and MyD88-adaptor-like protein (MAL) or TIR domain-containing adaptor protein 
inducing IFN-β (TRIF) and TRIF-related adaptor molecule (TRAM). The downstream signaling cascade 
involves binding of IL-1R-associated kinases (IRAKs) and the adaptor molecules TNF receptor-associated 
factors (TRAFs), which leads to activation of the mitogen-activated protein kinases (MAPKs), JUN N-terminal 
kinase (JNK) and p38 driving nuclear factor-κB (NF-κB) and the interferon-regulatory factors (IRFs) mediated 
transcription. But also cyclic AMP-responsive element-binding protein (CREB) and activator protein 1 (AP1) 
are important transcription factors. As major consequence sensing of extracellular ligands induces production 
of pro-inflammatory cytokines, while endosomal associated signaling drives Type I interferon transcription. 
dsRNA, double-stranded RNA; IKK, inhibitor of NF-κB kinase; LPS, lipopolysaccharide; MKK, MAP kinase 
kinase; RIP1, receptor-interacting protein 1; rRNA, ribosomal RNA; ssRNA, single-stranded RNA; TAB, TAK1-
binding protein; TAK, TGFβ-activated kinase; TBK1, TANK-binding kinase 1. 
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The activation of these transcription factors leads to the expression of a series of genes of 
pro-inflammatory cytokines such as IL-6, IL-18, IL-1β and TNF-α orchestrating the 
inflammation. These immediate and strong reactions to DAMPs or PAMPs are unspecific 
and eliminate most of the invading pathogens. However, when this first step of defense is 
overcome by an invading pathogen the presentation of antigens by dendritic cells and 
tissue macrophages associated with MHC class I or II (major histocompatibility complex) 
molecules leads to activation of further lymphocytes such as B cells and T cells as part of 
the adaptive immunity. Eventually after pathogen clearance, tissue repair and anti-
inflammatory signaling represses the pro-inflammatory activation of the mobilized immune 
cells. 
 
 
1.2.1 Lipopolysaccharide as model for sepsis and systemic immune activation 
 
Sepsis and septic shock as systemic inflammatory response to infection with bacteria, 
viruses or fungi exhibit a high lethality and are among the leading causes of death in 
intensive care units worldwide (Bone et al. 1992, Angus et al. 2001). It is believed that 
many features of such a severe bacterial infection with symptoms like fever, hypotension, 
sepsis induced brain dysfunction, multiple organ failure or even death are due to the 
activation of macrophages and the secretion of pro-inflammatory cytokines like IL-18, IL-6, 
IL-1β and TNF-α (reviewed in Blackwell and Christman 1996). Subsequently, however 
also an extensive production of anti-inflammatory cytokines like IL-10 and TGF-β occurs 
and can lead to immune paralysis and an overwhelming pathogen load due to immune 
inactivation (Bogdan et al. 1993, Astiz et al. 1996). So it seems that sepsis and septic 
shock are likely caused by an imbalance of pro- and anti-inflammatory signaling. As a 
consequence of a severe bacteraemia also brain functions can be affected. Symptoms 
like impairment in attention and memory, delirium and coma can occur and are 
summarized as septic or sepsis-induced encephalopathy (Pine et al. 1983, Sprung et al. 
1990, Wilson and Young 2003). 
In rodents, the intraperitoneal administration of lipopolysaccharide (LPS) is widely used to 
mimic severe bacterial infections and sepsis as it was shown that the application of this 
endotoxic Gram negative bacterial cell wall component is sufficient to induce high 
production of IL-1β and TNF-α (Michie et al. 1988, Cannon et al. 1990). In this model, not 
only the level of blood or liver cytokines was increased only hours after LPS 
administration, but also the cytokine production in the brain parenchyma was increased 
(Qin et al. 2007, Semmler et al. 2008). Already more than one decade ago, studies 
revealed impairment in synaptic plasticity upon peripheral immune stimulation only hours 
after application. Most studies used intraperitoneal administration of different E.coli LPS 
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types and showed the acute influences of a systemic immune stimulation. The acute 
consequences of the peripheral LPS administration range from impairment in long-term 
potentiation (Commins et al. 2001, Jo et al. 2001, Hennigan et al. 2007, Strehl et al. 2014) 
to deficits in learning and memory (Arai et al. 2001, Shaw et al. 2001, Sparkman et al. 
2005). In the Morris water maze task, mice injected intraperitoneally with E.coli LPS took 
longer to find the hidden platform after 6 hours of incubation. Also the number of correct 
choices in the Y-maze was significantly reduced (Arai et al. 2001). This demonstrates that 
reference as well as working memory function is impaired. It was also suggested, that 
these changes in learning performance are not transient but more stable and linger even 
when the initial illness is overcome (Valero et al. 2014). 
However, long-term influences of a peripheral immune activation have not been 
satisfyingly addressed so far. In addition to this, also factors like age and the innate 
immune activation as facilitator of neurodegenerative disease have probably not been 
adequately taken into account.  
 
 
1.2.2. Sepsis induced by Gram positive bacteria 
 
Until the 1990s, sepsis was considered to be specific for Gram negative bacteria (Parrillo 
et al. 1990). Today most cases of sepsis are actually caused by Gram positive bacteria 
with the most prominent representatives Staphylococcus aureus, Streptococcus 
pyogenes, Pseudomonas aeruginosa and Klebsiella spp. (Martin et al. 2003). 
Sepsis in its different aspects is a complex inflammatory immune response of the host’s 
immune system to virulence factors like endotoxins. The two major components of the 
Gram positive cell wall are peptidoglycan (PGN) and lipoteichoic acid (LTA). Both, in 
synergy, are able to severely activate the innate immune system. At LTA recognition, the 
immune activation is mediated by TLR 2, LBP, and CD14, whereas TLR 4 and MD-2 are 
not involved (Schröder et al. 2003). PGN recognition also uses TLR 2. In contrast to LPS, 
as it seems PGN or LTA does not cause lethality or multi organ failure alone. These two 
components in synergy however cause septic shock and organ toxicity only 6 hours after 
intravenous application in rats at doses of 10 µg/g and 3 µg/g, respectively (De Kimpe et 
al. 1995). Nevertheless, the magnitude of the inflammatory reaction towards Gram 
positive bacteria seems to be smaller (Abe et al. 2010). And therefore still most immune 
stimulatory experiments in rodents are performed with LPS and research about 
appropriate doses for a long-term study with PGN/LTA stimulation and consequences for 
neuronal architecture, synaptic plasticity and spatial learning is missing. 
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1.3. Chronic central nervous system infection with Toxoplasma gondii 
 
Toxoplasma gondii (T.gondii) is a protozoan parasite of the family of apicomplexa which 
can infect a great variety of mammals and birds. The three different routes for humans to 
get infected by this obligate intracellular pathogen are the food-born, zoonotic and mother-
to-child transmission. Humans and rodents only serve as intermediate or secondary hosts 
and sexual reproduction of T.gondii occurs only in members of the felidae (Dubey et al. 
1970). Most frequently, humans get infected via contaminated uncooked meat and 
therefore at first the pathogen crosses the gastrointestinal barrier as rapidly dividing 
tachyzoites (Frenkel et al. 1973). From the submucosal tissue, the pathogen disseminates 
throughout the body and eventually reaches immune protected sites like the brain, retina 
or fetus (Hunter and Remington 1994, Pavesio and Lightman 1996, Montoya and 
Remington 2008). T.gondii is most likely able to enter the brain via the “Trojan horse” 
mechanism, hijacking and activating immune cells such as macrophages, which 
subsequently squeeze through the blood endothelial cells of the blood brain barrier 
(Lachenmaier et al. 2011). After the acute phase of the infection which lasts about two 
weeks and can be asymptomatic or can feature symptoms typical for a common cold, 
T.gondii evades the host´s immune system and remains within the host over its whole 
lifespan via formation of intracellular cysts. Even though, this protozoan is able to infect 
and form intracellular cysts within astrocytes, microglia and neurons in vitro (Fischer et al. 
1997), in vivo the majority of cysts are found in the axon, cell body or dendrites or neurons 
(Ferguson and Hutchison 1987). The persistent form of the protozoan within these cysts is 
the slowly dividing bradyzoite (Frenkel 1973). The conversion of tachyzoites into 
bradyzoites is mediated by factors of the immune system such as a heat shock during 
fever, nitric oxide, high or low pH and IFN-γ production (Lyons et al. 2002). Encysted in 
neurons, bradyzoites remain undetected by invading immune cells such as T cells due to 
a lack of MHC class I normally mediating the CD8+ T cell executed death of infected cells. 
On the other hand, the silent bradyzoite stage can be reversed to the active tachyzoite 
form in the absence of IFN-γ, TNF-α, IL-12, NO and T cell response (Lyons et al. 2002). 
While a latent Toxoplasma infection remains unnoticed in most people, it can cause 
severe complications in immunocompromised patients, where a transition back to the 
tachyzoites can have a lethal course (Montoya and Liesenfeld 2004). Nowadays, we know 
that Toxoplasma gondii causes way more subtle symptoms in immune competent people 
promoting mental disorders including depression and schizophrenia (Flegr 2007). 
However, these studies are based on the seroprevalence of patients as brain cysts can 
only be detected post-mortem. In rodents, infection with T.gondii leads to a more curios 
and active behavior (Hay et al. 1985, Webster et al. 1994) and infected animals lose their 
innate fear of feline odors (Berdoy et al. 2000) which most likely serves to increase 
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pathogen transmission. Even though some studies already suggested a contribution of 
low-level inflammation (Hermes et al. 2008), neurotransmitter imbalance (Gatkowska et al. 
2012) or dopamine overproduction (Prandovszky et al. 2011) most likely more than a 
single factor is involved in the complex manipulation of neuronal networks. Further studies 
on the mouse model of chronic T.gondii CNS infection are necessary to gain a complete 
picture of the underlying mechanisms. 
 
 
1.4. Immune cells of the central nervous system 
 
For a very long time, it was believed that the central nervous system, separated from the 
peripheral organs by the blood brain barrier, exhibit an immune-privileged status with no 
communication to or interaction with the peripheral immune system. Indeed, the blood 
brain barrier which is build via tight junctions between the brain blood capillary epithelial 
cells prevents pathogens and immune cells in larger quantity from entering the CNS. 
Nevertheless, even in the absence of an infection, there is communication between the 
immune system and the central nervous system and brain specific as well as peripheral 
immune cells occupy the brain (for a review see Ousman and Kubes 2012).  
Part of the CNS innate immunity are the brain resident astrocytes and microglia cells. 
These two types of glia cells were first described as glue-like connective tissue between 
neurons and introduced in 1846 by Rudolf Virchow. However, the differentiation between 
astroglia, microglia and oligodendrocytes was established by Pio del Rio Hortaga, a 
student of Santiago Ramón y Cajal, in 1932 (del Rio Hortaga 1920, 1932). Del Rio 
Hortaga already postulated that microglia are cells with amoeboid morphology of 
mesodermal origin invading the brain during early development. There, they evenly 
disperse and transform into a branched, ramified morphological phenotype in the more 
mature brain each cell occupying a defined territory. After a pathological event, these cells 
acquire amoeboid morphology similar to the one observed early in development. And 
these cells have the capacity to migrate, proliferate and phagocytose. Correctly pointed 
out by H. Kettenmann and colleagues, all these statements are still valid today 
(Kettenmann et al. 2011). Microglia are the specialized CNS macrophages and – 
depending on the brain area – make up 5 – 20% of the glial cell population (Lawson et al. 
1990, Perry & Gordon 1991). They express several macrophage-associated markers like 
CD11b, CD14 and F4/80 (also known as EGF-like module-containing mucin-like hormone 
receptor-like 1 (EMR1), but they also differ from peripheral macrophages in the following 
aspects: The primary role of microglia is the support and maintenance of tissue function. 
Under non-activated conditions or as resting microglia with their highly branched and 
motile processes, they constantly contact neurons, astrocytes and blood-vessels sensing 
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even subtle changes in their microenvironment (Nimmerjahn et al. 2005). This status is 
promoted by neurons which down regulate the microglia activation via cell-cell-contact 
and soluble factors like neuronal CX3CL1, CD47, CD200 and CD22. These factors bind to 
the receptors CX3CR1, CD172, CD200R and CD45 on the microglia cell surface, 
respectively (Ransohoff and Cardona 2010). Also the expression of TREM-2 (triggering 
receptor expressed on myeloid cells 2) induced via IL-4 signaling attenuates microglia and 
macrophage activation (Turnbull et al. 2006). 
As house-keeping function microglia in this “steady-state” participate in synapse 
maintenance via direct contact to astrocytic processes, dendritic spines and synaptic 
clefts (Murabe and Sano 1982, Wake et al. 2009, Paolicelli et al. 2011, Tremblay et al. 
2011). They also provide support of neuronal development and function by expression of 
the neurotrophins NT-3 (neurotrophin-3) and BDNF (brain-derived neurotrophic factor). 
The microglia themselves also react to neurotrophins and they enhance proliferation and 
phagocytic activity in vitro (Elkabes et al. 1996). Almost any manipulation or insult of the 
brain homeostasis can lead to microglia activation causing rapid changes in morphology 
and upregulation or de novo synthesis of cell surface receptors (Kreutzberg 1996, Perry et 
al. 2010). Microglia display a huge diversity of activation phenotypes with a linear 
activation progression from partial to full activation (Perry et al. 2010). However, this 
diversity is most likely not detectable by changes in morphology and expression of a 
limited number of surface markers. Therefore, it is widely accepted that microglia as well 
as peripheral macrophages appear in two major activation variants: M1 or classical 
activation via TLR and interferon signaling and M2 or alternative activation mediated by 
IL-4 and IL-13 (Martinez et al. 2008). The M1 activation is associated with pro-
inflammatory signaling and production of TNF-α, IL-1β, superoxide, nitric oxide (NO), 
reactive oxygen species (ROS), and different proteases (reviewed by Block et al. 2007). 
Besides the signaling via TLRs and IFNs, also necrotic neurons and amyloid-β aggregates 
lead to classical activation of microglia (Figure 1.2). The M1 state of activation was coined 
for peripheral macrophages and underlines the close relationship between T cells and 
macrophages. Thereby, the interaction with Th1 cells leads to M1 activation of 
macrophages. In the brain, not only T cells produce the M1 triggering cytokines, but also 
astrocytes and microglia themselves are reported to do so (Kawanokuchi et al. 2006). In 
return, microglia enhance the differentiation of naïve T cells via the expression of MHC 
class II (O´Keefe et al. 2002).  
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Figure 1.2 | Classically activated microglia in the context of neurodegenerative disease (Saijo and 
Glass 2011). The M1 or classical activation of microglia is triggered via signaling through pattern-recognition 
and purinergic receptors. Factors like infections with HIV, damage-associated molecular patterns (DAMPs) 
like HMGB1, histones and ATP, as well as protein aggregates typical for certain neurodegenerative diseases 
like Alzheimer´s (amyloid-β) and Parkinson´s disease (α-synuclein) lead to production of pro-inflammatory 
mediators. Communication between microglia and astrocytes via pro-inflammatory cytokines such as CSF1 
amplifies the reaction and contribute to pathology of neurodegenerative disease. IL-1β, interleukin-1β; 
HMGB1, high-mobility group box 1 protein; NLRP3, NOD-, LRR- and pyrin domain-containing 3; NO, nitric 
oxide; RAGE, receptor for advanced glycation end-products; ROS, reactive oxygen species; TLR, Toll-like 
receptor.  
 
 
On the other hand, the M2 activation is characterized by an anti-inflammatory phenotype 
of microglia with its function in immune suppression, cell debris clearance and tissue 
repair. The concept of alternative activation was adapted from peripheral macrophages as 
well, which showed mannose receptor (CD206) expression upon IL-4 binding, a 
phenotype not seen so far and therefore termed “alternative” (Stein et al. 1992). 
In the M2 state, microglia and peripheral macrophages produce anti-inflammatory 
mediators like IL-10, extracellular matrix protecting proteins, ornithine and polyamines for 
wound repair (synthesized by argniase 1 as counterpart of iNOS, both using arginine as 
substrate) and receptors associated with phagocytosis, such as scavenger receptors 
(reviewed by Saijo and Glass 2012). Under normal conditions, an infection or injury is a 
self-limited process characterized by the down regulation of inflammation after the 
pathogen or danger associated molecules are cleared and tissue repair is fulfilled. 
However, it is not clear so far whether microglia return to a resting state with the same 
phenotype as before the insult or whether they hold some kind of memory function (Saijo 
and Glass 2012). Under certain conditions however, microglia can maintain their M1 state 
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and drive ongoing production of pro-inflammatory factors. Such conditions are found in 
chronic inflammatory disease like type 2 diabetes or arteriosclerosis (reviewed by Olefsky 
and Glass 2010, Hansson and Hermansson 2011). Here, a low-grade of inflammation 
contributes to the disease pathology.  
Moreover, there is evidence that markers of classical microglia activation are upregulated 
in mice and also humans as a consequence of normal aging: The expression of TLRs 
(Letiembre et al. 2007), major histocompatibility complex (MHC) class II and complement 
receptor 3 (CD11b) (Morgan et al. 1999; Nicolle et al. 2001, Godbout et al. 2005) is 
enhanced in aged rodents. Also here this “priming state” of microglia leads to a stronger 
and prolonged production of the pro-inflammatory cytokines such as IL-1β and IL-6 after a 
peripheral immune stimulus (Godbout et al., 2005; Barrientos et al., 2009a). And, even 
more interesting the hyper reactive inflammatory response of the microglia was shown to 
be restricted to the brain (Godbout et al., 2005; Barrientos et al., 2009a, 2015a). 
Also astrocytes are involved in the CNS innate immunity. Astrocytes are the most 
abundant cell population in the brain and long believed to solely support nervous tissue 
structure. Today it is known that there is a huge morphological, biochemical and functional 
heterogeneity amongst astrocytes. Roughly, the astrocytic population is divided into the 
protoplasmic astrocytes with various fine branched processes found in the gray matter 
and the fibrous astrocytes of the white matter exhibiting many long fiber-like processes. 
Protoplasmic astrocytes contact neurons via enwrapping of synapses. In this so called 
tripartite synapse, bidirectional communication takes place between the pre- and 
postsynaptic neuron and an astrocyte (for a review see e.g. Clarke et al. 2013). Here, they 
actively regulate neuronal and synaptic transmission by responding to neuronal signaling 
with changes in their intracellular Ca2+ levels mediated via neurotransmitter binding 
(reviewed by Perea et al. 2009). Moreover, astrocytes release several neuroactive 
molecules like ATP, D-serine, GABA, glutamate, NO and TNF-α and they also take up 
excessive neurotransmitter and various ions such as chloride, hydrogen, potassium and 
sodium contributing to ion homeostasis (Simard and Nedergaard 2004, Ota et al. 2013).  
In association with brain microvessels, astrocytes support neurons within “neurovascular 
units”. With their specialized perivascular end feed they contact blood vessels and 
contribute to the physical, metabolic and transport barrier features of the blood brain 
barrier (BBB) and ion and water homeostasis (Abbott et al. 2006). Besides their 
physiological role, modulation of the BBB phenotype and integrity is probably the most 
important factor also for the brains immunity. Furthermore, in case of brain injury a strong 
astrogliosis and astroglial scar formation shutting off degenerative and infected tissue is 
often detectable by upregulation of the GFAP-signal. Of note, immunohistochemical 
identification of astrocytes via GFAP expression seems not to be accurate for non-reactive 
astrocytes in a healthy brain (Sofroniew and Vinters 2010). Astrocytes also contribute to 
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neuroinflammation via secretion of pro-inflammatory cytokines such as IL-1, IL-6, IL-3, 
and TNF-α in response to IFN-γ, IL-1 signaling or LPS (Chung and Benveniste 1990). Like 
microglia, they are able to detect pathogens via a subset of TLRs and sense an 
inflammatory environment via expression of IL-1RI, TNF-αR and IFN-γR. But the 
inflammatory signaling of astrocytes is strikingly slower than in microglia.  
Surprisingly, also the third type of glia cells, the oligodendrocytes express immune 
modulatory receptors such as TLR 2 and 3 (Bsibsi et al. 2012) and receptors for TNF-α, 
IL-4, IL-6, IL-7, IL-10, IL-11, IL-12 and IL-18 (reviewed by Peferoen et al. 2014). And to a 
minor extent oligodendrocytes also secrete cytokines and chemokines, which either 
activate and attract (CCL2, IL-6 and IL-8) or inactivate (CD47, CD200) other immune cells 
like microglia (Amor et al. 2014, Peferoen et al. 2014). However, the main function of 
astrocytes and oligodendrocytes in contrast to microglia are clearly found in normal brain 
function and only secondary in disease. Although it was long believed that no appreciable 
immune functions are present in the brain, glia cells represent a very potent but unique 
subset of the innate immunity. 
 
 
1.5 Learning and memory 
 
The brain gives rise to our consciousness and is the base of thinking, feeling, curiosity, 
learning and memory. While learning describes the acquisition of new information and 
skills, memory comprises the storage and application of this information. Of course 
memory can be further classified according to the duration of storage and the type of 
information. Memories are available for seconds to minutes within the short-term memory 
which gives convenient access to information but bears limitation in its duration and 
storage capacity. After memories gained admission to the long-term memory, they can be 
recalled over hours, months and even a whole life time. The hippocampus as part of the 
limbic system is of crucial interest in the interface of short- and long-term memory (Alvarez 
et al. 1994). It was also identified to play a major role in the formation of episodic, 
contextual memory and formation of spatial maps (Kinsbourne and Wood 1975, O’Keefe 
and Nadel 1979). Humans and many other vertebrates possess two hippocampi under the 
neocortex which are linked via dorsal and ventral commissures. The hippocampus is 
named after its resemblance to a seahorse and is also compared to the ram´s horn of the 
Egyptian god Ammon. Hence, part of the hippocampus formation is the cornu ammonis 
(CA) or Ammon´s horn with its subregions CA1, CA2, CA3 and CA4 area. In the basic 
circuit of the hippocampus formation, signals from the entorhinal cortex as major gate way 
of sensory information gain entry to the hippocampus via the perforant path to the dentate 
gyrus, CA3 and CA1 area (figure 1.3). From the dentate, the information flow goes further 
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via the mossy fiber pathway to CA3. Subsequently, the major connection between the 
CA3 and CA1 are the axons of the Schaffer collateral pathway. From CA1, signals are 
transferred back to the entorhinal cortex which itself is connected to several other cortex 
areas.  
 
 
Figure 1.3 | Schematic illustration of the information flow through a transversal section of the mouse 
hippocampus and related cortical regions (Deng et al. 2010). (A) Signals from layer II and III of the 
entorhinal cortex along the medial and lateral perforant path into the dentate gyrus are further transmitted via 
the mossy fibers to CA3. Signals are further transferred from CA3 to CA1 via the Schaffer collaterals and back 
to the entorhinal cortex. (B) Simplified scheme of the information flow of the different layers of the entorhinal 
cortex into and within the hippocampus. EC entorhinal cortex; PP perforant path; LPP lateral PP; MPP medial 
PP; TA Temporoammonic pathway. 
 
 
In contrast to these different cortex areas, the connections within the hippocampus are 
mostly unidirectional. The excitatory neurons of the hippocampus are organized into 
several sublayers of the pyramidal neurons of the CA and granule neurons of the dentate. 
The cell bodies of the CA regions form the stratum pyramidale. The basal dendrites are 
localized within the stratum oriens, while the stratum radiatum and stratum lacunosum-
moleculare contains the proximal and distal apical dendrites of the CA pyramidal neurons, 
respectively. Even though information is not stored within single neurons or synapses 
within the hippocampus it plays an essential role in the processing of information, which 
was shown in studies of patients and animals with hippocampal damage or lesions 
(Scoville and Milner 1957, Eichenbaum 2004). Therefore, the interaction of the 
hippocampus with neocortical areas and other brain regions promotes strengthening and 
reorganization of neuronal connections as well as information consolidation. Molecular 
and cellular mechanisms enabling memory consolidation are based on the so called 
activity dependent synaptic plasticity. 
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1.6. Functional and structural synaptic plasticity of hippocampal neurons 
 
Synaptic plasticity provides the basis of learning and memory processes. In neuroscience, 
the term synaptic plasticity indicates the activity-dependent alterations of connections 
between neurons and their ability to adapt to a diversity of stimuli. It thereby combines 
functional and structural modifications as growth and retraction of neuronal protrusions 
and synapses as well as the changes in synaptic efficacy. These changes can result in 
strengthening or weakening of synapses and are therefore bidirectional. Moreover, plastic 
changes can be short- or long-lived alterations and are called short-term and long-term 
plasticity, respectively. On the one hand parts of short-term plasticity are alterations 
lasting only seconds or minutes such as the neuronal facilitation, augmentation or post 
tetanic potentiation (Zucker and Regehr 2002). On the other hand, enduring changes in 
synaptic transmission can last hours to days. The long-term potentiation (LTP) as long-
lasting enhancement of synaptic efficacy was discovered in 1973 by Terje Lømo and 
Timothy Bliss (Bliss and Lømo 1973) in the rat hippocampus. The opponent mechanism is 
the long-term depression as activity-dependent reduction of synaptic efficacy (Dudek and 
Bear 1992). Further, LTP and LTD are divided into an early and a late phase. The early 
phase of LTP (E-LTP) can be experimentally induced in the hippocampus via a single 
tetanic stimulation and lasts only a few hours. Processes of E-LTP comprise post-
translational modifications of various post-synaptic proteins but are independent of protein 
synthesis and therefore quickly decaying. The late phase LTP (L-LTP) lasts several hours 
in vitro and even weeks or months in vivo (Frey et al. 1988, Bliss and Gardner-Medwin 
1973, Abraham 2003). Both forms of LTP and also LTD require the influx of Ca2+ into the 
postsynaptic compartment, the activation of Ca2+/calmodulin-dependent protein kinase II 
(CamKII) and protein kinase C (PKC) and  trafficking of AMPA (α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid) receptors in or out of the postsynaptic membrane 
(Collingridge et al. 2004, Malenka and Bear 2004). LTP at the Schaffer collateral pathway 
from CA3 to CA1 neurons is also dependent on activation of N-methyl-D-aspartate 
(NMDA) receptors and protein kinase A (PKA). NMDA receptors are so called 
“coincidence detectors“ as their activation depends on binding of the pre-synaptically 
released neurotransmitter glutamate and the depolarization of the postsynaptic membrane 
above – 50 mV (Collingridge 2003). 
NMDAR-dependent LTP is characterized by input-specificity, associativity and 
cooperation (Bliss and Collingridge 1993, Bear and Malenka 1994, Malenka and Nicoll 
1999). Therefore, upon successful induction of LTP only stimulated synapses are 
strengthened allowing participation of single synapses in separate circuits. Furthermore, a 
strong stimulation of adjacent synapses can lead to expression of LTP in weakly 
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stimulated synapses of the same cell. Lastly, two distinct afferent systems can “cooperate” 
and the summation of EPSPs leads to induction of LTP in a postsynaptic cell.   
LTP and LTD as processes of synaptic plasticity are associated with changes within the 
structure of the postsynaptic compartments, termed structural plasticity. Besides the 
remodeling of dendritic and axonal arbors, shrinkage, growth, elimination and de novo 
formation of dendritic spines and axonal boutons promote the strengthening, weakening 
or rewiring of synaptic connections (Holtmaat and Svoboda, 2009). Dendritic spines are 
small protrusions on dendritic branches forming the postsynaptic site of a synapse. Only 
two years after the discovery of LTP, an enlargement of dendritic spines within the 
stimulated vs. non-stimulated pathways was discovered by electron microscopy 
(Harreveld and Fifkova 1975). Spines form biochemical compartments allowing changes 
in Ca2+ concentration at single synapses and therefore mediate input specificity (Hayashi 
and Majewska 2005). The architecture of dendritic spines is very divers, but they are 
usually classified as stubby, thin, mushroom and filopodia. While thin spines and filopodia 
lack an appreciable head and represent an immature “learning spine” phenotype. 
Mushroom spines posses a well defined neck and prominent spine head, and due to their 
strong stability they are also referred to as “memory spines” (Bourne and Harris 2007). 
Mushroom spines exhibit the most mature spine phenotype as head volume correlates 
with synaptic strength, area of the postsynaptic density and the number of inserted AMPA 
receptors (Harris and Stevens 1989, Takumi et al. 1999). Especially thin spines and 
filopodia are very dynamic structures and form or disappear rapidly in response to 
changes in synaptic transmission. These rapid morphological changes are mediated by 
changes in the actin cytoskeleton which is highly enriched in dendritic spines. Upon LTP, 
a transient depolymerization of F-actin in the stimulated spines allows transport of 
plasticity related proteins and polyribosomes mediating the long-lasting alterations in 
synaptic efficacy on the level of single spines (Ouyang et al. 2005). Subsequent increase 
in F-actin ratio however facilitates spine growth and stabilization (Lin et al. 2005). 
Changes in G-actin to F-actin ratio are mediated by the activity of small GTPases and 
their regulators, through the action of actin-binding proteins such as profilin and cofilin. As 
the actin cytoskeleton serves as regulator of protein trafficking and structural framework of 
dendritic spines a tight control of these proteins is always required. Together, functional as 
well as structural alterations on the level of single spines in response to specific stimuli are 
necessary to allow adaptation during learning and memory events.  
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1.7 Crosstalk between the immune and central nervous system 
 
The first evidence that the brain is quite different from the rest of the body in respect to 
immune functions was gained in 1921 when an experiment showed that rat sarcoma cells 
proliferate intensely in the brain parenchyma but do not after subcutaneous or 
intramuscular transplantation (Shirai 1921). The perception that indeed the brain - along 
with the eyes and testis - is an immune-privileged site was persistently locked in peoples´ 
brains for almost 90 years. The isolation from the peripheral circuitries by the BBB, the 
lack of lymphatic vessels, low constitutive levels of MHC class I and II and the supposed 
immunoincompetence of microglia (Carson et al. 2006) were further points supporting this 
hypothesis. Research in the last decades shifted the view of the immune-privileged brain: 
“It has become increasingly clear that the central nervous system is immune-different 
rather than immune-privileged” (Josep Dalmau, University of Pennsylvania). 
Indeed, the brain and the immune system communicate via shared messengers namely 
neurotransmitters, cytokines or hormones, which have overlapping functions in both 
systems. The brain regulates the production of immune modulators via the hypothalamic-
pituitary-adrenal (HPA) axis. Here, the hypothalamus and the pituitary gland stimulate the 
production of these mediators in the adrenal gland. In return products generated by the 
immune system influence the neuroendocrine axis activity. Cytokines as major immune 
modulators are not only transported into the brain across the BBB but also expressed by 
brain cells. Astrocytes, microglia and neurons express pro-inflammatory cytokines such as 
IL-1β, IL-6 and TNF-α (Vitkovic et al. 2000) during tissue insult as well as normal brain 
function, e.g. after induction of LTP (Schneider et al. 1998) or for normal sleep regulation 
(Krueger et al. 1998). Of note, impaired IL-1β signaling as well as an increased IL-1β 
concentration leads to deficits in hippocampal LTP and learning and memory processes 
(Avital et al. 2003, Hein et al. 2010, Tong et al. 2012). Today we know that the production 
of cytokines especially by microglia but also by astrocytes is only one important function 
shared with peripheral immune cells (see chapter 1.4.). Furthermore, also the tightly 
controlled access of peripheral immune cells must occur to maintain brain homeostasis. 
Peripheral immune cells can fulfill different tasks in the brain and are part of complex 
signaling cascades to protect the brain from health threats, but they also seem to 
participate in normal brain function. Indeed, immune cells from the periphery can enter the 
cerebrospinal fluid (CSF) via the choroid plexus and the leptomeningeal vessels with the 
help of selectins and integrins controlling cell-adhesion, rolling and endothelial passage 
(Engelhardt and Ransohoff 2012). It was further revealed, that also the blood brain barrier, 
the perivascular space and the basement membranes of endothelial cells and astrocytes 
can be crossed by different leukocytes, which is called diapedesis. The underlying 
mechanism is best described for the α4-integrins mediated crossing of CD4+ T cells into 
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the brain parenchyma during multiple sclerosis (Engelhardt 2006). Here and in other 
diseases, the integrity of the BBB can be reduced by dysregulation of tight junction 
proteins. In addition to their role during disease, CNS-specific T cells seem important for 
spatial learning and neurogenesis (Ziv et al. 2006). T cells also migrate into the meninges 
and acquire Th2 activation upon learning tasks (Marin and Kipnis 2013). T cells, B cells 
and blood monocytes are also able to secrete the brain-derived neurotrophic factor 
(BDNF) and respond to the nerve growth factor (NGF) (Kerschensteiner et al. 1999, 
Prencipe 2014), which can activate microglia and promote anti-inflammatory processes 
despite their classical role as neurotrophic factors (Jiang et al. 2010, Tong et al. 2012). 
However, numerous questions about the functions of immune cells and immune 
modulators during normal brain functions are yet to be answered. 
 
 
1.8 Alzheimer´s disease 
 
Alzheimer´s disease (AD) was first described by Dr. Alois Alzheimer in 1906, when he 
reported progressive cognitive impairment, focal symptoms, hallucinations, delusions, and 
psychosocial incompetence in his patients Auguste Deter. Today, according to the 
Alzheimer´s association about 44 million people suffer from Alzheimer´s disease which 
makes it the most common cause of dementia in the elderly. Already in the early 20th 
century Dr. Alzheimer described the pathological hallmarks of the disease: First, the 
extracellular amyloid-β or senile plaques (he called these miliary foci, Alzheimer et al. 
1907, translated into English in 1995) identified as an accumulation of a 4.2 kDa peptide 
primarily of 40 – 42 amino acids of length (Glenner and Wong 1984). The amyloid-β 
peptide as major component of senile plaques is a byproduct of the amyloidogenic 
cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. And second, the 
abnormal intracellular aggregates he named neurofibrillary tangles. Today we know that 
these tangles are composed of hyperphosphorylated forms of the microtubule-associated 
and stabilizing protein tau (Mandelkow and Mandelkow 1998). The tau protein loses its 
ability to promote microtubule assembly in neurons upon phosphorylation, which is due to 
an imbalance in kinase and phosphatase activity (Gong and Iqbal 2008). However, it is 
most likely the gain of a neurotoxic function which causes tau associated 
neurodegeneration as other microtubule associated proteins could substitute for tau 
function (Gong and Iqbal 2008). While the incidences of amyloid plaques cannot be 
correlated with severity of cognitive decline during AD progression, the aggregation of 
intraneuronal phopho-tau and the extraneuronal “ghost tangles” which appear after death 
of tau bearing neurons parallel neuronal and synaptic loss (Braak and Braak 1991). 
During the disease progression, the death of single neurons as well as the early loss of 
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single synapses is strongly correlated with the cognitive impairments. Only after a long 
preclinical phase of at least 10 – 20 years and a very slow progression in the early stage 
of AD cognitive symptoms appear (Price and Morris 1999). Early stage AD symptoms 
include impairment in short-term memory, slight temporal or spatial disorientation 
(Tarawneh and Holtzmann 2012) and even subtle changes in personality such as 
depression (Zubenko et al. 2003). While there is a marked progressive decline in cognitive 
functions and behavioral symptoms such as aggression, anxiety, and aimless or restless 
activities during the moderate stage of disease (Devanand et al. 1997), in the severe 
stage of AD patients are usually bedridden due to impairment in basic motor functions and 
they often die of complications with aspiration or infection (Tarawneh and Holtzmann 
2012). While there are cases of early onset AD which are mediated by mutations in either 
the APP or the catalytic subunits presenilin 1 or 2 (PS1 or PS2) of the γ-secretase leading 
to increased Aβ production (Bertram and Tanzi 2008), most cases are of sporadic nature 
with age as the most important risk factor. Besides the two AD specific hallmarks 
neuroinflammation, astrogliosis and microglia activation are associated with 
neurodegeneration during disease progression (Beach et al. 1989, Itagaki et al. 1989). 
The idea that neuroinflammation may be an early event in AD pathogenesis was proposed 
in the same breath as the disease discovery (Fischer 1907, Eikelenboom 2010). In fact, 
elevated levels of cytokines, chemokines and their receptors were found in post-mortem 
AD brain tissue (Cartier et al. 2005) and microglia surrounding Aβ plaques are positive for 
activation markers and pro-inflammatory mediators such as MHC class II, Cox-2, MCP-1, 
TNF-α, IL-1β, and IL-6 (Akiyama et al. 2000, Glass et al. 2010). However, it is quite 
challenging to study and understand the sources and patterns of this multi-factorial 
disease and the involvement of inflammatory processes solely in human post-mortem 
tissue. Not to mention that early stages of the pathology and healthy controls are difficult 
to identify. Therefore, several mouse models have been developed reflecting one or more 
pathological hallmarks of the disease even with young age. These mouse models are 
based on mutations within the human APP, PS or tau gene of familial AD cases. A variety 
of these different transgenic mouse models have been developed during the last 20 years. 
Some mice are transgenic for the APP such as APP23 (Sturchler-Pierrat et al. 2009), 
APP-Au (Van Broeck et al. 2008), PD-APP (Games et al. 1995), Tg2576 (Hsiao et al. 
1996), or tg APP_ArcSwe (Lord et al. 2006). Others carry two mutations with either a 
stronger amyloid-plaque phenotype like APPswe/PSEN1dE9 (Borchelt et al. 1997) 
APP/PS1 (Blanchard et al. 2003) and PS2APP (Richards et al. 2003) or reflect the APP 
and tau pathology such as APP/tau (Ribé et al. 2005), 3xTg (Oddo et al. 2003) or 
TauPS2APP (Grueninger 2009). Even though, these mouse models have been proven to 
be very valuable tools in AD research, none of them combines all features of the disease. 
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One of the widely-used and best characterized mouse models is the APPswe/PSEN1dE9 
(in the following APP/PS1) mouse, first described in the late 1990s (Borchelt et al. 1997, 
Jankowsky et al. 2001). This mouse model reflects the amyloid-portion of the pathology as 
a chimeric mouse/human APP with the Swedish mutation K595N/M596L found in early 
onset AD and the relevant γ-secretase presenilin1 which facilitates the amyloidogenic 
cleavage of the APP are overexpressed in the murine brain. The APP/PS1 mouse model 
for AD is characterized by an increasing Aβ plaque load starting with about 6 months of 
age resulting in a substantial plaque load in the hippocampus and cortex by 9 months 
(Jankowski et al. 2004) and a peak in plaque formation until 12 months of age (Garcia-
Alloza et al. 2006). This leads to neurodegenerative phenotype with neuronal death, 
synapse loss and learning and memory deficits. Various studies show decreased numbers 
and altered morphology of synapses in the hippocampus of APP/PS1 mice (Moolmann et 
al. 2004, Grutzendler et al. 2007, Kummer et al. 2011, Alonso-Nanclares et al. 2013, 
Heneka et al. 2013, Šišková et al. 2014). Also synaptic plasticity was investigated in this 
and other AD models and studies showed that an elevation in aggregated Aβ causes 
impairment in LTP (Nalbantoglu et al. 1997, Chapman et al. 1999, Kummer et al. 2011, 
Heneka et al. 2013). Deficits in learning and memory start as early as 6 months of age 
and extent over the whole lifespan of the animals (Cao et al. 2007, Ding et al. 2008). 
 
 
1.9 Alzheimer´s disease and innate immune response 
 
During the last decade, cumulative evidence points to a connection between inflammatory 
conditions in the brain or the body and Alzheimer´s disease progression. For example as 
microglia cells, the resident brain macrophages, are the main cell type to clear Aβ 
deposits a pro- or anti-inflammatory environment could likely influence phagocytosis of 
senile plaques. In AD mouse models as well as post mortem tissue of AD patients, there 
is an elevation of activated microglia, astrogliosis and pro-inflammatory mediators 
(reviewed by Wyss-Coray 2006, Heneka and O´Banion 2007).  
In AD brains microglia convert from their ramified inactive to an amoeboid state and 
express several activation markers and the production of all important pro-inflammatory 
cytokines and chemokines is up regulated (Akiyama et al. 2000, Cartier et al. 2005). Even 
if the neurotoxic properties of Aβ deposits alone might be sufficient to induce neuronal 
death and cognitive decline, this activation of microglia and astrocytes via TLR-, NLR- and 
RAGE-pathways further amplifies these reactions. But not only local inflammatory 
reactions might drive disease pathogenesis, but also the activation of the systemic innate 
immune system enhances or at least modifies AD progression. Infection as cause of 
peripheral immune activation may be involved in the early stages of AD pathogenesis 
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(Perry et al., 2007). Also traumatic brain injury can increase the risk to develop AD. 
Activated microglia can persist for months or even years after injury highlighting the 
secondary neuroinflammatory reaction as pathophysiologically even more relevant than 
the initial insult (Heneka et al. 2015). But also less obvious immune activities associated 
with obesity and type 2 diabetes act as risk factors for AD (Granic et al. 2009, Jones et al. 
2009). Here, activated macrophages in the white fat tissue constantly secrete pro-
inflammatory cytokines. Type 2 diabetes and AD both are associated with desensitization 
of insulin receptors in the brain and might involve changes in BBB integrity. Therefore, 
both conditions lack neuroprotective properties of insulin independent of glucose 
utilization and feature alterations in BBB protection. 
Research on AD mouse models provides some hints for the involvement of immune 
activation in disease onset and progression. In the context of an additional activation of 
the innate immune system, some studies suggest a worsening of Aβ accumulation, tau 
pathology and even cognitive function in AD models upon peripheral immune stimulation 
with LPS (Qiao et al. 2001, Sheng et al. 2003, Lee et al. 2010, Valero et al. 2014). But 
also an enhanced clearance of Aβ plaques and improved AD pathology under pro-
inflammatory conditions were reported (DiCarlo et al. 2001, Michaud et al. 2012). 
Interestingly, the production of nitric oxide as inflammatory response was found to 
enhance Aβ aggregation. NO mediates post-translational nitrosylation of Aβ filaments 
promoting their aggregation (Kummer et al. 2011). Even more interesting, the genetic 
ablation of the NLRP3 inflammasome rescues the AD phenotype (Heneka et al. 2013). IL-
1β and IL-18 both are expressed as inactive pre-cursor forms pro-IL-1β and pro-IL-18 
respectively which require cleavage by the protease caspase-1 for activation and 
secretion as mature cytokines. The caspase-1 protein itself gets activated via cleavage by 
cytosolic multiprotein complexes called inflammasomes. The most prominent 
inflammasome is the NOD-like receptor family, pyrin domain containing 3 (NLRP3) in 
macrophages and microglia. NLRP3 expression is activated in parallel to pro-IL-1β and 
pro-IL-18 expression usually by PAMPs like LPS, but a second stimulus is necessary to 
promote NLRP3 oligomerization with the adaptor protein ASC (apoptosis-associated-
speck-like protein) which leads to autocatalytic cleavage of caspase-1 protease. Not only 
PAMPs but also amyloid-β aggregates are able to activate the NLRP3 inflammasome 
(Halle et al. 2008). It was shown that NLRP3 or ASC deficiency can indeed prevent AD 
related pathology in the APP/PS1 model (Heneka et al. 2013).  
As currently no cure or preventive method is available for AD, the observation that 
exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) decreases the risk to develop 
AD provided new hope. Most NSAIDs exhibit pain-killing, fever-reducing and anti-
inflammatory properties due to the inhibition of cyclooxygenase-1 (COX-1) and -2 (COX-2) 
and synthesis of prostaglandins and thromboxanes. Several clinical trials with different 
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NSAIDs identified the respective component, duration of treatment and the age of patients 
as critical for success. However, trials designed to preventively inhibit brain inflammation 
in AD patients have failed which again brings up the question if inflammation is purely 
detrimental in neurodegenerative disease or may also promote clearance of aggregated 
protein and cell debris.  
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1.10. Aim of study 
 
Inflammation, the response of the innate immune system to danger signals, can not only 
occur in the periphery but also in the central nervous system. Here, processes and 
molecules associated with the immune response can have protective as well as 
detrimental effects. Also an acute inflammation in the periphery exclusive of brain invasion 
can negatively affect neuronal morphology, plasticity and learning behavior in rodents. 
 
To gain knowledge about the influences of the immune system long after or in the chronic 
phase of an infection or immune stimulation, the focus of the presented study was divided 
into the following aspects: 
 
1) Different types of lipopolysaccharide as well as peptidoglycan and lipoteichoic acid 
were applied to examine whether distinct immune-stimulatory components differ in their 
ability to influence neuronal structure and function in the mice CNS. 
 
2) Adult and old mice were used to address a possible age-dependent vulnerability 
towards a peripheral immune stimulation. 
 
3) The APP/PS1 mouse model of Alzheimer´s disease was deployed for a systemic 
immune stimulation to investigate whether the genetically induced neurodegeneration in 
this model is further driven by the peripheral immune system. 
 
4) The NLRP3 KO mouse model was used to analyze the involvement of the NLRP3 
inflammasome in effects of a long-term immune stimulation on neuronal structure and 
function. 
 
5) The parasite Toxoplasma gondii was taken as a model of chronic CNS infection to 
compare effects of a peripheral immune activation with an infection also spreading into the 
brain.  
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2. MATERIAL AND METHODS 
 
2.1. Material 
 
2.1.1. Chemicals 
 
All chemicals used in this thesis were obtained from AppliChem, Invitrogen, PAA, Roth or 
Sigma. Exceptions were mentioned respectively. 
 
 
2.1.2. Immune stimulatory reagents 
 
Table 1: Bacterial cell wall components used for peripheral immune stimulations 
reagent description dose 
Lipopolysaccharide, Salmonella 
enterica serogroup typhimurium 
Sigma Aldrich, product No. 
L6511  
2 x 0.2 µg/g 
bodyweight 
Lipopolysaccharide, Escherichia coli 
O127:B8 
Sigma Aldrich, product No.  
L3129  
2 x 0.2 µg/g 
bodyweight 
Peptidoglycan, Staphylococcus  
aureus   
Sigma Aldrich, product No.  
77140  
2 x 0.5 µg/g 
bodyweight 
Lipoteichoic acid, Staphylococcus  
aureus   
Sigma Aldrich, product No. 
L2515 
2 x 0.5 µg/g 
bodyweight 
 
 
2.1.3. Buffers and solutions 
 
10 x PBS, pH 7.3  
NaCl 1.37 M  
KCl 0.027 M  
KH2PO4 0.015 M  
Na2HPO4 0.08 M pH 7.3 
 
 
ACSF, pH 7.4  
NaCl 124 mM  
KCl 4.9 mM 
MgSO4 7H2O 2 mM 
CaCl2 2H2O 2 mM 
NaHCO3 25.6 mM 
D+ Glucose (water free) 10 mM 
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DNA lysis buffer  
Tris/HCl pH 8.5 100 mM  
NaCl 200 mM 
EDTA 5 mM 
SDS 0.2% 
Proteinase K 100 µg/ml (stock solution 1 mg/ml) 
 
 
Blocking solution for 
immunohistochemistry  
 
Triton X-100 0.2% 
Goat serum 10 % 
BSA 1% 
in PBS  
 
 
2.1.4. Antibodies 
 
Table 2 | Primary and secondary antibodies for immunohistochemical experiments 
Immunohistochemisty 
antibody description manufacturer dilution  
anti - GFAP mouse monoclonal  
product number G 3893 
 
Sigma-Aldrich 
 
1:1000 
anti - IL-1b rabbit polyclonal 
catalogue number AB9722 
charge 083M4785 
 
Abcam 1:250 
anti - TNF-a rabbit polyclonal 
catalogue number R4-6A2 
 
Thermo Scientific 
 
1:250 
/1:500 
anti - IBA 1 rabbit polyclonal 
catalogue number 234003 
 
Synaptic Systems 
 
1:1000 
anti – CD11b  
 
rat monoclonal 
catalogue number AB-N05 
  
Advanced Targeting 
Systems 
1:500 
anti – rabbit Cy2 goat polyclonal  
product number 111-225-144 
charge 81780 
 
Jackson Immuno 
Research 
Laboratories 
1:500 
anti – mouse Cy3 goat polyclonal 
product number 115-165-068 
charge 95966  
Jackson Immuno 
Research 
Laboratories 
1:500 
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2.1.5. Mouselines 
 
2.1.5.1. APP/PS1 transgenic mice 
 
The Alzheimer mouse model used in this thesis was the B6C3-Tg (APPswe, 
PSEN1dE9)85Dbo/Mmjax on C57Bl/6 background of donating investigator David 
Borchelt, McKnight Brain Institute, University of Florida (Borchelt et al. 1997). The mouse 
model includes two transgenes inserted at a single locus controlled by the mouse prion 
protein promotor. One transgene encodes for the chimeric amyloid beta precursor protein 
(3 mouse aminoacids of the A-beta domain were replaced by the human sequence) with 
the Swedish mutation K595N/M596L (APPswe). The mutation is found in humans with 
familial cases of Alzheimer´s disease. The second transgene gives raise to mutated 
presenilin 1 protein. The “DeltaE9” mutation leads to deletion of exon 9, which is 
associated with the early-onset of Alzheimer´s disease. 
 
 
2.1.5.2. NLRP3 knockout mice 
 
NLPR3 knockout (KO) mice lack the NOD-like receptor family, pyrin domain containing 3 
inflammasome and therefore also lack IL-18 and IL-1β maturation. NLRP3 KO mice were 
provided by Michael T. Heneka, German Center for Neurodegenerative Diseases (DZNE) 
and Dept. of Neurology, Clinical Neuroscience, Bonn, Germany. Breeding, genotyping and 
the aging of these mice were realized at the DZNE. There, NLRP3-deficient animals 
(Millennium Pharmaceuticals) were backbred onto C57BL/6 mice genotype to more than 
99% C57BL/6, which was confirmed by microsatellite analysis. Aged mice were 
transported 2 weeks prior to the immune stimulation experiments to the animal facility of 
the TU Braunschweig.  
 
 
2.2. Methods 
 
2.2.1. Genotyping of APP/PS1 transgenic mice 
 
For the identification of transgene positive APP/PS1 mice, genotyping experiments were 
performed by Heike Kessler and Eva Saxinger. Genomic DNA was extracted from short 
tail pieces digested with 500 µl lysis buffer with proteinase K at 650 rpm and 55°C 
overnight. Genomic DNA was cleaned from cellular debris by centrifugation at 14.000 g 
for 10 minutes and precipitated with 500 µl isopropanol. The DNA pellet was washed once 
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with 70% ethanol. The DNA was stored at -20 °C in 20 mM Tris/ HCl (pH 8). Three µl of 
genomic DNA was used for one polymerase chain reaction (PCR, table 3 - 5) to detect the 
presence of the APPswe, PSEN1dE9 transgene. Results were obtained via agarose gel 
electrophoresis. 
 
Table 3 | PCR protocol for genotyping of APP/PS1 transgenic mice 
Reagent Volume 
ddH2O 37.6 µl 
10x PCR buffer 5 µl 
MgCl2 1.5 µl (50 mM) 
dNTPs 1 µl (5 mM) 
BACE HC69 0.2 µl (50 µM) 
BACE HC70 0.2 µl (50 µM) 
S36 0.1 µl (50 µM) 
237F 0.2 µl (50 µM) 
Antisense J 0.2 µl (50 µM) 
Taq polymerase 1 µl 
Genomic DNA 3 µl 
 
 
Table 4 | PCR program for genotyping of APP/PS1 transgenic mice 
Step Temperature Time 
First Denaturation 94°C 3 min 
Denaturation 94°C 30 sec 
Annealing 65°C 1 min 
Elongation 72°C 1 min 
Last Elongation 72°C 4 min 
Hold 4°C infinite 
 
 
Table 5 | Primer sequences for genotyping of APP/PS1 transgenic mice 
Primer Sequence 
BACE HC69 AGGCAGCTTTGTGGAGATGGTG 
BACE HC70 CGGGAAATGGAAAGGCTACTCC 
S36 CCGAGATCTCTGAAGTGAAGATGGATG 
237F CAGGTGGTGGAGCAAGATG 
Antisense J AGCCTAGACCACGAGAATGC 
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2.2.2. Immune stimulation with endotoxic bacterial cell wall components 
 
To stimulate the peripheral innate immunity in adult and aged mice, well characterized 
bacterial endotoxins were used. Prior to the immune stimulation, the mice were weighed 
and monitored daily for at least 4 days up to one week to acclimate to the balance and to 
daily handling. The bodyweight one day before injection was taken to calculate the 
necessary volume of the immune stimulatory component. For intraperitoneal 
administration 1 ml syringe with an 26 G x 1/2 ” 0.45 x 12 mm cannula with the 
appropriate volume of LPS Escherichia coli, LPS Salmonella typhimurium, PGN/LTA or 
0.9% NaCl (Table 1) was prepared. Therefore, 25 g of LPS-, PGN- or LTA-powder was 
diluted in 12.5 ml sterile 0.9% NaCl solution and stored as stock (concentration 2 mg/ml) 
at -20°C until use. The stock solutions of both LPS types were further diluted 1:10 with 
0.9% NaCl directly before use and given for 2 days at a concentration of 0.2 µg per g of 
bodyweight. The PGN and LTA stock were diluted 1:5 in sterile 0.9% NaCl to a 
concentration of 0.4 mg/ml. The same volume of PGN and LTA was used to prepare a 
solution with each 0.2 mg/ml per component. PGN/LTA was given for 2 days at a 
concentration of 0.5 µg/g bodyweight. The mice were weighed, fixed and the suitable 
volume was injected in the lower right body quadrant. The needle was pulled out slowly to 
avoid further injury. The leakage of fluid was controlled to make sure no internal organs 
were hit. 
On the second day of immune stimulation, the mice were weighed and put directly into a 
rodent restrainer (34 mm in diameter, Süd-Laborbedarf Gauting) to take a blood sample 
from the tail vein. Subsequently, the mice were fixed and the same dose of immune 
stimulatory component was administered as on day one. Again the lower right body 
quadrant was chosen for the injection. On the next 13 consecutive days the body weight 
and sickness behavior of the mice was documented. These procedures had been 
conducted in accordance with the applicable European and National regulations 
(Tierschutzgesetz) and approved by the responsible authority (Nds. Landesamt für 
Verbraucherschutz und Lebensmittelsicherheit; permit number: 33.9-42502-04-13/1106). 
 
 
2.2.3. Infections with Toxoplasma gondii  
 
The experiments concerning the chronic infections with the protozoan Toxoplasma gondii 
(T.gondii) were planned and performed by Dr. Alexandru Parlog and Dr. Ildiko Rita Dunay, 
Institute of Medical Microbiology, Otto-von-Guericke University Magdeburg. The infections 
with T.gondii were approved, according to German and European legislation by the 
Landesverwaltungsamt Halle (Sachsen-Anhalt, Germany, approval number IMMB/G/01-
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1089/11). Shortly, adult C57BL/6 female mice (8 weeks old, purchased from Janvier) were 
housed in standard lighting conditions (12:12 h light-dark cycle) and temperature (21-
23°C), 4 to 5 animals per cage, with food and water ad libitum. T. gondii cysts of the ME49 
type II strain were harvested from mice of NMRI strain, infected with T. gondii cysts 4 to 5 
months earlier. Brains were isolated from infected mice and dispersed in 1 ml sterile PBS 
by mechanical disruption of the tissue followed by several passages through needles with 
regressing diameter.  
Cysts were counted under a light microscope and the total number of cysts per brain was 
calculated. Three cysts were administered intraperitoneally in a total volume of 200 μl per 
mouse. Control (noninfected) mice received injections with sterile PBS. 
 
 
2.2.4. Perfusion of the mouse brain and preparation of fixed brain slices 
 
For the preparation of the brain slices, immune stimulated and control C57Bl/6 wildtype 
mice or APP/PS1 were sacrificed by CO2 asphyxiation. The mice were placed in an 
airtight container with CO2 fed in from a compressed gas cylinder. The animals were 
observed until all muscle activity and signs of life have been absent for at least 30 
seconds. Quickly the mouse was fixed on a plate and the body cavity was opened. After 
removing skin and muscles of the abdomen the thorax was opened. The right atrium of 
the heart was cut and a butterfly needle (0.5 x 13 mm G25) was inserted into the left 
ventricle. Via this needle about 30 ml of 4°C cold 4% PFA and 4% sucrose was directed 
into the blood circuit by force of gravity. After 10 minutes of perfusion, the mouse was 
rapidly decapitated. The skull was opened and the brain was removed. The cerebellum 
and the olfactory bulb were departed and the brain hemispheres were separated along 
their longitudinal axis with a razor blade. 
The brain hemispheres were incubated in 4% PFA with 4% sucrose at 4°C for 30 minutes 
and subsequently transferred into phosphate buffered saline. The brain hemispheres were 
cut into 400 µm thick transversal slices with a vibratome (VT 1000 S, Leica Microsystems, 
Germany). Therefore, the brain was embedded into 2% agar in phosphate buffered saline 
and glued onto the sample plate. The cutting was performed in a PBS filled buffer tray. 
The brain slices were collected in a PBS filled tissue culture plate. 
 
 
2.2.5. DiOlistic labeling of single neurons 
 
Hippocampal and cortical neurons from C57Bl/6 and APP/PS1 control and immune 
stimulated mice were labeled, 3 month post-stimulation using DiOlistics on fixed brain 
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slices. For the preparation of the DiI bullets, tungsten particles (50 mg; 1.7 µm in diameter; 
Bio-Rad) were spread on a glass slide and merged with 100 µl of dye solution prepared by 
dissolving 3 mg of lipophilic dye DiI (Invitrogen) in 100 µl of methylene-chloride (Sigma-
Aldrich). The dried dye-coated particles were removed from the glass slide, suspended in 
3 ml of distilled water, and sonicated. The dye solution was subsequently diluted 1:60, 
1:70 and 1:80 and used to coat the inside of a TEFZEL tubing (Bio-Rad). After drying the 
bullets were stored at room temperature (RT). Before labeling, 400 µm thick coronal 
sections of both hemispheres were post-fixed with 4% PFA and 4% sucrose in 0.1 M PB 
for 1 h. Slices were washed with PBS and transferred onto a tissue culture insert (Merk-
Millipore). Dye-coated particles were delivered to the brain slices using a hand-held gene 
gun (Bio-Rad; Helios Gene Gun System) with a pressure of 120 psi. A membrane filter (3 
µm; Millipore) was inserted between the gene gun and the slice to prevent clusters of 
large particles from landing on the tissue. After shooting, brain slices were kept in PBS for 
20 h at RT to allow dye diffusion. The consecutive day, slices were stained with DAPI-
solution 1:1000 for 10 min and mounted with an anti-fading water-based mounting 
medium (Biomeda). Because of a strong increase of the tissue back ground fluorescence 
neurons of the hippocampus and cortex were imaged within one week after mounting to 
assure best image quality. 
 
 
2.2.6. Imaging and analysis of DiI stained neurons 
 
To examine the dendritic architecture as well as the spine density of the DiI stained 
hippocampal and cortical neurons, single neurons were first imaged with a 20x objective 
(0.8 N.A., Zeiss) with a z-sectioning of 1 µm.at an Axioplan 2 imaging microscope (Zeiss) 
equipped with an ApoTome module (Zeiss) to assess dendritic complexity. Afterwards, 
mid-apical and basal dendrites were imaged with a BX61WI FluoView 1000 (FV1000) 
Olympus confocal microscope. Image stacks with z-steps of 0.5 μm were acquired using a 
40x oil objective (NA1.3). The dendritic morphology was analyzed via tracing of the 
neuronal processes in three dimensions using the Neurolucida and Neuroexplorer 
software (MicroBrightField). The density of dendritic spines was determined by counting of 
spines with the multipoint tool on a stretch of dendrite defined with help of the segmented 
line in the ImageJ program (US National Institutes of Health). Data were calculated as 
mean ± SEM and compared to control conditions with an unpaired two-tailed Student's t-
test. P values of less than 0.05 were considered significant and plotted as follows: * = p < 
0.05; ** = p < 0.01; *** = p < 0.001. 
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2.2.7. Immunohistochemical analysis of immune response in the central nervous 
system 
 
To characterize the phenotype of CNS cells involved in innate immune response, 
astrocytes and microglia were stained in an immunohistochemical approach. Therefore, 
400 µm thick fixed brain slices were dehydrated in 30% sucrose in 0.1 M PB. After slices 
were sunken to the ground, they were frozen in Tissue-Tek® O.C.T.™ compound 
(A.Hartenstein Laborversand) on a freezing microtome and cut into 30 µm thick slices. 
The brain slices were incubated in blocking solution for 1 h RT. Slices were incubated with 
the primary antibody diluted in 0.2% Triton X-100 and 10% goat serum at 4°C covered in 
plastic wrap on a shaker overnight. After washing with 1 x PBS, slices were incubated with 
the secondary antibody diluted in 1x PBS for 2 h at RT. Cell bodies were stained with 
DAPI-solution 1:1000 for 5 min. Slices were mounted with an anti-fading water-based 
mounting medium (Biomeda). Images of the stratum radiatum within the CA1 area of the 
hippocampus were taken with a 20x objective (0.8 N.A., Zeiss) with a z-sectioning of 1 
µm.at an Axioplan 2 imaging microscope (Zeiss) and an ApoTome module (Zeiss). GFAP- 
and IBA-1 positive cells as well as primary processes of IBA-1 positive cells were counted 
in overlap with the DAPI signal with the help of the multipoint tool of ImageJ (US National 
Institutes of Health).Data were analyzed with Microsoft excel as mean ± SEM and 
compared between control and immune stimulated groups using an unpaired two-tailed 
Student's t-test. P values of less than 0.05 were considered significant and plotted as 
follows: * = p < 0.05; ** = p < 0.01; *** = p < 0.001. 
 
 
2.2.8. Preparation and incubation of hippocampal acute slices 
 
To assure cell survival, acute hippocampal slices were prepared in 4°C cold ACSF. From 
a 10x ACSF stock solution 1 L of fresh ACSF was complemented with the respective 
amount of D+Glucose and NaHCO3. The ACSF was purged with carbogen (95% O2 and 
5% CO2) for 20 min prior to use. The interface chamber was washed with MilliQ-H2O for 
30 min and with ASCF for another 20 min with a flow rate of 0.79 ml per min and heated 
to 32°C.  
Mice were deeply anaesthetized by CO2 asphyxiation and quickly sacrificed by 
decapitation. The skull was opened, the brain was removed and rapidly put into 4°C cold 
carbogenated ACSF. First, the cerebellum as well as the olfactory bulb, prefrontal cortex 
and striatum were eliminated with a scalpel. Then, the hemispheres were separated and 
one was immediately put back into the cold ACSF. The hippocampus was prepared with 
two spatulas by gently removing the midbrain and thalamus. Thereon, the hippocampus 
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was disconnected from the cortex buy loosening the fimbria hippocampi and cleaned with 
cold ACSF before cutting. Therefore, the hippocampus was placed onto the tissue 
chopper plate in a 70° angel to the razor blade to maintain intra-hippocampal neuronal 
circuitry. 400 µm thick slices were cut and collected in cold ACSF with a brush. The slices 
were placed on a custom made nylon net into the interface brain slice chamber and keep 
under ACSF (pH 7.3, flow rate 0.7 ml per minute) bathing at 32°C, heated by a 
proportional temperature controller (PTC) (Scientific System Design). The slices were 
incubated under these conditions for 2 h prior to the electrophysiological measurements to 
assure metabolic recovery.  
 
 
2.2.9. Electrophysiological recordings 
 
Recordings of field excitatory postsynaptic potentials (fEPSPs) were performed on 
hippocampal acute slices in an interface brain slice chamber (Scientific System Design). 
After an incubation time of 2h at 32°C under constant carbogenated ACSF flow at 0.7 
ml/min in the interface chamber, two stimulating and one recording electrode were placed 
in the hippocampal acute slice (figure 2.1A). Therefore, one stainless-steel recording 
electrode (5 MΩ; AM-Systems) was placed at 100 µm depth in the stratum radiatum of the 
CA1 region of the slice. Two monopolar lacquer-coated, stainless-steel electrodes (5 MΩ; 
AM-Systems) were positioned in this region of apical CA1 dendrites to each side of the 
recording electrode to allow stimulation of two independent populations of Schaffer 
collateral axons. Later, one stimulating electrode was used to evoke LTP, one served as 
control pathway. After an initial fEPSP could be detected with both stimulating electrodes, 
the slices were incubated for another 20 minutes in the previous mentioned conditions. 
 
 
2.2.9.1. Input-Output curve 
 
To identify the basal synaptic transmission properties for each channel, an input-output 
relationship between the given stimulus intensity in µA was correlated to the evoked 
fEPSP slope as indicator for synaptic output of a certain population of CA1 neurons. 
fEPSPs were recorded at 100 to 600 µA stimulus intensity in intervals of 50 µA. The 
maximal size of the fEPSP slope was measured and 40% there from was calculated for 
the further electrophysiological experiments. For this, the steepest fEPSP slope without 
dominant population spike as impurification of the maximal fEPSP slope at high stimulus 
intensities was set as maximum (figure 2.1B). Basal synaptic transmission values were 
indicated as mean ± SEM and the different experimental conditions were only compared 
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to controls within the same set of experiments using an unpaired two-tailed Student's t-
test. Asterisks show levels of significance as follows: * = p < 0.05; ** = p < 0.01; *** = p < 
0.001. 
 
 
2.2.9.2. Paired pulse facilitation 
 
Paired pulse facilitation (PPF) describes the characteristic increase of the EPSP, 
population spike and unitary firing of a second response if an afferent pathway is 
electrically stimulated twice in rapid chronology (Fujita and Sakata 1962, Lømo 1971 b; 
Bliss and Gardner-Medwin 1973). PPF can be evoked as the small increase in the 
presynaptic calcium concentration at the first stimulus increases the probability for an 
action potential upon the second stimulus (reviewed by Zucker, 1989), providing that the 
transmitter pool is not exhausted by previous release (Debanne et al. 1996). In the 
present study, PPF ratio of the second over the first fEPSP slope was measured at 40% 
of the maximum fEPSP slope calculated during the input-output experiments. The two 
stimuli were given in an increasing inter-stimulus interval (ISI) from 10 ms, 20 ms, 40 ms, 
60 ms, 80 ms and 100 ms. PPF values were calculated as mean ± SEM and compared to 
control conditions via an unpaired two-tailed Student's t-test. P values of less than 0.05 
were considered significant and plotted as follows: * = p < 0.05; ** = p < 0.01; *** = p < 
0.001. 
 
 
2.2.9.3. Long-term potentiation 
 
Long-term potentiation (LTP) as enduring enhancement of synaptic efficacy is believed to 
serve as cellular correlate for learning and memory processes (Bliss and Lømo 1973, 
Bliss and Gardner-Medwin 1973; Bliss and Collingridge 1993). Therefore, the 
investigation of long-term synaptic plasticity in the form of LTP was performed subsequent 
to the PPF as short-term plasticity experiments and the evaluation of the basal synaptic 
transmission for each hippocampal acute slice. After 20 minutes of baseline recordings at 
40% of the maximal fEPSP slope and with four 0.2 Hz biphasic, constant-current pulses 
(0.1 ms/polarity) per input channel at 0.003 Hz, LTP was induced via theta burst 
stimulation (TBS, figure 2.1c). The TBS, 10 trains of 4 pulses at 100 Hz with an inter-burst 
interval of 200 ms, applied 3 times in 10 s interval, was given with the beforehand 
calculated stimulus intensity and is considered as comparable to physiological changes 
during learning as it reflects naturally occurring firing patterns in the hippocampus of freely 
moving rats (Larson and Lynch 1986, Bland 1986). After induction, LTP was measured for 
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60 minutes and analyzed as [(fEPSP slope LTP / mean fEPSP slope baseline) * 100]. LTP 
was shown as mean ± SEM of fEPSP slope [%]. Values of immune stimulated mice were 
compared to controls using an unpaired two two-tailed Student's t-test. Levels of 
significances were plotted as follows: * = p < 0.05; ** = p < 0.01; *** = p < 0.001. 
 
 
Figure 2.1 | Schematic illustration of the field excitatory postsynaptic potential recorded in the CA1 
area of a hippocampal acute slice and theta burst protocol for recordings of long-term potentiation. 
(A) Transversal hippocampal acute slice with positioning of one stimulating electrode and one recording 
electrode in the stratum radiatum sublayer of CA1 area, adapted from Kim and Diamond 2002. (B) Scheme of 
an exemplary fEPSP signal, fEPSP slope measurement (left) and population spike as criterion of exclusion 
(right) indicated. (C) Theta burst stimulation (TBS) protocol. 
 
 
2.2.10. Morris water maze navigation task 
 
For the analysis of spatial learning in rodents the water maze of Richard Morris was used 
(Morris 1981, 1984). The Morris water maze pool with 160 cm in diameter was filled with 
water at 21 ± 1°C colored opaque with non-toxic white paint (Titanoxid, Euro OTC 
Pharma) and a white platform was hidden 1 cm under the water surface in the northwest 
quadrant of the maze in 38 cm distance to the pool wall. Different black and white visual 
cues (circle, triangle, 4 vertical stripes) were provided an average distance of 30 cm to the 
maze.  
Mice were handled 2 weeks prior to the task for a few minutes every day. The mice were 
kept on a 12h light/dark cycle with ad libitum access to water and food. The training was 
performed during the light phase of the day. To assess swimming and visual abilities of 
the animals, a pre-training of 3 days with a cued platform was performed. The mice were 
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pre-exposed to the platform at 2 trails per day of maximal 45 s. Mice were either placed 
on the platform or allowed to stay there for 10 s at the end of each trail. The platform 
position was changed for every trail and the mice were put into the maze on the opposite 
side of the pool. Mice were trained for 8 consecutive days with 4 trails at a 5 min intertrail 
interval. Each trail lasted maximum 60 sec and the mice were placed or allowed to stay on 
the platform for another 15 sec. Entrance into the pool occurred at 4 different position 
(Northeast, East, South, Southeast, Fig. 2.2) per day.  
The mice were tracked with a camera in the ceiling and for each learning day the escape 
latency, the moved distance and the used search strategies were analyzed. To access 
memory formation the mice were tested in a probe trail without the hidden platform on day 
3 and day 9 of the training. The time spent in the target quadrant as well as the crossings 
of the former platform position were quantified. 
Search strategies were divided into hippocampus-dependent and –independent strategies 
according to the time spent at the edge of the pool, the annulus zone or the goal corridor 
as described by Garthe et al. 2009 (Fig. 2.2.). Hippocampus-independent strategies were 
random search (> 60 % surface coverage), scanning (< 60 % and > 10 % surface 
coverage) and chaining (> 80 % in the annulus zone). Hippocampus-dependent strategies 
contained directed search (> 80 % time in 40° goal corridor), focal search (<0.3 x radius to 
mean distance to the platform, <0.35 x radius to mean distance to swim path centroid) and 
direct swimming (> 90 % in 10° goal corridor). To access memory formation the mice were 
tested in a probe trail without the hidden platform on day 3 and day 9 of the training. The 
time spent in the target quadrant as well as the crossings of the former platform position 
were quantified.  
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Figure 2.2 | Schematic illustration of the Morris water maze (MWM) arena used for the analysis of 
spatial learning and memory subclassified in different zones of the arena used for the division into 
distinct search strategies. (A) MWM arena, hidden platform indicated in the north west quadrant of the 
maze. Black symbols in the north, west and east serve as visual cues for the animals, starting position of the 
mice during the training and probe trail (PT) visualized as gray arrows. (B) MWM arena divided into the four 
quadrants, the annulus zone and goal corridor. (C) Hippocampus-independent (random search, scanning and 
chaining) and hippocampus-dependent strategies (directed search, focal search and direct swimming) 
according to the time spent in the respective area of the MWM arena, adapted from Garthe et al. 2009. 
 
 
For the Morris water maze experiments, the one way variance ANOVA was used to 
calculate statistical significance. The search strategy analysis was carried out with using 
2-way repeated ANOVA followed by a non-parametric Mann–Whitney U-test. Values of p 
< 0.05 were considered statistically significant (* =p < 0.05) p-values lower than 0.01 are 
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describes as highly significant (** = p < 0.01; *** = p < 0.001). All data presented in this 
study are shown as mean ± standard error of the mean (SEM). 
 
 
2.19 Statistical analysis 
 
All the statistical analyses were performed with Microsoft Excel, Graphpad Prism 5 
(Graphpad software) or SPSS (IBM Statistics). A two-tailed student´s t-test was chosen 
whenever two groups, genotypes, treatments or experimental conditions were compared. 
This was also the case, when two different treatments were depicted in one graph or 
figure a comparison was only drawn between the treated and control group, but not the 
treated groups among themselves as they were considered not dependent on each other.  
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3. RESULTS 
 
3.1. Long-term effects of an immune stimulation with different kinds of LPS  
 
Sepsis and septic shock as systemic inflammatory response to infection go along with 
activation of macrophages and massive secretion of pro-inflammatory cytokines like IL-18, 
IL-6, IL-1β and TNF-α (reviewed in Blackwell and Christman 1996). Symptoms like 
impairment in attention and memory, delirium and coma can occur and are summarized 
as septic or sepsis-induced encephalopathy (Pine et al. 1983, Sprung et al. 1990, Wilson 
and Young 2003). In the rodent model of peripheral LPS injections, the acute 
consequences of the peripheral LPS administration range from impairment in long-term 
potentiation (Commins et al. 2001, Jo et al. 2001, Hennigan et al. 2007, Strehl et al. 2014) 
to deficits in learning and memory (Arai et al. 2001, Shaw et al. 2001, Sparkman et al. 
2005). However, long-term influences of a peripheral immune activation have not been 
satisfyingly addressed so far. In addition to this, also factors like age and the innate 
immune activation as facilitator of neurodegenerative disease have not been adequately 
taken into account. Therefore, to investigate the long-term influences of a systemic 
immune stimulation on neuronal morphology and function, the peripheral immune system 
of young adult and old C57Bl/6 mice or transgenic APP/PS1 C57Bl/6J mice was activated 
via intraperitoneal injection of either Escherichia coli or Salmonella enterica serovar 
typhimurium lipopolysaccharide. In treated mice, 0.2 µg of LPS were given on two 
consecutive days, while control mice received injections with an equal volume of 0.9% 
sterile saline (vehicle). The body weight of all animals was controlled over the first two 
weeks after the immune stimulation to establish the successful injection and subsequent 
recovery of all immune stimulated mice. Body weight loss of rodents can be correlated to 
pathogen burden and cytokine release for many infectious diseases as well as to sepsis 
(Breuillé et al. 1993, Cooney et al. 1999) 
With both types of LPS, young immune stimulated WT mice showed a strong loss of body 
weight up to 15% in the first 2 days after beginning of the immune stimulation with 
subsequent recovery to about 95% of the initial body weight within another week (Fig. 
3.1A, LPS S.typhimurium, day 3: 84.92 ± 0.74 % of body weight from day 1, day 15: 95.31 
± 0.74 %; LPS E.coli, day 3: 86.57 ± 1.05 % body weight from day 1, day 15: 98,00 ± 0.73 
%). The stimulation with LPS of S.typhimurium resulted in a slightly stronger reduction in 
body weight. Control animals showed no change in body weight over the whole period of 
measurement (Fig. 3.1A, control, day 3: 99.39 ± 0.44 % body weight from day 1, day 15: 
101.1 ± 0.83 %). 
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Figure 3.1 | Body weight loss of young adult (4 months) and aged (16 months) C57Bl/6 WT mice during 
peripheral immune stimulation with E.coli or S.typhimurium lipopolysaccharide (LPS). Intraperitoneal 
injections of 0.2 μg/g body weight of LPS from Escherichia coli or Salmonella enterica serotype 
typhimurium were given for 2 consecutive days (0.4 µg/g body weight in total). Control mice received 
the injection of the vehicle, sterile 0.9% NaCl solution. (A) Recovery curve of young adult mice 
documented the first two weeks during and after the immune stimulation. (B) Body weight loss of old mice as 
cause of the immune stimulation on the first two days, indicated in red, and subsequent recovery during the 
first 15 days. Data presented as mean ± SEM, n = number of animals. 
 
 
Also the 16 months old WT mice exhibited a rapid loss in body weight on day 2 and 3 of 
immune activation with both kinds of LPS. However, here the recovery started one day 
later and proceeded in a less steep fashion. Nevertheless, also the aged WT mice 
showed a gain of weight up to 95% of the starting body weight in the first two weeks of the 
experiment (Fig. 3.1B, LPS S.typhimurium, day 3: 86.7 ± 0.79 % of body weight from day 
1, day 15: 95.60 ± 0.87 %; LPS E.coli, day 3: 86.50 ± 0.91 % body weight from day 1, day 
15: 95.5 ± 1.17 %). The body weight of the old control mice remained constant over the 
examined 15 days (Fig. 3.1B, control, day 3: 97.9 ± 1.04 % body weight from day 1, day 
15: 98.8 ± 1.39 %). Altogether injections with both LPS of E.coli and S.typhimurium 
caused reproducible degree of bodyweight loss in all immune stimulated individuals 
independent of their age even though the body weight of the 16 months old group of mice 
showed a higher variation then the 4 months old cohort. 
 
 
3.1.1. Influence of LPS E.coli and LPS S.typhimurium on neuronal morphology in 
aged mice 
 
Systemic inflammation caused by peripheral administration of LPS is able to provoke 
neuroinflammation (Godbout et al. 2005, Qin et al. 2007), which causes morphological 
changes of cortical and hippocampal neurons (Milatovic et al. 2010), inhibits long-term 
potentiation (Vereker et al. 2000, Commins et al. 2001, Hennigan et al. 2007, Min et al. 
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2009, Strehl et al. 2014) and impairs cognitive function and spatial learning (Pugh et al. 
1998, Arai et al. 2001, Sparkman et al. 2005, Chen 2008) during or only shortly after 
application. 
However, the effect of an acute and systemic inflammation on neuronal morphology after 
the initial sickness behavior and immune activation is overcome has not been investigated 
so far. In this study, I focused on the architecture of excitatory neurons in different brain 
regions also known to be susceptible and involved in Alzheimer´s disease. Therefore, I 
analyzed dendritic complexity and spine density of cortex layer II/III pyramidal neurons as 
well as pyramidal neurons of the hippocampal CA1 area and the dentate gyrus granule 
cells. In cortex layer II/III neurons, the Sholl analysis of both, the apical and basal 
dendrites showed no changes in complexity upon immune stimulation with E.coli LPS 
(Fig. 3.2A) compared to control neurons.  
Also the spine density of basal and apical dendrites was only slightly reduced (Fig. 3.2B, 
3.2C, basal: control 1.614 ± 0.060 spines/µm dendrite, LPS E.coli 1.461 ± 0.091 
spines/µm, p = 0.1782; 3.2D, 3.2E, apical: control 1.864 ± 0.063 spines/µm dendrite, LPS 
E.coli 1.690 ± 0.062 spines/µm, p = 0.0626). Three months after the stimulation with LPS 
from S.typhimurium however, there was a slight decrease in the number of intersections 
of cortex LII/III apical dendrites and significant reduction in the complexity of proximal 
basal dendrites at a 20 and 30 µm distance from the cell body (Fig. 3.2A). In addition, both 
the apical and basal compartment exhibited a significantly lower number of dendritic 
spines per µm than seen in control animals (Fig. 3.2B, 3.2C, basal: control 1.614 ± 0.060 
spines/µm dendrite, LPS S.typhimurium 1.303 ± 0.100 spines/µm, p = 0.0121; 3.2D, 3.2E, 
apical: control 1.864 ± 0.063 spines/µm dendrite, LPS S.typhimurium 1.487 ± 0.114 
spines/µm, p = 0.0096). 
Also the basal and apical compartments of CA1 pyramidal neurons were analyzed 
separately. Again, the treatment with E.coli LPS had no effect on basal dendritic 
complexity after 3 months incubation, but in contrast a significant reduction of 
intersections in the Sholl analysis of the apical dendritic tree was revealed between 60 
and 110 µm from the soma (Fig 3.2F). While the spine density of the basal CA1 dendrites 
was not altered, the mid-apical dendrites have fewer spines per dendrite in comparison to 
control neurons (Fig 3.2I, 3.2J, control: 2.025 ± 0.06 spines/µm dendrite, LPS E.coli: 1.849 
± 0.049 spines/µm, p = 0.0303). 
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Figure 3.2 | Long-term effects of an immune stimulation with lipopolysaccharide from Escherichia coli 
or Salmonella typhimurium on dendritic morphology and spine density of hippocampal and cortical 
neurons in 19 months old C57Bl/6 mice. (A) Exemplified tracings and Sholl analysis of cortical layer II/III 
neurons. (B, D) Confocal microscopic images from basal and apical cortex LII/III dendrites. (C, E) Spine 
density of basal and apical dendrites from cortex LII/III pyramidal neurons. (F) Dendritic complexity of CA1 
pyramidal neurons of immune stimulated and control mice, (G, H) Confocal image of basal CA1 dendrites and 
respective spine density. (I, J) Exemplified confocal images of CA1 apical dendrites and quantification of the 
spine density. (K) Sholl analysis of dentate gyrus granule cells. (L, M) Spine density of granule cells from the 
dentate gyrus, confocal image. Data presented as mean ± SEM, n = number of neurons and dendrites 
respectively, scale bar of tracings 100 μm, scale bar confocal microscopic images 10 µm, * = p < 0.05; ** = p < 
0.01. 
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The treatment with LPS from S.typhimurium resulted in a slight reduction in the number of 
proximal apical dendrites from CA1 pyramidal neurons and in a highly significant reduction 
in the proximal basal ones at a 30 and 40 µm distance from the cell body. The spine 
density was significantly lower in apical and basal CA1 dendrites after LPS S.typhimurium 
treatment if compared to control neurons (Fig. 3.2G, 3.2H, basal: control 1.906 ± 0.055 
spines/µm dendrite, LPS S.typhimurium 1.663 ± 0.069 spines/µm, p = 0.0104; 3.2I, 3.2J, 
apical: control 2.025 ± 0.060 spines/µm dendrite, LPS S.typhimurium 1.819 ± 0.063 
spines/µm, p = 0.0241).  
The granule cells of the dentate gyrus manifested a significant higher dendritic complexity 
3 months after stimulation with LPS of E.coli between 130 and 170 µm from the soma 
while the spine density was not altered (Fig. 3.2K, 3.2L, 3.2M, control: 2.093 ± 0.77 
spines/µm dendrite, LPS E.coli: 2.019 ± 0.080 spines/µm, p = 0.5057). In comparison, 
dendritic complexity of granule cells from LPS S.typhimurium treated animals was on 
control level (Fig. XK) and the spine density was only slightly reduced (Fig 3.2L, 3.2M, 
control: 2.093 ± 0.77 spines/µm dendrite, LPS S.typhimurium: 1.932 ± 0.045 spines/µm, p 
= 0.0845).  
Taken together, 3 months after an immune stimulation performed in old C57Bl/6 mice with 
two different types of LPS resulted, 3 months later in changes in dendritic complexity and 
spine density of different types of excitatory neurons. The treatment with LPS from 
Salmonella typhimurium caused more pronounced alterations. 
 
 
3.1.2. Effects of LPS E.coli and LPS S.typhimurium on synaptic plasticity in old 
mice 
 
Several studies showed the acute influences of a systemic immune stimulation on 
synaptic plasticity. For example, long-term potentiation was impaired 6 to 24 hours after 
treatment with E.coli LPS (Arai et al. 2001, Commins et al. 2001, Di Filippo et al. 2013, 
Strehl et al. 2014).  
In this study, short term as well as long-term plasticity was investigated in hippocampal 
acute slices of 19 months old C57Bl/6 mice 3 months after peripheral injection of either 
E.coli or S.typhimurium LPS. After 20 minutes of baseline recordings E-LTP was induced 
via TBS and recorded for 1 h. In control slices, it was possible to induce a stable LTP with 
a mean value of 139.4 ± 8.2 % for the last 10 minutes of recording (Fig 3.3A, 3.3B). 
Compared to the controls, no change could be observed for LTP in acute slices from 
E.coli LPS treated animals with a mean LTP of 146.2 ± 14.2 % for the last 10 minutes of 
recording. Interestingly however, the induction as well as the maintenance of LTP after 
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S.typhimurium LPS treatment was significantly impaired at all time points of the recording 
(Fig 3.3A, 3.3B, 119.0 ± 4.0 % for the last 3 time points of measurement, p = 0.02).  
To examine whether the defect in LTP induction and maintenance is caused by impaired 
basal synaptic transmission, the input-output properties of the Schaffer collateral pathway 
were addressed. Here, with increasing stimulus intensities also the negative fEPSP slope 
increased in all treatments. While there was a perfect overlap of input-output curves under 
control and LPS S.typhimurium treated conditions, surprisingly the slices of E.coli LPS 
treated animals showed significantly lower response at stimulus intensities of 200 to 600 
µA in comparison to controls (Fig 3.3C).  
 
 
 
Figure 3.3 | Short-term and long-term synaptic plasticity at the CA3-CA1 pathway in hippocampal 
acute slices of aged C57Bl/6 WT mice 3 months after peripheral immune stimulation with 
lipopolysaccharide (LPS) of Salmonella typhimurium or Escherichia coli. (A) Long-term potentiation 
induced via TBS after 20 minutes of stable baseline recordings. (B) Mean LTP value for the last 3 repeats. (C) 
Input-Output curve. (D) Presynaptic properties, paired pulse facilitation with increasing inter stimulus interval 
(ISI). All data shown as mean ± SEM; n = number of acute slices, * = p < 0.05; ** = p < 0.01 
 
 
With the help of the input-output relationship within a certain slice, 40% of the maximal 
fEPSP slope was calculated and the correlating stimulus intensity was adjusted for a 
second experiment, the paired pulse facilitation (PPF) to test whether a presynaptic defect 
is responsible for an altered LTP upon LPS S.typhimurium stimulation. Here, two pulses 
with increasing inter stimulus interval (ISI) were given and the slope of the second fEPSP 
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was compared to the first slope (fEPSP slope2/ fEPSP slope1). The PPF observed in 
slices derived from mice treated with both kinds of LPS was not distinguishable from the 
one in control slices (Fig 3.3D). 
In summary, treatment with LPS of S.typhimurium leaded 3 months later to a LTP defect 
which cannot be explained with impaired basal synaptic transmission or paired pulse 
facilitation. Upon immune stimulation with E.coli LPS only the basal synaptic transmission 
was altered. 
 
 
3.1.3. Influence of LPS E.coli and LPS S.typhimurium on learning behavior of aged 
mice 
 
As a decrease in neuronal complexity, spine density and LTP was observed in aged mice 
3 months after immune stimulation with S.typhimurium LPS, subsequently the Morris 
water maze navigation task was used to evaluate the behavioral consequences of the 
peripheral immune stimulation on spatial learning (Morris 1982, 1984). Sixteen months old 
C57Bl/6 mice were immune stimulated with intraperitoneal injections of 0.2 µg LPS of 
either E.coli or S.typhimurium per g body weight for 2 days for a total of 0.4 µg LPS per g 
body weight and tested in the Morris water maze navigation task at 19 months of age. 
After a pre-training period of 3 days, the mice were trained to locate the hidden platform in 
the northwest quadrant of the maze for 8 consecutive days. A probe trial experiment 
without platform was performed on day 3 prior to the training session and on day 9 after 
the entire training period. Independently of the treatment, all mice managed to learn the 
position of the hidden platform as a progressive improvement in the escape latency was 
documented over the training time (Fig. 3.4A: Controls 32.8 ± 2.9 s (day 1), 8.0 ± 1.3 s 
(day 8), F(7,48)= 11.001 p < 0.001; LPS E.coli 38.6 ± 2.9 (day 1), 9.8 ± 1.2 (day 8), F(7,48) = 
9.310, p < 0.01 ; LPS S.typhimurium 33.2 ± 5.0 (day 1), 11.0 ± 1.6 (day 8), F(7,64) = 6.538, 
p < 0.01). Interestingly, even though the escape latencies decreased in both controls and 
LPS S.typhimurium about the same degree during the whole training, the immune 
stimulated mice took a significantly longer time to find the hidden platform on day 4 of the 
training period (Fig 3.4A, Controls 17.2 ± 3.5 s, LPS S.typhimurium treated 30.7 ± 4 s, p = 
0.0262) and show slightly elevated escape latencies also on day 5 and 6 of the training 
(Fig 3.4A). 
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Figure 3.4 | Peripherally immune stimulated mice challenged in the Morris water maze. Control, LPS 
E.coli and LPS S.typhimurium stimulated C57Bl/6 mice (19 months old) were trained in the Morris 
water maze arena with a submerged platform for 8 consecutive days with 4 trials per mouse and day. 
The escape latency, target quadrant preference of two probe trials on day 3 and 9 and the executed 
search strategies were analyzed. (A) Escape latency, mean values of 4 trials per mouse per day (B) Target 
quadrant preference in comparison to time spent in other quadrants on day 3 of the training. (C) Percent time 
spent in the target quadrant in comparison to the mean time spent in other quadrants without platform on day 
9. (D) Illustration and quantification of the six different search strategies random search, scanning, chaining, 
directed search, focal search and direct swimming as mean of 4 trials per mouse per day. (E) Quantification of 
the hippocampus-dependent search strategies for every single training day. All data shown as mean ± SEM, n 
= number of mice, * = p < 0.05. 
 
 
To test early memory formation during the Morris water maze, the first probe trial 
experiment was performed after two days of learning, on the third day of the training 
period. In absence of the hidden platform, control mice spent significantly more time in the 
target quadrant, when compared to the other quadrants (Fig 3.4B, controls: other 
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quadrants 24.1 ± 1.4 % vs. target quadrant 36.9 ± 4.6 %, p = 0.0199). Notably, LPS 
treated mice did not show this early target quadrant preference (Fig 3.4B). In the probe 
trial on day 9, all mice spent significantly more time in the target quadrant than in the other 
3 quadrants (Fig 3.4C, controls 53.5 ± 4.5 %, p = 0.0001; LPS E.coli 48.5 ± 3.4 %, p = 
0.0001; LPS S.typhimurium 52.6 ± 4.5 %, p = 0.0001). Here, a difference between the 
three groups is not perceptible. 
These data confirm the observation from the platform escape latencies, that LPS 
S.typhimurium treated animals show some deficits in memory formation or consolidation 
earlier during the training period (day 4 to day 6), but are undistinguishable from the 
controls during the last days of training (day 7 & 8) and complete the training session with 
a probe trial on control level.  
To investigate the quality of spatial learning during these critical days for the LPS 
S.typhimurium treated group and to emphasize possible differences in the learning 
behavior of the immune stimulated mice, the search strategies during the learning period 
were analyzed. For this purpose, the search tracks of each mouse and trial were 
analyzed. The quantification of the time spent in the middle of the pool, the outer regions, 
the annulus zone or the goal corridor (Fig. 2.2., Material and Methods chapter 2.2.10.), 
gives the opportunity to divide the search strategies used by the mice into hippocampus-
dependent or spatial learning, allocentric search strategies including focal search, directed 
search and direct swimming, with increasing accuracy and hippocampus-independent or 
non-spatial learning, egocentric strategies like chaining, scanning and random search 
(Fig. 3.4D, Garthe et al 2009, Garthe and Kempermann 2013). In control mice, random 
search and scanning progressively decreased over the 8 days of training. Chaining was 
only marginally used. These hippocampus-independent strategies decreased especially in 
favor of direct swimming, which increased from 3.6 ± 3.6 % (day 1) to 60.7 ± 13.2 % (day 
8). Also the LPS E.coli treated mice showed a steady decrease of random search and 
scanning. These mice however, applied chaining in about 6 % of all cases on every 
training day (Fig 3.4C). Also here, a dramatic increase of direct swimming from 3.6 ± 3.6 
% (day 1) to 42.9 ± 4.6 % (day 8) was visible. 
In the LPS S.typhimurium treated mice, from day 1 to day 5 of the training there was 
nearly no change in the proportion of the six evaluated search strategies. Only from day 6 
to day 8 of learning, random search and scanning were used less, but still to a higher 
extend then in control or LPS E.coli treated mice. The most precise search strategy, direct 
swimming, increased from 0.0 ± 0.0 % (day 1) to 30.6 ± 6.9 % (day 8) in Salmonella 
typhimurium LPS treated aged WT mice (Fig. 3.5A, day 7: controls 50.0 ± 12.2 %, LPS 
S.typhimurium 13.9 ± 4.4 %, p = 0.023). Altogether, the hippocampus-dependent 
strategies increased dramatically from 7.1 ± 4.6 % (day 1) to 82.1 ± 4.6 % (day 8) in 
controls (F(7,48)= 7.77, p = 0.0001) and substantially from 10.7 ± 5.1 % (day 1) to 64.3 ± 
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9.2 % (day 8) in LPS E.coli (F(7,48) = 7.333, p = 0.001), while LPS S.typhimurium treated 
mice showed a less pronounced increase from 11.1 ± 4.4 % (day 1) to 55.6 ± 10.8 % (day 
8) (F(7,64) = 4.610, p = 0.001). Even though the differences in the distribution of search 
strategies was not significant for a single training day, the observation that control mice 
used hippocampus-dependent strategies in about half of the trials in contrast to one fourth 
of HC-dependent strategies in LPS S.typhimurium treated mice is worth mentioning.  
In a second approach only the first trial of every mouse per day was analyzed. As mice 
were trained for 4 trials per day, a bad performance in the first trial speaking for impaired 
long-term memory could be balanced via the last 3 trials taking advantage of short term 
memory as well.  
 
 
 
Figure 3.5 | Search strategies in the Morris water maze applied by 19 months old C57Bl/6 mice 3 
months after peripheral immune stimulation with LPS of E.coli or LPS of S.typhimurium. Control (n = 
7), LPS E.coli (n = 7) and LPS S.typhimurium (n = 9) treated mice were trained in the Morris water maze 
arena with a submerged platform for 8 consecutive days with 4 trials per mouse and day. (A) Illustration 
of the 3 hippocampus-dependent search strategies directed search, focal search and direct swimming and 3 
hippocampus-independent random search, scanning and chaining. Quantification of search strategies of the 
first trial per mouse and day (B) Quantification of the hippocampus-dependent search strategies for every 
single training day, only the first trial was taken into account. All data shown as mean ± SEM. * = p < 0.05. 
 
 
In control mice, the search strategy proportions of only the first trial are highly comparable 
to the results from all 4 trials per day. Random search and scanning decreased 
progressively and from day 5, no random search was shown at all (Fig. 3.5A). Scanning 
was reduced to 28.6 ± 18.4 % for the days 6 to 8. Chaining was again only shown 
marginally. The hippocampus-dependent strategy directed search was not shown on day 
3 and 7 of the training, while focal search was not used at all. Direct swimming was 
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increased from 14.3 ± 14.3 % on day 3 to 57.1 ± 20.2 % on day 8 of the learning period 
(Fig 3.5A). In contrast to that, the LPS E.coli and S.typhimurium treated mice show a 
dramatically different pattern of search strategies. The LPS E.coli treated mice did not 
show hippocampus-dependent strategies on day 1, 2, 4 and 5 of the training. Even though 
random search was rapidly decreased, scanning was shown to a very high extent until 
day 6 of the learning period (Fig 3.5A, LPS E.coli, day 6: 71.4 ± 18.4 %). The 
implementation of the hippocampus-dependent strategies increased appreciable only from 
day 6 (28.6 ± 18.4 %) to day 8 (71.4 ± 18.4 %). The Salmonella LPS treated mice showed 
even less hippocampus-dependent learning (Fig 3.5A). In the first 5 days, only directed 
search was executed as hippocampus-dependent strategy with the highest amount on 
day 3 with 22.2 ± 14.7 %. Focal search and direct swimming were only used on day 8 of 
learning. Altogether, LPS S.typhimurium treated mice showed slightly less hippocampus-
dependent searching on day 5 (Fig 3.5B, controls: 42.9 ± 20.2 % vs. LPS S.typhimurium: 
0.0 ± 0.0 %, p = 0.055) and significantly less on day 6 (Fig 3.5B, controls: 71.4 ± 18.4 % 
vs. LPS S.typhimurium: 11.1 ± 11.1 %, p = 0.042).  
The analysis of the 1st trial resulted in even more pronounced effects, showing deficits in 
hippocampus-dependent spatial learning for LPS S.typhimurium treated aged WT mice. 
Amazingly however, they were identical to the control mice on the last day of training and 
finished the Morris water maze with a probe trial comparable to controls. One possible 
explanation for this learning impairment is the heavy production of pro-inflammatory 
cytokines by either brain resident microglia and astrocytes or invading immune cells. 
 
 
3.1.4. Quantification of glial immune response in the brain of old immune stimulated 
mice 
 
Even though some studies already suggest long lasting inflammatory events and 
enhanced classical activation of microglia and astrocytes happening in the brain of aged 
individuals upon a peripheral immune stimulation (Godbout et al., 2005; Barrientos et al., 
2009a), time courses longer than two weeks, have not been investigated so far. In the 
present study, I immunostained microglia and astrocytes in the hippocampus of 19 
months old C57Bl/6 mice 3 months after a peripheral immune stimulation with 
lipopolysaccharide of Escherichia coli or Salmonella enterica serovar typhimurium. For 
this purpose, hippocampi of immune stimulated and control mice were fixed, deep frozen 
and cut into 30 µm thick transversal slices. To visualize astrocytes in the tissue, an 
antibody against the glial fibrillary acidic protein (GFAP) was used. GFAP-positive cells 
were counted in a defined region of interest (ROI) and compared to the control samples, 
which were normalized to 1. The number of astrocytes quantified via GFAP staining, was 
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not elevated in the stratum radiatum of CA1 in hippocampi of immune stimulated mice 3 
months after incubation independent of the LPS component used (Fig 3.6B, controls: 1.00 
± 0.08 GFAP+ cells/ROI; LPS E.coli: 1.04 ± 0.07, p = 0.898; LPS S.typhimurium: 1.06 ± 
0.09, p = 0.6402). 
 
 
Figure 3.6 | Astrocyte and microglia phenotype of 19 months old C57Bl/6 mice 3 months after 
peripheral immune stimulation with lipopolysaccharide (LPS) of Escherichia coli or Salmonella 
typhimurium in 30 µm hippocampal transversal slices (A) Maximum intensity projection of staining of 
astrocytes and microglia/macrophages in the stratum radiatum of the CA1 area with primary antibodies 
against Glial fibrillary acidic protein (GFAP) and ionized calcium-binding adapter molecule 1 (IBA-1) 
respectively, scale bar large frame 100 µm, smaller detail 10 µm. (B) Quantification of GFAP
+
 cells, 
normalized to controls. (C) Number of microglia/macrophages of immune stimulated mice CA1 area compared 
to controls, n = number of ROIs analyzed (D) Number of primary branches of IBA1
+
 cells in control and 
immune stimulated aged WT mice, n = number of cells. All data are presented as mean ± SEM, * = p < 0.05; 
** = p < 0.01. 
 
 
The second cell type analyzed was the IBA1-positive cell population. IBA1 or ionized 
calcium-binding adapter molecule 1 is also known as allograft inflammatory factor 1 (AIF-
1). It is expressed on microglia and macrophages and up regulated upon inflammation.  
Counting of IBA-1-positive cells revealed a significant increase in the number of 
microglia/macrophages only upon stimulation with LPS from S.typhimurium, whereas 
there was only a slight increase with E.coli LPS (Fig 3.6C, controls: 1.00 ± 0.07 IBA1+ 
cells/ROI; LPS S.typhimurium: 1.21 ± 0.05, p = 0.0310; LPS E.coli: 1.15 ± 0.06, p = 
0.1119). 
  RESULTS | 51 
 
In a following approach, the number of primary microglia/macrophage branches was 
counted per IBA1-positive cell. In microglia, a very complex, branched structure indicates 
the resting housekeeping function, which is rapidly transformed into a macrophage like 
amoeboid structure upon proinflammatory activation (reviewed by Kettenmann 2011).  
The activation status of the microglia/macrophages quantified counting the number of 
primary branches of IBA-1-positive cells was altered in the hippocampi of aged mice with 
both types of LPS. The number of primary processes was significantly decreased upon 
immune stimulation with E.coli LPS (Fig 3.6D, controls: 7.33 ± 0.24 prim. processes/IBA1+ 
cell; LPS E.coli: 6.07 ± 0.40, p = 0.0200). The reduction of primary branches was even 
more pronounced and highly significant 3 months after the treatment with LPS from 
S.typhimurium (Fig 3.6D, controls: 7.33 ± 0.24 prim. processes/IBA1+ cell; LPS 
S.typhimurium: 5.79 ± 0.31, p = 0.0013). 
In summary, even though there was no astrogliosis detectable in hippocampi of aged 
mice, the microglia/macrophage phenotype indicates a pro-inflammatory activation even 3 
months after the immune stimulation with LPS of either E.coli or S.typhimurium with a 
more severe activation seen in the later. 
 
 
3.1.5. Influence of E.coli and S.typhimurium LPS on neuronal morphology in adult 
mice 
 
The analysis of neuronal structure and signaling revealed a sensitivity of aged mice 
towards a peripheral immune stimulation with LPS of S.typhimurium. To examine, whether 
also young adult mice show alterations in neuronal architecture as long-term 
consequence of a systemic immune stimulation, 4 months old C57Bl/6 mice were 
peripherally immune stimulated with lipopolysaccharide of either Escherichia coli or 
Salmonella enterica serovar typhimurium and 3 months after incubation neuronal 
architecture was analyzed using a DiOlistic approach.  
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Figure 3.7 | Dendritic architecture and spine density of hippocampal and cortical neurons 3 months 
after immune stimulation of 4 months old C57Bl/6 mice with LPS S.typhimurium or LPS E.coli. (A) 
Dendritic complexity of cortex layer II/III cells of immune stimulated and control mice, scale bar of exemplified 
tracing 100 μm. (B, C) Confocal microscopic image and density of basal cortex LII/III spines, scale bar 10 µm. 
(D, E) Spine density of cortex layer II/III cells upon immune stimulation, scale bar of DiI stained dendrites in 
confocal images 10 µm. (F) Dendritic morphology of CA1 hippocampal neurons, scale bar 100 μm (G, H) 
Spine density of basal CA1 dendrites, 10 µm scale bar of confocal images. (I, J) Apical CA1 dendrites, 
confocal microscopic images, scale bar 10 µm and quantified spine density. (K) Sholl analysis of dentate 
gyrus granule cells, scale bar of tracing 50 µm. (L, M) Spine density and exemplified image of granule cells, 
scale bar 10 µm. Data presented as mean ± SEM, n = number of neurons or dendrites respectively, * = p < 
0.05. 
 
 
Similarly to the experiments with aged mice, pyramidal neurons of the CA1 area and 
cortex layer II/III as well as dentate gyrus granule cells were examined. In the cortex layer 
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II/III, 3 months after immune stimulation with LPS of E.coli, the Sholl analysis revealed a 
dendritic complexity on control level for both apical and basal dendrites (Fig 3.7A). Also 
there was no change in spine density of either apical or basal dendrites (Fig 3.7B, 3.7C, 
basal: control 1.619 ± 0.064 spines/µm dendrite, LPS E.coli 1.673 ± 0.081 spines/µm, p = 
0.6010, 3.7D, 3.7E apical: control 1.692 ± 0.94 spines/µm dendrite, LPS E.coli 1.766 ± 
0.101 spines/µm, p = 0.6029). While the number of spines per µm apical or basal Cortex 
LII/III dendrites in S.typhimurium LPS treated mice was equal to the controls (Fig 3.7B, 
3.7C, basal: control 1.619 ± 0.064 spines/µm dendrite, LPS S.typhimurium 1.658 ± 0.093 
spines/µm, p = 0.7250, 3.7D, 3.7E apical: control 1.692 ± 0.94 spines/µm dendrite, LPS 
S.typhimurium 1.684 ± 0.064 spines/µm, p = 0.9395), the dendritic complexity was 
significantly elevated in the basal and proximal apical compartment, between 10 and 60 
µm and 20 and 60 µm from the soma respectively (Fig 3.7A).  
The Sholl analysis of the CA1 pyramidal neurons showed an almost perfect overlap for 
both LPS E.coli and S.typhimurium treatment (Fig 3.7F). Furthermore, the spine densities 
for apical and basal dendrites were on control level for both kinds of immune stimulation 
(Fig 3.7G, 3.7H, basal: control 1.825 ± 0.033 spines/µm dendrite, LPS E.coli 1.834 ± 
0.064 spines/µm, p = 0.8988; LPS S.typhimurium 1.796 ± 0.047 spines/µm, p = 0.6162; 
Fig 3.7I, 3.7J, apical: control 1.866 ± 0.34 spines/µm dendrite, LPS E.coli 1.900 ± 0.071 
spines/µm, p = 0.6692; LPS S.typhimurium 1.835 ± 0.041 spines/µm, p = 0.5589). 
In the dendritic complexity of the granule cells of the dentate gyrus, the treatment with 
S.typhimurium LPS caused a stronger increase in intersections, which was significant 
between 220 and 230 µm from the cell body, while the E.coli LPS treatment resulted in a 
complexity at control level (Fig 3.7K). The spine density of these granule cells was not 
affected by either treatment (Fig 3.7L, 3.7M, control 1.832 ± 0.034 spines/µm dendrite, 
LPS E.coli 1.775 ± 0.038 spines/µm, p = 0.2777; LPS S.typhimurium 1.832± 0.037 
spines/µm, p = 0.9957).  
Taken together, independently of the kind of LPS, the immune stimulation of young adult 
mice did not cause any detrimental long-term influences on neuronal structure. Due to this 
absence of a clear structural phenotype, the consequences for neuronal function or the 
spatial learning of younger mice were not addressed in this study. 
 
 
3.1.6. Comparison of the glial phenotype in young and old mice 
 
To investigate whether the glial immune response to a peripheral immune stimulation is as 
long lasting in adult as seen in aged mice, microglia and astrocytes were immunostained 
in the hippocampus of 7 months old C57Bl/6 mice 3 months after a peripheral immune 
stimulation with lipopolysaccharide of Escherichia coli or Salmonella enterica serogroup 
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typhimurium. The number of astrocytes in the stratum radiatum of CA1 in hippocampi of 
immune stimulated mice 3 months after incubation was not different from the one 
observed in control mice (Fig 3.8B, controls: 1.00 ± 0.10 GFAP+ cells/ROI; LPS E.coli: 
1.00 ± 0.08, p = 1.0000; LPS S.typhimurium: 0.98 ± 0.11, p = 0.9073). 
 
 
 
Figure 3.8 | Astrocyte and microglia phenotype of 7 months old C57Bl/6 mice 3 months after peripheral 
immune stimulation with LPS of Escherichia coli or Salmonella typhimurium in 30 µm hippocampal 
transversal slices (A) Quantification of astrocytes in the stratum radiatum of the CA1 area with primary 
antibodies against GFAP (Glial fibrillary acidic protein), normalized to controls, n = number of ROIs analyzed. 
(B) Number of microglia/macrophages of immune stimulated mice analyzed via IBA-1 (ionized calcium-binding 
adapter molecule 1) antibody staining in the CA1 area compared to controls, n = number of ROIs analyzed (C) 
Number of primary branches of IBA1
+
 cells in control and immune stimulated adult WT mice, n = number of 
cells. (D) Comparison of astrocyte numbers in 7 and 19 months old mice under control conditions via GFAP-
staining. (E) Number of microglia/macrophages of 7 and 19 months old control mice, n = # of ROIs. (F) 
Quantification of primary processes of IBA-1-positive cells in adult and aged controls, n = # of cells. All data 
are presented as mean ± SEM, *** = p < 0.001. 
 
 
Also the number of IBA-1-positive microglia/macrophages was not altered in adult mice 3 
months after immune stimulation when compared to the control conditions (Fig 3.8C, 
controls: 1.00 ± 0.05 IBA-1+ cells/ROI; LPS E.coli: 1.13 ± 0.10, p = 0.2788; LPS 
S.typhimurium: 1.00 ± 0.05, p = 0.9864). The activation of these immune cells was not 
different from controls in the CA1 area of young adult immune stimulated mice (Fig 3.8D, 
controls: 9.30 ± 0.34 prim. processes/IBA-1+ cell; LPS E.coli: 8.94 ± 0.96, p = 0.3764; LPS 
S.typhimurium: 8.93 ± 0.96, p = 0.3253). 
As the microglia/macrophage phenotype seen in old mice indicates a pro-inflammatory 
activation even 3 months after the immune stimulation with LPS, which was not visible in 
their young counterparts, the basal level of astrocytes and microglia was compared 
between young and old individuals. The number of astrocytes was only mildly reduced 
with age (Fig 3.8E, controls 7 months: 1.00 ± 0.10 GFAP+/ROI; controls 19 months: 0.95 ± 
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0.08, p = 0.7179), whereas the quantification of microglia showed a slight increase (Fig 
3.8F, controls 7 months: 1.00 ± 0.05 IBA-1+ cells/ROI; controls 19 months: 1.13 ± 0.16, p = 
0.1618). The pro-inflammatory activation of these microglia cells however, was heavily 
increased in old control mice seen in a highly significant reduction of primary microglia 
processes (Fig 3.8G, controls 7 months: 9.30 ± 0.34 primary processes/IBA-1+ cell; 
controls 19 months: 7.33 ± 0.24, p = 0.0002). This supports the hypothesis of an age-
dependent “primed status” of immune cells in the brain, which leads to a prolonged 
activation in response to a peripheral immune stimulation not seen in young mice. 
 
 
3.1.7. Changes in neuronal morphology upon LPS stimulation in aged APP/PS1 
mice 
 
In the context of an additional activation of the innate immune system in promoting the 
progression of Alzheimer´s disease, some studies suggest a worsening of Aβ 
accumulation, tau pathology and even cognitive function in AD models upon peripheral 
immune stimulation with LPS (Qiao et al. 2001, Sheng et al. 2003, Lee et al. 2010, Valero 
et al. 2014). Other studies report an enhanced clearance of Aβ plaques and improved AD 
pathology under pro-inflammatory conditions (DiCarlo et al. 2001, Michaud et al. 2012). 
However, time points longer than one month after immune stimulation and consequences 
for neuronal morphology and synapse loss were not examined and a short-term 
improvement or worsening cannot be excluded. In addition to that, all studies were 
performed with young adult mice and the influence of age was neglected so far. It was 
tempting to hypothesize, that the immune stimulation of old AD mice with a 
proinflammatory priming of the brain leads to an even more severe neurodegenerative 
phenotype than seen in WT mice with the same stimulation protocol. 
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Figure 3.9 | Effect of an immune stimulation with lipopolysaccharide (LPS) from E.coli or 
S.typhimurium on neuronal morphology in 19 months old APP/PS1 mice 3 months after 
treatment. (A) Dendritic complexity of cortex layer II/III neurons, 100 µm scale bar. (B, C) Basal 
dendritic spine density of cortical pyramidal neurons, confocal image scale bar 10 µm (D, E) Apical 
spine density of cortex LII/III cells, image scale bar 10 µm (F) Sholl analysis and exemplified tracing 
of CA1 pyramidal neurons, scale bar 100 µm. (G, H) Spine density of basal CA1 dendrites, scale 
bar 10 µm. (I, J) Spines/µm of mid-apical CA1 dendrites (K) Dendritic architecture of granule cells 
of the dentate gyrus. (L, M) Spine density of DG, scale bar 10 µm. Data presented as mean ± 
SEM, n = number of cell/dendrites, * = p < 0.05; ** = p < 0.01). 
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Therefore, I used LPS of Escherichia coli or Salmonella typhimurium to stimulate the 
peripheral immune system of 16 months old APP/PS1 mice. Three months later dendritic 
morphology and spine density were analyzed for hippocampal CA1 and dentate gyrus 
granule cells as well as cortex layer II/III neurons via Diolistics. Tracings of cortical 
neurons of the layer II and III showed no differences in dendritic complexity 3 months after 
the immune stimulation with either LPS from E.coli or S.typhimurium when compared to 
control cells of non-immune stimulated old APP/PS1 mice (Fig 3.9A). On the synaptic 
level, both types of LPS caused a significant decrease in spine density of basal dendrites 
(Fig 3.9B, 3.9C, control: 1.670 ± 0.082 spines/µm dendrite; LPS E.coli: 1.306 ± 0.069 
spines/µm, p = 0.0033; LPS S.typhimurium: 1.435 ± 0.058 spines/µm, p = 0.0262). But 
apical dendrites of Cortex LII/III cells only had lower numbers of spines per µm when the 
mice were treated with S.typhimurium LPS (Fig 3.9D, 3.9E, control: 1.667 ± 0.056 
spines/µm dendrite; LPS E.coli: 1.499 ± 0.079 spines/µm, p = 0.1058; LPS S.typhimurium: 
1.457 ± 0.063 spines/µm, p = 0.0244).  
In the CA1 area of the hippocampus, pyramidal neurons showed no change in dendritic 
complexity in the apical dendrites to both LPS treatments. In the basal compartment, LPS 
from E.coli and S.typhimurium caused a significant reduction in complexity in the close 
proximity to the soma. In the S.typhimurium LPS treatment however, a higher dendritic 
complexity is visible in the more distal part of the basal dendritic tree (Fig 3.9F). In 
contrast to the dendritic level, the more severe changes in spine density occurred in the 
apical dendritic tree of the CA1 pyramidal neurons. Here, the spine density was 
significantly reduced with both kinds of LPS when compared to control conditions (Fig 
3.9I, 3.9J, control: 2.038 ± 0.077 spines/µm dendrite; LPS E.coli: 1.716 ± 0.059 
spines/µm, p = 0.0030; LPS S.typhimurium: 1.636 ± 0.052 spines/µm, p = 0.0002). The 
basal dendritic spine density was significantly reduced only upon stimulation with LPS 
from E.coli in aged APP/PS1 mice (Fig 3.9G, 3.9H, control: 1.756 ± 0.056 spines/µm 
dendrite; LPS E.coli: 1.539 ± 0.067 spines/µm, p = 0.0238; LPS S.typhimurium: 1.736 ± 
0.076 spines/µm, p = 0.8424).  
The granule cells of the dentate gyrus exhibited a reduced number of intersections in the 
Sholl analysis upon treatment with either LPS from E.coli or S.typhimurium over the whole 
length of the dendritic tree, which was statistically significant for the E.coli treatment at a 
distance between 140 and 210 µm from the cell body (Fig 3.9K). The spine density of 
these cells was significantly reduced under both treatment conditions (Fig 3.9L, 3.9M, 
control: 1.851 ± 0.053 spines/µm dendrite; LPS E.coli: 1.672 ± 0.066 spines/µm, p = 
0.0485; LPS S.typhimurium: 1.565 ± 0.062 spines/µm, p = 0.0035). Taken together, both 
LPS types caused changes in the dendritic complexity and spine density of CA1 and 
Cortex pyramidal neurons and dentate gyrus granule cells in aged APP/PS1 mice with 
unequal pattern and degree. 
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3.1.8. Synaptic plasticity in aged APP/PS1 mice 3 months after stimulation with LPS 
 
The APP/PS1 mouse model for Alzheimer´s disease is characterized by an increasing Aβ 
plaque load starting with about 6 months of age which leads to neurodegenerative 
phenotype with neuronal death, synapse loss and learning and memory deficits. Also 
synaptic plasticity was investigated in this and other AD models. Studies showed that an 
elevation in aggregated Aβ causes impairment in LTP (Nalbantoglu et al. 1997, Chapman 
et al. 1999). This observation was also made for the APP/PS1 mouse model used in this 
study (Kummer et al. 2011, Heneka et al. 2013).  
 
 
Figure 3.10 | Changes in short-term and long-term synaptic plasticity in the hippocampus of 19 
months old APP/PS1 mice immune stimulated with lipopolysaccharide (LPS) of E.coli or 
S.typhimurium 3 months after the peripheral application. (A) Long-term potentiation at Schaffer Collateral 
pathway measured at stimulus intensity of 40% maximal fEPSP slope, LTP induction after 20 minutes of 
baseline recording via TBS (3 trains with 10 s interval of 10 bursts containing 4 pulses at 100 Hz with 200 ms 
interval), recording for 1 hour. (B) Mean LTP of the last 10 minutes of recording. (C) Input-Out-relationship, 
fEPSP slope measured in the CA1 area at increasing stimulus intensities. (D) Short-term synaptic plasticity, 
paired pulse facilitation at 40% of the maximal fEPSP slope. n = number of hippocampal acute slices, * = p < 
0.05; ** = p < 0.01. 
 
 
In the present study, the effect of a peripheral immune stimulation with LPS was examined 
in old APP/PS1 mice. Here, the morphological phenotype of CA1 and dentate gyrus 
neurons suggests also a functional consequence for the hippocampal circuitry. Therefore, 
basal synaptic transmission as well as short and long-term synaptic plasticity was 
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measured as mentioned above (Fig. 2.2.9., 3.1.2). After 20 minutes of stable baseline 
recordings LTP was successfully induced via TBS and maintained stable over 1 hour 
recording under all experimental conditions. When compared to control injection in 
APP/PS1 mice, the induction of LTP was significantly lower 3 months after treatment with 
both LPS from E.coli and from S.typhimurium (Fig 3.10A), which resulted in a highly 
significant reduction also in the stable phase of the LTP, here indicated as mean value of 
the last 10 minutes of recording (Fig 3.10B, control: 156.2 ± 8.6 fEPSP slope in % of 
baseline; LPS E.coli: 125.3 ± 5.1, p = 0.007; LPS S.typhimurium: 122.8 ± 6.2 %, p = 
0.009). Basal synaptic transmission was not altered in the LPS S.typhimurium treated 
group, but in slices from LPS E.coli treated old APP/PS1 mice the fEPSP slope was 
significantly higher than control signals at stimulus intensities between 200 and 600 µA 
(Fig 3.10C). The ratio of the second to the first fEPSP slope in the paired pulse facilitation 
paradigm was on control level with both types of LPS (Fig 3.10D), which indicates normal 
presynaptic function and ready releasable neurotransmitter pool despite the peripheral 
immune stimulation. 
Conclusively, a peripheral immune activation in old APP/PS1 mice led to impairment in 
LTP with normal presynaptic properties independent of the type of stimulatory LPS. So, in 
contrast to the aged WT mice, APP/PS1 mice were more vulnerable towards stimulation 
with E.coli LPS. As the formation of Aβ plaques starts already at 6 months of age, it was 
interesting to see whether also young adult APP/PS1 show detrimental effects of an 
innate immune activation while their age matched WT counterparts show no reduction in 
dendritic complexity or spine density 3 months after the immune stimulation (3.1.5). 
 
 
3.1.9. Neuronal architecture of young APP/PS1 mice 3 months after stimulation with 
LPS 
 
In this study, I saw detrimental effects of a peripheral immune stimulation with LPS on 
neuronal morphology and signaling in aged WT as well as APP/PS1 mice, but adult WT 
mice seemed unaffected. Therefore, I aimed to analyze the long-term effects of a 
peripheral immune stimulation with LPS on neuronal morphology in young adult APP/PS1 
mice to see whether neurodegeneration is enhanced upon pro-inflammatory conditions in 
the periphery.  
Young adult (4 months old) APP/PS1 mice were intraperitoneally injected with 0.4 µg/g 
bodyweight LPS of either Escherichia coli or Salmonella typhimurium. 3 months after 
incubation dendritic morphology and spine density of cortex layer II/III, CA1 and dentate 
gyrus cells were analyzed after neurons were stained with the fluorescent dye DiI. In the 
cortex layer II/III pyramidal neurons did not show any differences in dendritic complexity of 
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basal or apical dendrites with both types of LPS (Fig 3.11A). The spine density was not 
changed with LPS S.typhimurium either, but the LPS E.coli treatment caused a significant 
reduction in the spine number of basal and apical dendrites (Fig 3.11B, 3.11C basal: 
control 1.852 ± 0.080 spines/µm dendrite; LPS E.coli: 1.560 ± 0.059 spines/µm, p = 
0.0146; LPS S.typhimurium: 1.701 ±  0.052 spines/µm, p = 0.1277, Fig 3.11D, 3.11E 
apical: control 1.763 ± 0.076 spines/µm dendrite; LPS E.coli: 1.533 ± 0.063 spines/µm, p 
= 0.0394; LPS S.typhimurium: 1.706 ±  0.088 spines/µm, p = 0.6281). Also the dendritic 
complexity of the CA1 pyramidal neurons showed no significant differences upon immune 
stimulation with LPS of E.coli or S.typhimurium in young APP/PS1 mice (Fig 3.11F). Only 
the basal CA1 spine density was significantly reduced in the LPS S.typhimurium treated 
group (Fig 3.11G, 3.11H, basal: control 1.668 ± 0.055 spines/µm dendrite; LPS E.coli: 
1.721 ± 0.041 spines/µm, p = 0.4815; LPS S.typhimurium: 1.486 ±  0.041 spines/µm, p = 
0.0126), while the apical dendrites and the E.coli LPS treatment resulted in spine 
densities at control level (Fig 3.11I, 3.11J, apical: control 1.771 ± 0.029 spines/µm 
dendrite; LPS E.coli: 1.765 ± 0.032 spines/µm, p = 0.8999; LPS S.typhimurium: 1.756 ±  
0.045 spines/µm, p = 0.7753). The Sholl analysis of the granule cells from the dentate 
gyrus showed a perfect overlap in the LPS S.typhimurium and control treatment, while the 
neurons in the LPS E.coli treatment showed a shift in morphology with slightly higher 
numbers of intersections in the proximal and slightly less intersections in the distal part of 
the dendritic tree (Fig 3.11K). Here, the spine density was affected with both kinds of LPS. 
The LPS of E.coli caused a significant reduction in the spine density of dentate gyrus 
granule cells of young adult APP/PS1 mice 3 months after incubation and the LPS 
S.typhimurium caused an even stronger decrease (Fig 3.11L, 3.11M, control: 1.990 ± 
0.045 spines/µm dendrite, LPS E.coli: 1.825 ± 0.064 spines/µm, p = 0.0389; LPS 
S.typhimurium: 1.687 ± 0.075 spines/µm, p = 0.0019). 
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Figure 3.11 | Immune stimulation with lipopolysaccharide (LPS) from E.coli and S.typhimurium causes 
changes in neuronal morphology of hippocampal and cortical neurons in 19 months old APP/PS1 
mice 3 months after the treatment. (A) Dendritic complexity of cortex Layer II/III neurons, 100 µm scale bar. 
(B, C) Spine number per µm of basal dendrites, 10 µm scale bar in microscopic image (D, E) Apical spine 
density of neurons from cortex LII/III, confocal microscopic images, 10 µm scale bar (F) Sholl analysis and 
exemplified tracing of CA1 pyramidal neurons, scale bar 100 µm. (G, H) Spine density of basal CA1 dendrites, 
scale bar of confocal images 10 µm. (I, J) Number of spines per µm of mid-apical CA1 dendrites, scale bar 10 
µm in confocal images (K) Dendritic architecture of granule cells of the dentate gyrus. (L, M) Spine density of 
DG, scale bar 10 µm. Data presented as mean ± SEM, n = number of cells or dendrites respectively, * = p < 
0.05; ** = p < 0.01. 
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In summary, the changes in neuronal morphology in young APP/PS1 mice after immune 
stimulation with LPS were less dramatic than in the aged APP/PS1 mice but stronger than 
in the young adult WT counterparts suggesting a synergizing effect of amyloid β plaque 
deposition and an activation of the peripheral innate immunity in this AD mouse model. 
Functional consequences for the neuronal signaling or the learning behavior were not 
analyzed in the present study. 
 
 
3.1.10 Changes in neuronal architecture of aged NLRP3 knockout mice after 
peripheral immune stimulation 
 
It was shown that deficiency of the NLRP3 inflammasome and the maturation of IL-1β and 
IL-18 prevents neurodegeneration in the APP/PS1 mouse model of Alzheimer´s disease 
(Heneka et al. 2013). As impaired neuronal signaling and learning in aged C57Bl/6 WT 
mice were paralleled by an increase of microglia numbers and activation 3 months after 
immune stimulation with LPS S.typhimurium, the hypothesis that the absence of the 
NLRP3 inflammasome could also be beneficial in the context of a peripheral immune 
activation was addressed next. 
Therefore, 16 months old NLRP3 knockout (KO) mice were immune stimulated via 
peripheral administration of 0.4 µg LPS of S.typhimurium or control injected with saline. 
Three months later neuronal morphology and spine density were analyzed in cortex layer 
II/III, CA1 and dentate gyrus. And indeed, there was neither a change in the dendritic 
morphology (Fig. 3.12A) nor the spine density of basal (Fig 3.12B, 3.12C, basal: control 
1.425 ± 0.092 spines/µm dendrite; LPS S.typhimurium: 1.397 ±  0.086 spines/µm, p = 
0.8295) and apical dendrites (Fig 3.12D, 3.12E, apical: control 1.450 ± 0.048 spines/µm 
dendrite; LPS S.typhimurium: 1.434 ±  0.058 spines/µm, p = 0.8391) in cortex layer II/III 
upon immune stimulation of aged NLRP3 KO mice. Likewise, the dendritic architecture of 
CA1 neurons was not altered upon immune stimulation (Fig. 3.12F). In the basal 
compartment, even an increase in the number of intersections could be observed. In 
contrast to that, the spine density of basal CA1 dendrites was significantly reduced (Fig 
3.12G, 3.12H, basal: control 1.796 ± 0.050 spines/µm dendrite; LPS S.typhimurium: 1.597 
± 0.056 spines/µm, p = 0.0156). The spine density of apical dendrites was at control level 
(Fig 3.12I, 3.12J, apical: control 1.682 ± 0.057 spines/µm dendrite; LPS S.typhimurium: 
1.572 ± 0.065 spines/µm, p = 0.2194).  
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Figure 3.12 | Changes in neuronal morphology in 19 months old NLRP3 KO mice 3 months after 
immune stimulation with LPS of S.typhimurium. (A) Dendritic complexity of cortex layer II/III pyramidal 
neurons, tracing scale bar 100 μm. (B, D) Confocal fluorescent microscopic images of DiI stained cortical 
basal and apical dendrites, scale bar 10 μm. (C, E) Spine density of basal and apical cortex layer II/III 
dendrites, NLRP3KO controls vs. LPS S.typhimurium. (F) Sholl analysis of CA1 pyramidal, scale bar 100 μm. 
(G, H) Microscopic image and quantification of the spine density from CA1 basal dendrites. (I, J) Spine density 
and representative image of CA1 apical dendrites, scale bar 10 µm. (K) Dendritic architecture of dentate gyrus 
granule cells. (L, M) Confocal microscopic images and spine density of granule neurons of the dentate gyrus. 
Data presented as mean ± SEM, n = number of cells and number of dendrites, respectively, * = p < 0.05. 
 
 
In the dentate gyrus, after immune simulation in aged NLRP3 KO mice with LPS 
S.typhimurium the granule cells exhibited a similar dendritic architecture as the control 
64 | RESULTS   
 
cells (Fig. 3.12 K). Also the spine density was not altered here (Fig 3.12L, 3.12M: control 
1.688 ± 0.057 spines/µm dendrite; LPS S.typhimurium: 1.690 ± 0.050 spines/µm, p = 
0.9733).  
Taken together, it can be concluded, that NLRP3 inflammasome deficiency led to a partial 
rescue of the morphological degeneration observed in age matched WT mice. 
 
 
3.1.11 Synaptic plasticity of aged NLRP3 KO mice 3 months after stimulation with 
LPS 
 
It was found that a neurodegenerative phenotype in the morphology of CA1 neurons seen 
in AD mice could be rescued upon deletion of the NLRP3 inflammasome (Heneka et al. 
2013). Likewise, also impairment in cognitive function and synaptic plasticity could be 
prevented via NLRP3 or ASC deficiency (Heneka et al. 2013). In this study, NLRP3 KO 
mice showed a partial rescue of the detrimental effects on neuronal morphology seen 
upon immune stimulation in aged mice. It was hypothesized that the properties of synaptic 
plasticity could be at control level despite a peripheral immune stimulation as well. 
Therefore, 16 months old NLRP3 KO mice were immune stimulated via peripheral 
administration of 0.4 µg LPS of S.typhimurium or control injected with saline. Three 
months later hippocampal acute slices were prepared and synaptic plasticity was 
measured at the CA3-CA1 Schaffer-collateral pathway. After 20 minutes of baseline 
recordings LTP was induced via theta burst stimulation and recorded for another 60 
minutes. In both control and LPS S.typhimurium stimulated aged NLRP3 KO mice the 
potentiation was stable for the whole recording period (Fig. 3.13A). There was no change 
in the level of LTP in the last 10 minutes of recording between control and immune 
stimulated mice (Fig 3.13B, control: 132.9 ± 8.4 % fEPSP slope of baseline, LPS 
S.typhimurium: 129.3 ± 8.7 %, p = 0.621). Also the basal synaptic transmission within the 
CA3-CA1 pathway was not altered after immune stimulation with S.typhimurium LPS (Fig 
3.13C). The presynaptic properties were not affected either as there is no change in the 
paired pulse facilitation paradigm (Fig 3.13 D). Taken together, the deficiency of the 
NLRP3 inflammasome prevented detrimental effects on synaptic plasticity caused by 
peripheral immune stimulation with LPS of S.typhimurium as seen in this study with old 
WT animals.  
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Fig 3.13 | Long-term synaptic plasticity at Schaffer-collateral CA3-CA1 pathway in hippocampal acute 
slices of 19 months old NLRP3 KO mice 3 months after peripheral immune stimulation with 
lipopolysaccharide (LPS) from Salmonella enterica serogroup typhimurium. (A) Long-term potentiation 
(LTP) was induced via theta burst stimulation (10 bursts containing 4 pulses at 100 Hz at an inter burst interval 
of 200 ms, repeated 3 times with 10 s interval) after 20 minutes of baseline recording (B) Quantification of the 
last 10 minutes of LTP (C) Basal synaptic transmission measured as input-output relationship at increasing 
stimulus intensities (D) Presynaptic properties addressed in the paired pulse facilitation with increasing ISI = 
interstimulus intervals. All data shown as mean ± SEM, n = number of slices. 
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3.2. Peripheral immune stimulation with components of Gram positive 
bacteria  
 
Until the 1990s, sepsis was considered to be specific for Gram negative bacteria (Parrillo 
et al. 1990). Today, we know that most cases of sepsis are actually caused by Gram 
positive bacteria (Martin et al. 2003). In the present study, PGN and LTA as major 
endotoxic components of the Gram positive cell were given intraperitoneally at 
concentrations of 0.5 µg/g bodyweight each on two consecutive days. That made a total of 
1.0 µg/g body weight for each component. These relatively low doses were chosen to 
avoid a high rate of lethality in aged WT mice. The groups used for the Gram-positive 
immune stimulations were adult (4 months) WT and APP/PS1 and old (16 months) WT 
and APP/PS1 mice.  
 
 
Figure 3.14 | Body weight (BW) loss of young adult (4 months) and aged (16 months) C57Bl/6 WT mice 
during peripheral immune stimulation with peptidoglycan (PGN) and lipoteichoic acid (LTA) from 
Staphylococcus aureus. The immune stimulation with 1.0 µg/g BW was realized by intraperitoneal 
injection of 0.5 μg/g BW of each LTA and PGN for 2 consecutive days. Control animals received 
injections of sterile 0.9% NaCl solution. (A) BW of adult mice in % of starting weight during the first 15 days 
of immune stimulation (B) Body weight of old control and PGN/LTA stimulated mice during and two weeks 
after the immune stimulation. Data presented as mean ± SEM, n = number of mice. 
 
 
In comparison to control animals, neither the younger nor the old WT mice showed body 
weight loss after the application of the full dose PGN/LTA on day 3 of immune stimulation 
(Fig 3.14A, young adult mice, control: 99.39 ± 0.44 %, PGN/LTA: 99.15 ± 0.55 %; Fig 
3.14B, old mice, control: 97.86 ± 1.04 % body weight from day 1, PGN/LTA: 98.03 ± 0.81 
%). Also in the course of the following days, there was no change in the body weight loss 
of PGN/LTA treated or control mice until day 15 of the immune stimulation (Fig. 3.14A, 
day 15, control: 101.08 ± 0.81 % body weight from day 1, PGN/LTA: 100.07 ± 0.64 %). 
This indicated no dramatic inflammatory response in the initial phase of the immune 
stimulation. Certainly, the used doses were not comparable with a severe sepsis or septic 
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shock as seen for higher concentrations (De Kimpe et al. 1995) or with the classical LPS 
application, but a milder pro-inflammatory response cannot be excluded, since a 
correlation between Gram positive induced sepsis and body weight loss in rodents has not 
been described so far. 
 
 
3.2.1. Long-term effects of PGN/LTA from S.aureus on neuronal morphology in 
aged mice 
 
As in not many studies the Gram positive bacterial cell wall components peptidoglycan 
and lipoteichoic acid were used to provoke a stimulation of the innate immune system, 
even less is known about the influence of such an immune stimulation on the central 
nervous system. Here, for the first time I investigated the impact of a Gram positive 
peripheral immune stimulation on neuronal morphology of aged WT mice. Therefore, 16 
months old C57Bl/6 mice were intraperitoneally injected with 1 µg PGN and LTA per g 
body weight each. After 3 months of incubation single neurons in the cortex and 
hippocampus were labeled with the lipophilic fluorescent dye DiI. Tracings of cortex layer 
II/III neurons showed only a slightly reduced complexity in the apical dendrites whereas 
the basal dendritic tree was highly significantly less complex in PGN/LTA treated old WT 
mice compared to control neurons (Fig 3.15A). The spine density of basal as well as 
apical dendrites was highly significantly reduced upon PGN/LTA treatment in an 
analogous manner (Fig 3.15B, 3.15C basal: control 1.614 ± 0.06; PGN/LTA 1.166 ± 
0.099, p = 0.0001; Fig 3.15D, 3.15E apical: control 1.864 ± 0.063, PGN/LTA 1.364 ± 
0.080, p = 0.00007). CA1 neurons of the hippocampus reacted with a decrease in 
intersections in the proximal part of the apical dendritic tree, while basal dendrites were 
not affected (Fig 3.15F). In an opposite way, the spine density of CA1 pyramidal neurons 
was highly significantly reduced in the basal dendrites (Fig 3.15G, 3.15H control: 1.906 ± 
0.055, PGN/LTA: 1.647 ± 0.066 spines/µm dendrite, p = 0.0056), while apical dendrites 
showed only a slight reduction in the number of spines per µm dendrite (Fig 3.15I, 3.15J 
control: 2.025 ± 0.060, PGN/LTA: 1.874 ± 0.062 spines/µm dendrite, p = 0.0917). The 
dentate gyrus granule cells as second cell type evaluated in the hippocampus exhibited 
significantly more intersections between 140 and 170 µm from the soma (Fig 3.15K).  
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Figure 3.15 | Long-term effects of an immune stimulation with 1µg/g bodyweight peptidoglycan (PGN) 
and lipoteichoic acid (LTA) on dendritic morphology and spine density of hippocampal and cortical 
neurons of aged C57Bl/6 mice. (A) Sholl analysis of cortex layer II/III neurons. (B, D) Representative basal 
and apical dendrites of cortex layer II/III cells in control and treated mice. (C, E) Quantification of dendritic 
spine density in basal and mid-apical dendrites. (F) Number of intersections of apical and basal dendritic tree 
of hippocampal CA1 pyramidal neurons in relationship to the distance from the cell body. (G, H, I, J) Confocal 
images of CA1 apical and basal dendrites and the number of spines per µm of dendrite. (K) Sholl analysis of 
dentate gyrus granule cells of control and PGN/LTA treated old WT mice. (L, M) Confocal images and 
counting of dendritic spines of granule cells of the dentate gyrus in control and PGN/LTA treated animals. 
Data presented as mean ± SEM, scale bar tracings 100 µm, scale bar microscopic images 10 µm, n = number 
of cells/dendrites,  * = p < 0.05; ** = p < 0.01. 
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In contrast to that, the spine density was significantly reduced (Fig 3.15L, 3.14M control: 
2.093 ± 0.077, PGN/LTA: 1.812 ± 0.071 spines/µm dendrite, p = 0.0127), which indicates 
that the overall number of synapses might be stable in granule cells of the dentate.  
In summary, while cortical pyramidal neurons of old WT mice showed a severe reduction 
in dendritic complexity and spine density upon immune stimulation with PGN and LTA, the 
CA1 area showed a milder reduction of both criteria. The dentate gyrus granule cells were 
less sensitive towards the treatment with PGN/LTA. 
 
 
3.2.2. Enduring changes of PGN/LTA of S. aureus on synaptic plasticity in old mice 
 
In contrast to the wealth of experiments with Gram negative cell wall components as 
stimulator of the innate immune system, not as many were performed with peptidoglycan 
(PGN) and/or lipoteichoic acid (LTA) as major constituents of the Gram positive cell wall. 
The influence - whether acute or chronic - of the application of Gram positive endotoxins 
on synaptic plasticity in rodents has not been addressed at all.  
Here, I investigated whether a peripheral immune stimulation with an equal mixture of 
PGN and LTA can induce long-term changes in neuronal signaling the hippocampus in old 
WT mice. Therefore, 16 months old C57Bl/6 mice were injected with 0.5 µg of each LTA 
and PGN per g bodyweight for two days (1 µg/g bodyweight each in total). After 3 months 
of incubation, hippocampal acute slices were prepared and synaptic plasticity was 
measured at the CA3-CA1 Schaffer collateral pathway in an interface setup. TBS-induced 
LTP was measured for 1 hour after baseline recording. 
LTP was significantly lower in slices of PGN/LTA treated mice starting at 10 minutes after 
LTP induction and during the maintenance phase of the potentiation (Fig 3.16A). Hence, 
the mean LTP value of the stable phase was significantly reduced upon PGN/LTA 
treatment (Fig 3.16B, controls: 139.4 ± 8.2 fEPSP % of baseline, PGN/LTA: 121.0 ± 5.6 
%, p = 0.033). Basal synaptic transmission and the presynaptic properties addressed via 
paired pulse facilitation were similar in control and PGN/LTA treated old WT mice (Fig 
3.16C, 3.16D). Therefore, no obvious defect in the post- or presynaptic signaling 
accounted for a lower level of LTP in PGN/LTA treated aged WT mice 3 months after 
peripheral immune stimulation when compared to control slices. 
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Figure 3.16 | Long-term synaptic plasticity in hippocampal acute slices of aged C57Bl/6 mice 3 months 
after peripheral immune stimulation with lipoteichoic acid (LTA) and peptidoglycan (PGN) from 
Staphylococcus aureus. (A) Long-term potentiation, recorded 1 hour after induction via TBS and 20 minutes 
baseline recording. (B) Quantification of the last 30 minutes, the stable phase of LTP, control vs. PGN/LTA 
treatment (C) Basal synaptic transmission of PGN/LTA vs. control slices. (D) Paired pulse facilitation, ratio of 
the second over the first stimulus with increasing ISI = interstimulus interval, Data presented as mean ± SEM, 
n = number of acute slices, * = p < 0.05. 
 
 
3.2.3. Peptidoglycan/lipoteichoic acid treatment affects learning behavior of aged 
mice 
 
Even though peripheral administration of peptidoglycan and lipoteichoic acid did not cause 
bodyweight loss in aged WT mice, the dendritic complexity and spine density was 
negatively affected in different brain areas 3 months after. This most likely is the reason 
for a slightly impaired long-term potentiation in hippocampal acute slices of these animals. 
Therefore, it was interesting to see whether the structural and functional alterations in the 
hippocampus influence the hippocampus-dependent learning in the Morris water maze. 
Spatial learning was never addressed in mice immune stimulated with both PGN and LTA 
from Staphylococcus aureus. One study with adult mice induced meningitis via application 
of PCWs (pneumocoocal cell wall) of Streptococcus pneumoniae which of course 
contains both PGN and LTA as major constituent did not find any changes in the 
learning behavior of these mice in the Morris water maze (Hoffmann et al. 2007) . 
Only after induction of meningitis with living Streptococcus pneumoniae impaired 
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spatial learning and memory was documented (Wellmer et al. 2000). However, 
studies with aged mice have not been undertaken so far.  
Therefore, the performance of 19 months old C57Bl/6 mice treated by peripheral 
immune stimulation with 1µg PGN and LTA per g body weight at 16 months of age 
was analyzed in the Morris water maze. After a pre-training period of 3 days, the mice 
were trained for 8 consecutive days to find the submerged platform in the Morris water 
maze arena. A probe trial experiment was performed after 2 days and after 8 days of 
training. Controls and PGN/LTA treated mice managed to learn the position of the hidden 
platform as the documented escape latency decreased significantly during the training in 
both cases (Fig. 3.17A: controls 32.8 ± 2.9 s (day 1), 8.0 ± 1.3 s (day 8), F(7,48)= 11.001 p 
< 0.001; PGN/LTA 36.7 ± 3.6 (day 1), 10.2 ± 1.2 (day 8), F(7,64) = 13.765, p < 0.001).  
Even though there were no significant differences, PGN/LTA treated mice showed a 
slightly higher escape latency then control mice on day 7 of the training (Fig 3.17A, 
controls 7.3 ± 0.9 s, PGN/LTA treated 11.8 ± 0.9 s, p = 0.08871) and mildly elevated 
escape latencies also on day 4 and 6 of the training (Fig 3.17A). On day 3 and 9, after the 
second and eighth training session respectively, memory formation was tested in absence 
of the hidden platform. In these probe trial experiments, control mice spent significantly 
more time in the target quadrant, when compared to the other quadrants on day 3 (Fig 
3.17B, controls: other quadrants 24.1 ± 1.4 % vs. target quadrant 36.9 ± 4.6 %, p = 
0.01999) and day 9 (Fig 3.17C, controls: mean value of other quadrants 15.5 ± 1.5 % vs. 
target quadrant 53.5 ± 4.5 %, p < 0.0001). PGN/LTA treated mice showed a significant 
preference for the target quadrant on day 9 as well (Fig 3.17 C, PGN/LTA: 15.3 ± 2.2. s in 
other quadrants compared to 54.1 ± 6.7 s in the target quadrant, p < 0.0001). In the probe 
trial on day 3 however, PGN/LTA treated mice spent the time almost equally in all 4 virtual 
quadrants of the water maze pool (platform quadrant 31.7 ± 6.5 % vs. other quadrants 
26.1 ± 1.0 %, p = 0.40377).  
Although PGN/LTA treated mice were able to successfully complete the Morris water 
maze task similarly to controls, they showed a slightly impaired early memory formation. 
To evaluate whether this is due to a difference in the quality of the learning and the used 
search strategies during the learning period, the search tracks of each mouse and trial 
were analyzed. Here, the time spent in the middle of the pool, the outer regions, the 
annulus zone or the goal corridor were quantified (Fig 2.2). The search strategies were 
divided into hippocampus-dependent, allocentric search strategies including focal search, 
directed search and direct swimming, with increasing accuracy and hippocampus-
independent, egocentric strategies like chaining, scanning and random search (Fig. 
3.17D, Garthe et al 2009, Garthe and Kempermann 2013).  
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Figure 3.17 | Performance of 19 months old C57Bl/6 mice in the Morris water maze 3 months after 
peripheral immune stimulation with each 1 µg peptidoglycan (PGN) and lipoteichoic acid (LTA) per g 
bodyweight. Control and PGN/LTA treated mice were trained in the Morris water maze arena with a 
submerged platform for 8 consecutive days with 4 trials per mouse and day. The escape latencies, 
target quadrant preferences and search strategies were analyzed: (A) Escape latency of control (n = 7) 
as well as PGN/LTA (n = 9) stimulated mice. (B, C) Probe trial experiment without platform on day 3 and day 9 
respectively. (D) Illustration and comparison of the usage of different search strategies. (E) Quantification of 
hippocampus-dependent search between control and PGN/LTA stimulated mice. * = p < 0.05. 
 
 
In control mice random search, chaining and scanning progressively decreased over the 8 
days of training. Instead, direct swimming was shown to increase (Fig 3.17 D, controls 3.6 
± 3.6 % (day 1) vs. 60.7 ± 13.2 % (day 8)). Altogether, hippocampus-dependent strategies 
increased significantly in control mice from 7.1 ± 4.6 % to 82.1 ± 4.6 % ((F(7,48)= 7.77, p < 
0.001). The PGN/LTA treated animals showed a decrease in random search and 
scanning as well, but in a less steep fashion when compared to control mice. Chaining 
was shown to a higher extent in this treated group. As a consequence, the hippocampus-
dependent strategies did not increase as strongly as seen in controls. PGN/LTA mice 
showed significantly less focal search, directed search and direct swimming on day 6 and 
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8 of the training in comparison to control animals (day 6, PGN/LTA: 22.2 ± 7.7 %, controls: 
60.7 ± 12.0 %, p = 0.014; day 8, PGN/LTA: 47.2 ± 7.7 %, controls: 82.1 ± 4.6 %, p = 
0.003).  
Altogether, PGN/LTA treated mice showed subtle deficits in spatial learning during the 
whole 8 training days as seen in a combination of the probe trial experiments and 
evaluation of the executed search strategies. 
As overproduction of pro-inflammatory cytokines can account for learning and memory 
deficits in a situation of a systemic or CNS localized infection or immune stimulation 
(Matsumoto et al. 2004, Moore et al. 2009, Silva et al. 2015), the activation of astrocytes 
and microglia as brain resident monocytes were evaluated next. 
 
 
3.2.4. Influence of an immune stimulation with PGN/LTA on the glial immune 
response 
 
Infections with Gram positive bacteria are of increasing importance and Staphylococcus 
aureus is of particular interest in the context of nosocomial infections. While the 
characteristics of an infection with Gram negative bacteria with their major endotoxic 
component LPS and the triggering of neuroinflammation are described well, the 
mechanisms underlying an infection with Gram positive bacteria, a Gram positive sepsis 
or septic shock and the influences on the brains immune system are not sufficiently 
illuminated yet. Therefore, it was of high interest to investigate whether the phenotype of 
brain cells participating in innate immune response is altered 3 months after the 
intraperitoneal administration of S.aureus peptidoglycan and lipoteichoic acid in aged WT 
mice. Therefore, the PFA fixed hippocampus was deep frozen and cut into 30 µm slices 
transversally and immunostained for GFAP and IBA-1.  
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Figure 3.18 | Quantification of astrocytes and microglia/macrophages in hippocampal tissue of 19 
months old C57Bl/6 mice immune stimulated with lipoteichoic acid (LTA) and peptidoglycan (PGN) at 
16 months of age. (A) Immunohistochemistry of stratum radiatum CA1 area of control vs. PGN/LTA 
stimulated 19 months old WT mice 3 months after incubation. Primary antibodies against GFAP (Glial fibrillary 
acidic protein) and IBA-1 (ionized calcium-binding adapter molecule 1) were used to visualize astrocytes and 
microglia/macrophages respectively, scale bar larger section 100 µm, scale bar  smaller frame 10 µm. (B) 
Quantification of GFAP-positive cells upon PGN/LTA treatment vs. control (normalized to 1). (C) The number 
of IBA-1 in PGN/LTA stimulated mice compared to controls, normalized to 1. (D) Number of primary 
microglia/macrophage processes in the CA1 area of PGN/LTA treated mice 3 months after application vs. 
control. 
 
 
The number of GFAP-positive cells was quantified in the stratum radiatum of the CA1 
area and the number of astrocytes in control sections was normalized to 1. 
There was no change in the relative number of GFAP-positive cells in the hippocampal 
tissue of PGN/LTA treated mice after 3 months incubation (Fig 3.18B, control: 1.0 ± 0.08 
GFAP+ cells; PGN/LTA: 1.05 ± 0.04 GFAP+ cells, p = 0.6059). In addition, the number of 
microglia/macrophages in the stratum radiatum of the CA1 area of PGN/LTA stimulated 
mice was not different from control tissue either (Fig 3.18C, control: 1.0 ± 0.07 IBA-1+ 
cells; PGN/LTA: 1.0 ± 0.09 IBA1+ cells, p = 1.000). Also the activation status of these cells 
seems to be alike, as the number of primary processes of the IBA-1-positive cell 
population was only very slightly decreased (Fig 3.18D, control: 7.3 ± 0.2 primary 
processes, PGN/LTA: 6.8 ± 0.3, p = 0.1512). 
Taken together, a dramatic long-term activation of astrocytes and microglia as seen in the 
neuroinflammation model with LPS was not detectable in aged WT mice 3 months after 
immune stimulation with PGN and LTA. 
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3.2.5. Long-term influences of PGN/LTA on neuronal morphology in young mice 
 
In aged mice already higher basal levels of proinflammatory cytokines like IL1β or TNF-α 
are detectable (Arumugam et al. 2010). After peripheral immune activation with the 
endotoxic cell wall components LTA and PGN these levels are even higher (Linge et al. 
2010). This might explain why the 19 months old mice in the present study showed 
morphological as well as functional alteration on neurons with detrimental outcome for the 
spatial learning ability of the mice in response to a subclinical PGN/LTA dose. To examine 
whether indeed, this strong vulnerability towards stimulation with Gram positive cell wall 
components is age dependent, young adult mice at 4 months of age were studied. 
C57Bl/6 mice were immune stimulated with 1.0 µg/g body weight each of LTA and PGN 
via intraperitoneal injection and after a 3 months incubation period, the neuronal 
architecture of cortical and hippocampal neurons was examined using the Diolistic 
technique.  
In the cortex layer II/III pyramidal neurons with their characteristic short but strongly 
ramified basal dendrites, the dendritic complexity was slightly elevated in PGN/LTA 
treated mice over the whole distance of the dendritic tree when compared to control 
neurons (Fig 3.19A). The Sholl analysis of the apical dendrites in cortex layer II/III showed 
a perfect overlap in the number of intersections between control and neurons of PGN/LTA 
treated mice (Fig 3.19A). The spine density is not altered for basal nor for apical dendrites 
in cortex layer II/III of PGN/LTA treated animals vs. controls (Fig 3.19 C, basal: control 
1.629 ± 0.064 spines/µm of dendrite; PGN/LTA 1.570 ± 0.060 spines/µm dendrite, p = 
0.5854; Fig 3.19 E, apical: control 1.692 ± 0.094 spines/µm of dendrite; PGN/LTA 1.617 ± 
0.058 spines/µm dendrite, p = 0.4915). 
The number of intersections of apical or basal dendrites in the hippocampal CA1 area was 
not altered upon treatment with PGN/LTA 3 months after incubation in adult C57Bl/6 mice 
(Fig 3.19F). The same was true for the spine density of these neurons (Fig 3.19H, basal: 
control 1.825 ± 0.033 spines/µm dendrite; PGN/LTA 1.767 ± 0.050 spines/µm, p = 0.3431; 
Fig 3.19J, apical: control 1.866 ± 0.034 spines/µm dendrite; PGN/LTA 1.838 ± 0.037 
spines/µm, p = 0.5811). 
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Figure 3.19 | Dendritic morphology and spine density of hippocampal and cortical neurons in adult 
C57Bl/6 mice 3 months after immune stimulation with 1µg/g bodyweight of lipoteichoic acid (LTA) and 
peptidoglycan (PGN) - (A) Tracing and Sholl analysis of cortex layer II/III pyramidal neurons, scale bar 100 
µm. (B, C) Confocal microscopic image and quantification of basal dendritic spines of cortex LII/III cells, scale 
bar 10 µm. (D, E) Spine density and exemplified confocal images, scale bar 10 µm, of apical cortex LII/III 
neurons (F) Dendritic complexity of CA1 pyramidal neurons with tracing example, scale bar 100 µm. (G, H) 
Spine density and confocal microscopic images of basal CA1 dendrites, scale bar 10 µm. (I, J) Quantification 
of dendritic spines of mid-apical CA1 dendrites, representative images, scale bar 10 µm. (K) Sholl analysis of 
dentate gyrus granule cells, scale bar 100 µm. (L, M) Spine density of dentate gyrus granule cells, confocal 
image, scale bar 10 µm. Data presented as mean ± SEM, n = number of neurons/dendrites 
 
 
Also tracings of the granule cells of the dentate gyrus revealed no changes in dendritic 
architecture upon stimulation with PGN/LTA of young adult WT mice (Fig 3.19K). In the 
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dentate gyrus, if anything, a slight increase in the spine density of granule cells was visible 
(Fig 3.19M, control: 1.832 ± 0.034 spines/µm dendrite; PGN/LTA: 1.904 ± 0.051 
spines/µm, p = 0.2466). 
Summarized, young adult WT mice showed no long-term consequences of an immune 
stimulation with the Gram positive bacterial cell wall components PGN and LTA 3 months 
after peripheral application. Therefore, effects on synaptic transmission and the learning 
behavior of the mice were not further addressed in this study. 
 
 
3.2.6. Changes in neuronal morphology upon PGN/LTA stimulation in old APP/PS1 
mice 
 
In the present study I saw reduced neuronal complexity and functional deficits leading to 
impaired spatial learning in aged WT mice 3 months after peripheral immune stimulation 
with the Gram positive cell wall components peptidoglycan (PGN) and lipoteichoic acid 
(LTA). The consequences of the same peripheral immune stimulation for an already 
challenged system like the AD brains of old APP/PS1 mice were therefore interesting to 
explore. 
Thus, 16 months old APP/PS1 mice were injected i.p. with 1 µg/g body weight of each 
PGN and LTA or NaCl solution for control. After 3 months of incubation, single neurons in 
the cortex and hippocampus were stained with the fluorescent dye DiI and analyzed for 
dendritic morphology and spine density. 
The pyramidal neurons of the cortex layer II/III showed a significant lower number of 
intersections in the Sholl analysis between 70 and 90 µm from the soma in the basal and 
between130 and 210 µm from the soma in the apical dendritic compartment (Fig 3.20A). 
The spine density was significantly reduced in both apical and basal dendrites as well (Fig 
3.20B, 3.20C, basal: control 1.670 ± 0.082 spines/µm dendrite, PGN/LTA 1.316 ± 0.056 
spines/µm, p = 0.0016; Fig 3.20D, 3.20 E apical: control 1.667 ± 0.056 spines/µm 
dendrite, PGN/LTA 1.338 ± 0.071 spines/µm, p = 0.0021). 
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Figure 3.20 | Cortical and hippocampal dendritic architecture and spine density of 19 months old 
APP/PS1 mice 3 months after immune stimulation with peptidoglycan (PGN) and lipoteichoic acid 
(LTA). – (A) Tracings and quantification of dendritic complexity of cortex layer II/III neurons, scale bar 100 µm. 
(B, D) Confocal microscopic images of DiI stained basal and apical dendrites of cortex LII/III, scale bar 10 µm. 
(C, E) Basal and apical spine density of cortex LII/III neurons. (F) Sholl analysis and exemplified tracing of 
CA1 pyramidal neurons, scale bar 100 µm. (G, H) Spine density and representative image of CA1 basal 
dendrites, scale bar 10 µm. (I, J) Spine density and confocal microscopic image of CA1 apical dendrites, scale 
bar 10 µm. (K) Sholl analysis of granule cells of the dentate gyrus, tracing scale bar 50 µm. (L, M) Spine 
density and image of dentate gyrus granule cells. Data presented as mean ± SEM, n = number of cells or 
dendrites respectively, * = p < 0.05; ** = p < 0.01. 
 
 
Also the dendritic complexity of CA1 pyramidal neurons was reduced between 30 and 50 
µm from the soma for the basal dendrites and at 60 and 70 µm from the cell body for the 
apical dendrites (Fig 3.20F). The number of spines per µm basal dendrite was not altered, 
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while the apical dendrites had a highly significantly reduced spine density (Fig 3.20G, 
3.20H, basal: control 1.756 ± 0.056 spines/µm dendrite, PGN/LTA 1.711 ± 0.044 
spines/µm, p = 0.5286; Fig 3.20I, 3.20J, apical: control 2.038 ± 0.077 spines/µm dendrite, 
PGN/LTA 1.741 ± 0.046 spines/µm, p = 0.0016). In comparison to the CA1 pyramidal 
neurons, the granule cells of the dentate gyrus did not react with a decrease in dendritic 
complexity upon PGN/LTA treatment (Fig 3.20K). The spine density here however, was 
strongly reduced in the granule cells of old APP/PS1 mice (Fig 3.20L, 3.20M, controls: 
1.851 ± 0.053 spines/µm dendrite, PGN/LTA: 1.615 ± 0.057 spines/µm, p = 0.0092). 
Compared to age matched WT mice, the AD mice showed a more dramatic impact of the 
peripheral immune stimulation with PGN/LTA on the granule cells of the dentate gyrus. 
The cortical and hippocampal pyramidal neurons showed a reduction in dendritic 
complexity and spine density, which was not stronger than the one observed for aged WT 
mice. 
 
 
3.2.7. Synaptic plasticity in old APP/PS1 mice 3 months after stimulation with 
PGN/LTA 
 
While several studies suggest detrimental effects of a peripheral immune activation with 
lipopolysaccharide of Gram negative bacteria in WT mice, only some draw the connection 
to the onset and progression of Alzheimer´s disease. The involvement of Gram positive 
bacteria and infections with Gram positive bacteria as risk factor or facilitator of 
neurodegeneration and cognitive impairment in an AD mouse model has not been 
addressed at all. I found, that 19 months old WT mice were vulnerable towards a 
peripheral immune stimulation with the Gram positive bacterial cell wall components 
peptidoglycan (PGN) and lipoteichoic acid (LTA) as they showed a decrease in neuronal 
complexity and spine density as well as in long-term potentiation even 3 months after the 
stimulation. I further saw that 19 months old APP/PS1 mice exhibited an even stronger 
effect on the dendritic architecture in some cell types of the cortex and hippocampus. The 
impact on neuronal function and plasticity should therefore be investigated.  
Thus, 16 months old APP/PS1 mice were immune stimulated via peripheral administration 
of 1 µg/g bodyweight of LTA and PGN. 3 months later, basal synaptic transmission as well 
as short- and long-term plasticity was addressed at the Schaffer collateral CA3-CA1 
pathway of hippocampal acute slices in an interface electrophysiology setup. 
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Figure 3.21 | Long-term synaptic plasticity of the CA3-CA1 Schaffer collateral pathway of 19 months 
old APP/PS1 mice 3 months after peripheral immune stimulation with lipoteichoic acid (LTA) and 
peptidoglycan (PGN) from Staphylococcus aureus. (A) Long-term potentiation (LTP) after 20 minutes 
baseline recording, induced via TBS (3 trains with 10 s interval of 10 bursts containing 4 pulses at 100 Hz with 
200 ms inter burst interval), shown as fEPSP slope % of baseline of control APP/PS1 and PGN/LTA treated 
APP/PS1 mice. (B) Quantification of the last 30 minutes, the stable phase of LTP, in control and PGN/LTA 
treatment. (C) Input-Output relationship and (D) short-term plasticity of CA3-CA1 pathway after control and 
PGN/LTA treatment in old APP/PS1 mice. ISI = interstimulus interval, All data are shown as mean ± SEM; * = 
p < 0.05, ** = p < 0.01, *** = p < 0.001 
 
 
After 20 minutes of baseline recordings, LTP was induced via TBS. In control as well as 
PGN/LTA treated aged APP/PS1 mice LTP was successfully induced and maintained 
stable for 60 minutes of recording (Fig 3.21A). However, in PGN/LTA treated mice the 
LTP was significantly lower for the whole measured period (Fig 3.21A) and highly 
significant reduced during the stable phase of recording (Fig 3.21B, control: 157.2 ± 8.6 
fEPSP slope % of baseline, PGN/LTA: 117.9 ± 5.6 % fEPSP slope, p = 0.0051). Also the 
basal synaptic transmission within the CA3-CA1 signaling was altered upon PGN/LTA 
treatment, but here a steeper fEPSP slope could be evoked at stimulus intensities 200 to 
600 µA when compared to control slices (Fig 3.21C). The presynaptic properties like the 
neurotransmitter vesicle capacity seemed not to be affected as there was no change in 
paired pulse facilitation upon immune stimulation with PGN/LTA in old APP/PS1 mice (Fig 
3.21D). 
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Even though hippocampal acute slice of immune stimulated aged APP/PS1 mice show 
higher fEPSP slopes in the input-output curve, the induction and maintenance of LTP was 
even lower than in age matched WT mice.  
 
 
3.2.8. Changes in neuronal structure upon PGN/LTA treatment in adult APP/PS1 
mice 
 
While most studies dealing with the communication between the peripheral immune 
system and the central nervous system use lipopolysaccharide of Gram negative bacteria 
to stimulate the innate immunity, not much is known about mechanisms underlying Gram 
positive based immune stimulation. In this study I could show, that aged WT as well as 
aged APP/PS1 mice exhibited a reduction in the neuronal complexity and spine density in 
different brain areas which led to impairment of long-term potentiation and even the 
spatial learning ability of the old WT mice actually 3 months after the treatment. Young 
WT mice on the other hand showed no effect or even an increase in the dendritic 
complexity of cortical and hippocampal neurons.  
Therefore, it was of special interest to examine the impact of a Gram positive bacterial 
immune stimulation on the neuronal architecture of adult APP/PS1 mice. Hence, I 
stimulated the peripheral immune system of 4 months old APP/PS1 mice with the 
intraperitoneal application of 1 µg LTA and PGN per g bodyweight. 3 months later the 
dendritic morphology and spine density of cortical and hippocampal neurons were 
analyzed with the help of the DiOlistic technique. 
Cortex layer II/III pyramidal neurons showed only a slight decrease in the number of 
intersections in the Sholl analysis of the basal dendritic tree (Fig 3.22A) but a significant 
reduction in the spine density at this level (Fig 3.22B, 3.22C, control: 1.852 ± 0.080 
spines/µm dendrite, PGN/LTA: 1.540 ± 0.070 spines/µm, p = 0.0066). The complexity (Fig 
3.22A) and also the spine density of the apical dendritic tree was only mildly reduced 3 
months after PGN/LTA treatment (Fig 3.22D, 3.22E, control: 1.763 ± 0.076 spines/ µm 
dendrite; PGN/LTA: 1.637 ± 0.065 spines/µm, p = 0.2137). 
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Figure 3.22 | Dendritic architecture and spine density in cortex and hippocampus of 7 months old 
APP/PS1 mice 3 months after immune stimulation with peptidoglycan (PGN) and lipoteichoic acid 
(LTA). – (A) Sholl analysis of cortex layer II/III pyramidal neurons, tracing scale bar 100 µm. (B, D) Confocal 
microscopic images of basal and apical dendrites PGN/LTA vs. control, 10 µm scale bar. (C, E) Quantification 
of spine density from basal and apical cortex LII/III dendrites. (F) Dendritic morphology and exemplified tracing 
of CA1 pyramidal neurons. (G, H) Spine density of basal CA1 dendrites, confocal image, scale bar 10 µm. (I, 
J) Images of apical CA1 dendrites and respective spine density, scale bar 10 µm. (K) Sholl analysis of granule 
cells of the dentate gyrus, tracing 50 µm scale bar. (L, M) Representative confocal microscopic images and 
evaluation of spine density from dentate gyrus granule cells. Data presented as mean ± SEM, n = # of 
neurons/dendrites * = p < 0.05; *** = p < 0.001. 
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In contrast, CA1 pyramidal neurons showed no change in dendritic complexity (Fig 3.22F) 
or spine density of basal (Fig 3.22G, 3.22H control: 1.668 ± 0.055 spines/µm dendrite, 
PGN/LTA: 1.616 ± 0.068, p = 0.5611) or mid-apical dendrites (Fig 3.22I, 3.22J control: 
1.771 ± 0.029 spines/µm dendrite, PGN/LTA: 1.807± 0.042, p = 0.4767). The granule cells 
of the dentate gyrus exhibited no alteration in the dendritic architecture upon stimulation 
with PGN/LTA in young APP/PS1 (Fig 3.22K), but a highly significantly decreased spine 
density (Fig 3.22L, 3.22M, control: 1.990 ± 0.45 spines/µm dendrite; PGN/LTA: 1.684 ± 
0.056 spines/µm, p = 0.0002). 
Conclusively, adult APP/PS1 showed slightly detrimental effects of a peripheral immune 
stimulation with PGN and LTA while their WT counterparts showed a tendency toward 
more beneficial effects. Therefore, the immune homeostasis of the young APP/PS1 is 
likely either easier to disturb or takes longer to revert into an anti-inflammatory status. 
However, CNS immune response of adult APP/PS1 mice and the effects on neuronal 
function and spatial learning of the mice were not examined in this study. 
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3.3. Changes in neuronal morphology upon infection with Toxoplasma 
gondii 
 
In rodents, the chronic infection with the protozoan parasite T.gondii leads to subtle 
neurological and behavioral changes such as a more active behavior (Hay et al. 1985, 
Webster et al. 1994) and infected animals lose their innate fear of cat odors (Berdoy et al. 
2000). Some studies already suggested that inflammation (Hermes et al. 2008), 
neurotransmitter imbalance (Gatkowska et al. 2012) or dopamine overproduction 
(Prandovszky et al. 2011) are involved in this phenotype. However, underlying 
mechanisms and effects on neuronal architecture and signaling have not been explored 
yet. 
To investigate the impact of chronic Toxoplasma gondii infection on neuronal morphology 
in adult mice, the dendritic arborization was analyzed in different brain regions 8 weeks 
after infection via intraperitoneal application of 3 tissue cysts from brain homogenate of 
infected mice. A Diolistic approach was used to analyze the morphology of single 
excitatory neurons in cortex layer II/III, the CA1 area and dentate gyrus of the 
hippocampus. To determine the effect of chronic T.gondii infection on inhibitory neurons, 
the medium spiny neurons of the striatum were examined. For the evaluation of the 
dendritic complexity the Sholl analysis was used (Sholl 1953).  
 
 
Figure 3.23: Dendritic complexity of hippocampal granule cells of the dentate gyrus during chronic 
Toxoplasma gondii infection – (A) Examples for the morphology of granule cells of the dentate gyrus of 
control vs. T.gondii infected mice (scale bar, 100 µm). (B) Sholl analysis of DG granule cells (C) Total 
complexity of DG granule cells (D) Total dendritic length of T.gondii infected vs. control DG cells, Data 
presented as mean ± SEM, n = numbers of cells, * = p < 0.05; ** = p > 0.01. 
 
 
In T.gondii infected mice, the granule cells of the dentate gyrus showed a reduction in the 
number of intersections over the whole dendritic tree (Fig. 3.23A and Fig. 3.23B), which 
was significant at 20, 70, 150 and 160 µm from the soma. This resulted in a significant 
reduction in total dendritic complexity (Fig. 3.23C, control = 84.8 ± 4.4 intersections; 
infected: 70.1 ± 4.4 intersections; p = 0.021). Also the total dendritic length was 
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significantly reduced in comparison to control neurons (Fig. 3.23D, control: 890.7 ± 46.0 
µm; infected: 742.5 ± 44.0 µm, p = 0.025). 
 
 
 
Figure 3.24: Dendritic complexity of hippocampal CA1 pyramidal neurons in mice chronically infected 
with Toxoplasma gondii – (A) Exemplified morphology of a CA1 neuron of a control vs. Toxoplasma infected 
animal (scale bar, 100 µm). (B) Dendritic complexity (Sholl analysis) of CA1 pyramidal neurons. (C) Total 
dendritic length of CA1 apical dendrites. (D) Total length of CA1 basal dendritic tree. (E) Total complexity of 
CA1 basal dendrites. (F) Total complexity of infected vs. control CA1 neurons of the apical tree, Data 
presented as mean ± SEM, n = number of neurons, * = p < 0.05 
 
 
Also the dendritic morphology of pyramidal neurons in the CA1 area of the hippocampus 
was altered in Toxoplasma gondii infected mice. The Sholl analysis of apical as well as 
the basal dendritic tree revealed a reduction in the number of intersections, which was 
statistically significant between 50 and 80 µm from the soma for the basal and at 50, 90, 
100, 110, 140 and 150 µm from the cell body for the apical tree (Fig. 3.24B). This led to a 
signficant reduction in total complexity for both the apical and the basal CA1 dendrites in 
T.gondii infected mice in comparison to the control neurons (Fig. 3.24E basal, control: 
141.6 ± 14.5 intersections, infected: 99.5 ± 13.0, p = 0.044; Fig. 3.24F apical, control: 
128.5 ± 11.2 intersections, infected: 95.2 ± 8.3, p = 0.037). The total dendritic length was 
only slightly reduced in the two different dendritic compartments (Fig. 3.24C, basal, 
control: 1514.7 ± 172.9 µm, infected: 1111.2 ± 148.3 µm, p = 0.094; Fig 3.24D apical, 
control: 1744.5 ± 169.1 µm, infected: 1359.1 ± 119.1, p = 0.088). 
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To determine whether the infection with T.gondii induces reduction in dendritic complexity 
in a cell type specific manner, inhibitory medium spiny neurons of the striatum were 
analyzed. Although a slight decrease in dendritic complexity was visible for the more 
proximal part of the dendritic tree in MSN of Toxoplasma gondii infected mice (Fig. 3.25B), 
there were no significant changes in the total complexity (Fig. 3.25C, control: 165.4 ± 19.1 
intersections, infected: 137.1 ± 16.2 intersections, p = 0.3025) and total dendritic length 
(Fig 3.25D, control: 1933.1 ± 213.7 µm, infected: 1708.1 ± 173.1, p = 0.4904) upon 
T.gondii infection in comparison to control neurons.  
 
 
Figure 3.25 | Changes in dendritic complexity of medium spiny neurons in the striatum of mice 
chronically infected with Toxoplasma gondii - (A) Tracings of control and T.gondii infected medium spiny 
neurons (MSN) in the striatum (scale bar 100 µm). (B) The Sholl analysis of MSN. (C) Total dendritic 
complexity of MSN from control vs. T.gondii infected mice (D) Total dendritic length of T.gondii infected vs. 
control MSNs, Data presented as mean ± SEM, n = number of neurons 
 
 
In addition to the hippocampus and striatum, pyramidal neurons of the cortex layer II/III 
were analyzed in mice chronically infected with T.gondii. Identification of the cortical layers 
was obtained via DAPI staining. In the appropriate layer, only neurons with a pyramidal 
shaped cell body and characteristic dendritic tree separated in several shorter basal 
dendrites and one primary apical dendrite with numerous branches reaching the brain 
surface were included. The dendritic complexity of the cortex layer II/III pyramidal cells 
was only slightly reduced in the apical part of the dendritic tree in T.gondii infected mice 
compared to control neurons (Fig 3.26A, 3.26B). The basal compartment showed a 
stronger decrease in intersections, which was significant for the more distal part between 
110 and 140 µm from the cell body. Therefore, only the basal part showed a significant 
reduction in total dendritic length (Fig. 3.26C, basal, control: 1872.5 ± 168.0 µm, infected: 
1357.4 ± 104.2 µm, p = 0.012) and total complexity (Fig. 3.26E, basal, control: 161.4 ± 
15.1 intersections, infected: 124.3 ± 9.0 intersections, p = 0.044). 
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Figure 3.26: Influence of a chronic Toxoplasma gondii infection on dendritic complexity of cortex layer 
II/III pyramidal neurons – (A) Exemplified morphology of a cortex layer II/II neurons of control vs. 
Toxoplasma infected conditions (scale bar, 100 µm). (B) Dendritic complexity of cortical pyramidal neurons 
(C) Total complexity of infected vs. control cortex layer II and III neurons of the apical tree. (D) Total 
complexity of cortex layer II/III pyramidal neuron basal dendrites. (E) Total dendritic length of cortex layer II/III 
apical dendrites. (F) Total length of CA1 basal dendritic tree, Data presented as mean ± SEM. * = p < 0.05. 
 
 
In the apical compartments only a very mild reduction in total dendritic length (Fig. 3.26D, 
basal, control: 1228.4 ± 102.8 µm, infected: 1059.7 ± 92.4 µm, p = 0.230) and total 
complexity (Fig. 3.26E, basal, control: 99.2 ± 8.2 intersections, infected: 86.5 ± 8.0 
intersections, p = 0.276) was visible.  
To summarize this line of evidence, even though the changes in dendritic architecture 
were not significant in the medium spiny neurons in the striatum, all evaluated cell types 
displayed a more or less string reduction in dendritic complexity 8 weeks after infection 
with Toxoplasma gondii in young adult mice. 
Next, density and morphology of dendritic spines were analyzed in cortex layer II/III. 
Therefore, spines were counted on the basal dendrites as well as on mid-apical 
secondary dendrites. The number of dendritic spines per defined stretch of dendrite was 
clearly decreased in cortex layer II/III pyramidal neurons of T.gondii infected mice 
compared to the not-infected controls, reaching significance for both apical and basal 
dendrites (Fig. 3.27A, 3.27B, apical, control: 1.539 ± 0.047 spines/µm dendrite, infected: 
.1.159 ± 0.095 spines/µm, p = 0.001; Fig. 3.27C, 3.27D, basal, control: 1.474 ± 0.63 
spines/µm dendrite, infected: 1.169 ± 0.116, p = 0.005). 
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Figure 3.27: Spine density and morphology of cortex layer II/III pyramidal neurons of mice chronically 
infected with Toxoplasma gondii – (A, C) Confocal fluorescent images of dendrites from pyramidal neurons 
of the cortex layer II/III stained via DiOlistic technique (scale bar, 10 µm). (B) Spine density of cortex LII/III 
mid-apical dendrites upon T.gondii infection (D) The number of spines per µm of basal dendrite in T.gondii 
infected cortex LII/III cells vs. control. (E, G) Spine length of apical and basal spines from cortex layer II/III 
pyramidal neurons of mice chronically infected with Toxoplasma gondii vs. control (F, H) Spine width of apical 
and basal spines from cortex LII/III cells, ** = p < 0.01. 
 
 
Besides the number of spines also the spine morphology as an indicator for the synaptic 
connectivity between neurons was analyzed by examining spine length and spine head 
width. While the spine length was significantly reduced on mid-apical dendrites of cortex 
layer II/III upon infection with T.gondii (Fig 3.27E, control: 1.530 ± 0.019 µm, infected: 
1.266 ± 0.086 µm, p = 0.0083), basal dendrites showed only a slight decrease in spine 
length compared to control neurons (Fig 3.27G, control: 1.436 ± 0.126 µm, infected: 1.204 
± 0.087 µm, p = 0.0995). The spine head width was not significantly altered in apical or 
basal part of cortical neurons from infected mice (Fig 3.27F, apical, control: 0.850 ± 0.024 
µm, infected: 0.764 ± 0.028 µm, p = 0.2300; Fig 3.27H basal, control: 0.848 ± 0.056 µm, 
infected: 0.790 ± 0.077 µm, p = 0.4565). 
Taken together, young adult mice chronically infected with Toxoplasma gondii showed a 
reduction in the dendritic complexity in different brain areas and cell types. In cortex layer 
II/III also the spine density was decreased while the morphology of the remaining spines 
was not dramatically altered. Especially as the head width was similar to the one 
measured in control mice, the functional integrity of the synapses seems not to be 
affected.  
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4. DISCUSSION 
 
Neuroinflammation is hypothesized to be an early event in the pathogenesis of 
neurodegenerative disease and systemic innate immune activation has been identified as 
risk factor for Alzheimer´s disease in humans. Whether a peripheral immune stimulation 
with different bacterial cell wall components in mice can induce a neurodegenerative 
phenotype and whether existing neurodegenerative pathology in an AD mouse model is 
worsened long after the acute immune stimulation has not been addressed yet.  
In this work I investigated the long-term effects of a systemic immune activation with 
different endotoxic bacterial components on neuronal structure, function and learning 
behavior of mice. Different components as well as the influence of age were examined. 
Additionally, the APP/PS1 mouse model of Alzheimer´s disease was chosen to determine 
the influence of a peripheral immune stimulation on preexisting neurodegeneration. 
In the first and second part of the thesis (chapter 3.1. and 3.2.) the presented data provide 
evidence for an age-dependent vulnerability towards an immune stimulation with LPS of 
Salmonella typhimurium and peptidoglycan/lipoteichoic acid of Staphylococcus aureus. 
While adult mice do not show changes in neuronal architecture, aged mice exhibit 
decreased dendritic complexity and spine density in neurons of the hippocampus and 
cortex. Furthermore, impairment in LTP and in the formation of spatial memory in the 
Morris water maze is discovered in aged WT mice. Aged mice show a higher microglia 
activation under basal conditions and further activation upon LPS stimulation which is not 
detectable in adult mice. 
The treatment with E.coli LPS does not show these detrimental effects. However, in aged 
APP/PS1 mice, both E.coli and S.typhimurium LPS result in a reduction of dendritic 
branches and in spine density of hippocampal and cortical excitatory neurons. Likewise, 
synaptic plasticity is impaired with both kinds of LPS and upon PGN/LTA treatment. 
Interestingly, also adult APP/PS1 mice exhibit deleterious effects on neuronal architecture 
upon peripheral immune stimulation. 
Furthermore, I could demonstrate that the impairment in LTP and neuronal structure after 
LPS S.typhimurium treatment can be rescued by the genetic ablation of the NLRP3 
inflammasome which is required for the maturation of the proinflammatory cytokines IL-1β 
and IL-18. 
The last part of the thesis (chapter 3.3.) describes the impact of chronic Toxoplasma 
gondii infection. Here, the data demonstrate that even young adult mice are sensible 
towards a CNS infection with T.gondii as they show reduction in dendritic complexity in 
various neuronal cell types. Furthermore, cortical neurons displayed a dramatic decrease 
in dendritic spine density and alterations in spine morphology. 
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4.1. Peripheral immune stimulation results in an age-dependent impairment 
in structural and functional synaptic plasticity  
 
Sepsis and septic shock are characterized by an overwhelming systemic production of 
pro-inflammatory mediators as response to infection with different pathogens (Bone et al. 
1992, Angus et al. 2001). Besides symptoms such as fever and hypotension also brain 
functions can be affected by a severe bacteraemia. During sepsis, up to 71% of the 
patients develop septic encephalopathy associated with attention and memory deficits, 
delirium and coma (Pine et al. 1983, Sprung et al. 1990, Wilson and Young 2003, 
Semmler et al. 2008).  
In rodents, the intraperitoneal administration of lipopolysaccharide (LPS) is widely used to 
mimic severe bacterial infections and sepsis. In this model, the application of the 
endotoxic Gram negative bacterial cell wall component LPS is sufficient to induce high 
production of IL-1β and TNF-α in the periphery (Michie et al. 1988, Cannon et al. 1990) as 
well as in the brain parenchyma (Qin et al. 2007, Semmler et al. 2008). The literature 
provides adequate information about the usage of E.coli LPS to investigate effects of a 
peripheral immune activation on brain functions. Here, LPS concentrations range from 
0.25 µg to 10 µg per g body weight for mice (Arai et al. 2001, Semmler et al. 2005, Qin et 
al. 2007, Richwine et al. 2008, Czapski et al. 2010, Lee et al. 2010). A lethal dose was 
described for 20 µg to 50 µg per g body weight (Jeong et al. 2009, Back et al. 2010). 
However, the distinct types of LPS and data on body weight loss, sickness behavior and 
mortality rate are not provided in most studies. Additionally, in the majority of cases 
analysis of different brain functions were executed only a few hours or days after the 
peripheral LPS application, therefore the survival of mice was not endangered even with 
higher doses. To examine the long-term effects of an immune stimulation with 
components of Gram negative bacteria, I established the peripheral applications of LPS 
from E.coli B8:0127 and Salmonella enterica serovar typhimurium. The long-term analysis 
of mice recovering from such an inflammatory insult, require lower doses of LPS than 
seen in most studies. Especially for the application of Salmonella typhimurium LPS not 
much is known about doses establishing a profound cytokine production in the periphery 
as well as in the CNS. In the present study, a dose of 0.4 µg/g body weight per mouse 
was established for E.coli and S.typhimurium LPS leading to a strong loss of body weight 
within the first days after immune stimulation with no fatalities in young adult and a 
mortality rate of around 20% in aged mice. As body weight loss of rodents can be 
correlated to pathogen burden and cytokine release during sepsis (Breuillé et al. 1993, 
Cooney et al. 1999), the chosen dosage was considered appropriate for the long-term 
study of a systemic immune activation.  
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Previous studies have addressed the acute consequences of a peripheral LPS 
administration including impairment of long-term potentiation in different hippocampal 
pathways. In the major output projection of the hippocampus, the CA1-subiculum 
pathway, LTP is impaired only 4 hours after peripheral LPS application (Commins et al. 
2001). In the perforant path, which connects the entorhinal cortex and the dentate gyrus, 
maintenance of LTP is inhibited already 3 hours after LPS injections (Hennigan et al. 
2007). Also within the Schaffer collaterals-CA1 synapses, mice show deficits in LTP 24 
hours after peripheral immune stimulation (Strehl et al. 2014). These acute effects include 
not only impairment of neuronal plasticity in vitro, but also deficits in learning and memory 
tested in vivo. In the Morris water maze, LPS stimulated mice take longer to find the 
hidden platform on day 1 and 2 after injections in one study (Arai et al. 2001), while others 
show higher escape latencies on day 4 and day 8 of the training after a single LPS 
injection on day 1 (Shaw et al. 2001). Of note, all studies used adult mice or rats and 
different types of E.coli LPS. The impairment in neuronal signaling and learning behavior 
observed in LPS stimulated mice are associated with a massive production of pro-
inflammatory cytokines not only in the periphery but also within the brain parenchyma. 
While the peak of cytokines in the brain such as IFN-γ, IL-1β, IL-6 and TNF-α appears 
around 6 hours after LPS injections (Biesmans et al. 2013), also several weeks after 
systemic infection or immune stimulation signs of neuroinflammation are still present (Qin 
et al. 2007, Bossù et al. 2012, Püntener et al. 2012, Valero et al. 2014). Even though the 
levels of pro-inflammatory cytokines were not quantified in this thesis, the data provided 
here show no long-term changes in neuroinflammation based on the microglia and 
astrocyte phenotype 3 months after systemic immune activation in adult mice. 
Also no long-term changes in the neuronal architecture are shown after either E.coli or 
S.typhimurium LPS injection. The morphology and spine density of CA1 pyramidal 
neurons are not altered 3 months after LPS administration in 7 months old mice. Also 
neither the dendritic complexity nor the spine density of dentate gyrus granule cells is 
reduced in adult WT mice 3 months after peripheral immune stimulation with LPS of E.coli 
or S.typhimurium. This is in agreement with the few other studies investigating the effect 
of a peripheral immune stimulation on neuronal architecture. One study shows that the 
morphology of dentate gyrus granule cells is not altered several weeks after a single LPS 
administration and only mild changes in the memory formation during Morris water maze 
training are observed in adult mice (Valero et al. 2014). The intracerebroventricular 
injection of LPS has been shown to promote a reduction in dendritic complexity of CA1 
pyramidal neurons in adult mice 24 hours after administration (Milatovic et al. 2010). 
However, 3 days after peripheral LPS injection the morphology of CA1 neurons is not 
affect in adult mice (Richwine et al. 2008). This suggests a stronger pro-inflammatory 
immune signaling in response to a local administration of LPS and that the peripheral 
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immune activation does not even lead to acute deleterious effects on neuronal 
morphology in adult mice. 
In summary, the neuronal phenotype after peripheral immune stimulation is consistent 
with results of other studies and implies that no long-term detrimental consequences can 
be observed after a systemic immune activation in adult mice. 
Several studies suggest that an acute peripheral inflammation causes stronger effects in 
aged animals. For example, CA1 neuronal complexity of apical dendrites is decreased in 
aged mice 3 days after peripheral immune activation with LPS, whereas CA1 neurons of 
young mice do not exhibit any alterations (Richwine et al. 2008). Similarly, while 3 months 
old mice do not show any changes in the late phase of long-term potentiation 4 days after 
infection with E.coli, aged mice 24 months of age exhibit significant lower theta burst 
induced L-LTP (Chapman et al. 2010). Also 7 days after infection with E.coli aged rats 
show impaired spatial memory formation in the Morris water maze, while there is no 
change between young infected and control rats. Interestingly, only hippocampus-
dependent long-term memory formation is affected (Barrientos et al. 2006). In another 
model of peripheral immune activation, the administration of heat-killed Mycobacterium 
butyricum (complete Freund´s adjuvant) leads to a decrease in LTP 3 weeks after 
application in 12 months old rats but not in their 2 months old counterparts (Liu et al. 
2012). Therefore, the acute effects occurring upon systemic inflammation caused by E.coli 
LPS have been reported to be stronger in aged rodents than in young. One focus of this 
study is whether this age-dependent vulnerability towards systemic inflammation is still 
visible after the initial sickness behavior was overcome. Three months after immune 
stimulation, the neuronal structure of hippocampal and cortical neurons in aged mice is 
only slightly reduced with E.coli LPS. Also both short-term and long-term synaptic 
plasticity in the hippocampus are not impaired. Solely the basal synaptic transmission is 
decreased after E.coli LPS administration. In line with this, also spatial memory formation 
in the Morris water maze was comparable to controls 3 months after E.coli LPS treatment. 
Taken together, even though E.coli LPS causes acute detrimental effects, I could not 
detect appreciable deleterious long-term consequences after LPS E.coli administration in 
aged, 16 months old mice.  
The same experimental setup with LPS of Salmonella typhimurium on the other hand 
indeed leads to enduring changes in neuronal structure and synaptic plasticity in aged 
mice. Here, the dendritic complexity and spine density of cortical and hippocampal 
pyramidal neurons is reduced. This is accompanied by a significant lower LTP at the 
Schaffer collateral pathway. Basal synaptic transmission and presynaptic properties are 
not affected. Moreover, also in the Morris water maze, aged mice treated with LPS of 
S.typhimurium showed higher escape latencies due to a diminished use of hippocampus-
dependent learning strategies. Unfortunately not much is known about the different modes 
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of action of E.coli and S.typhimurium LPS and studies are missing illuminating the 
influences on neuronal networks during the acute phase of inflammation. As described 
above for infections with E.coli or immune stimulation with E.coli LPS (Qin et al. 2007, 
Bossù et al. 2012, Valero et al. 2014), also infection with Salmonella typhimurium can 
induce long lasting neuroinflammation. Püntener and colleagues show a persistent 
production of IL-1β and IL-12 in the brain until three weeks after S.typhimurium infection 
(Püntener et al. 2012). However, a hint explaining the differences between the effects 
observed with S. typhimurium and E.coli LPS is given by an immunological study 
examining the role of different cytokine signaling cascades on the lethality linked to LPS 
types. While the deletion of TNF-α signaling leads to resistance against E.coli LPS 
induced lethality, the knockout mice still show sensitivity towards S.typhimurium LPS 
(Netea et al. 2001). On the other hand, mice with defective IL-1β and IL-18 signaling are 
completely protected against both types of LPS. These data propose a mainly TNF-α 
dependent induced inflammation via E.coli LPS and a mainly IL-1β and IL-18 dependent 
one with S.typhimurium LPS. Therefore, also studies discussing the effect of IL-1β and IL-
18 on neuronal structure and function can be taken into account to understand the effect 
of S.typhimurium LPS treatment. Especially IL-1β came into focus in the field of 
neurodegeneration and systemic infection as master manipulator of neuroinflammation. In 
the healthy brain, the concentration of IL-1β is very low (Rothwell and Luheshi 2000). 
Upon insult, this cytokine is mostly produced by microglia but also astrocytes, neurons, 
infiltrating immune cells, oligodendrocytes and epithelial cells. While defective IL-1β 
signaling can impair synaptic plasticity and spatial learning, also a high concentration of 
IL-1β negatively affects neuronal signaling: Acute application of IL-1β prevents the 
induction of LTP in hippocampal slices (Ross et al. 2003). IL-1β application is sufficient to 
interfere with BDNF and neurotrophin-3 associated signaling transduction in cortical and 
hippocampal neurons (Soiampornkul et al. 2008) and with BDNF induced neuroplasticity 
in the hippocampus (Tong et al. 2008). Also hippocampus-dependent learning in the 
Morris water maze is completely prevented by systemic IL-1β application (Gibertini et al. 
1995). It was further shown, that inhibition of IL-1 signaling circumvents damaging effects 
of systemic inflammation and that TNF-α signaling might not be required for 
neuroinflammation in certain scenarios. For instance, intrahippocampal administration of 
the IL-1 receptor antagonist IL-1RA prevents synaptic dysfunction and cognitive 
impairment in a mouse model of obesity (Erion et al. 2014). Also, blockade of circulating 
IL-1β was sufficient to rescue learning and memory deficits induced by a Legionella 
pneumophila infection (Gibertini et al. 1995).  
Taken together these data make it tempting to speculate that the main difference between 
E.coli and S.typhimurium LPS indeed is a higher concentration of IL-1β with 
S.typhimurium LPS leading to a stronger inflammatory phenotype in the CNS, prolonged 
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activation of immune cells and a greater impact on neuronal signaling. However, this 
higher production of IL-1β which seems to be associated with the detrimental effects on 
neuronal morphology and function in aged mice is not sufficient to cause any long-term 
effects in adult, 4 months old mice in this study.  
 
 
4.2. Peripheral immune stimulation with different LPS leads to an age-
dependent activation of brain immune cells 
 
While detrimental effects of a peripheral immune activation or infection on neuronal 
structure, synaptic plasticity and learning behavior are visible in aged rodents, younger 
individuals seem to be protected. The results presented in this thesis suggest a crucial 
role of the number and activation of microglia in aged, 16 months old mice. Already under 
baseline conditions, a higher activation of microglia, shown by a significantly lower 
number of primary processes was observed in aged mice. Interestingly, the number of 
microglia was not increased. Upon peripheral immune stimulation with either E.coli or 
S.typhimurium LPS an even stronger activation of microglia and macrophages is visible in 
the hippocampus of aged mice. Of note, S.typhimurium LPS led to an even more 
pronounced increase in microglia number and activation status. Unfortunately, it can only 
be speculated whether an initial increase of activation occurred in the acute phase of 
inflammation also in adult animals. However, there is no persistent activation of 
hippocampal microglia in adult mice. Although not tested in this study, the stronger 
activation of microglia seen in aged mice in this context is likely associated with a higher 
production of proinflammatory cytokines as demonstrated by Liu and colleagues (Liu et al. 
2012).  
Along with the data of this thesis, several other studies show differences in the CNS 
immune response of aged mice as well. Even despite the absence of a direct infection or 
inflammation to the CNS, the brain microglia have been shown to respond to a peripheral 
immune activation with the production of cytokines, chemokines and reactive nitrogen 
species similar to body macrophages and dendritic cells. Indeed, detecting peripheral 
inflammatory signals has been suggested to be an important feature of microglia (Nguyen 
et al. 2002). This inflammatory activation is normally transient and microglia go back to a 
resting state after the infection, injury or peripheral inflammation is overcome. This 
mechanism however, might be disturbed in the elderly. In fact, some markers of M1 
microglia activation are up-regulated in mice and also in humans as consequence of 
normal aging. It has been found, that the expression of TLRs (Letiembre et al. 2007), 
MHC class II and CD11b (Morgan et al. 1999; Nicolle et al. 2001, Godbout et al. 2005) is 
enhanced in microglia of aged rodents. Also the astrocytic marker GFAP is up-regulated 
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(Godbout et al. 2005, Lee et al. 2000, Morgan et al. 1999). In response to an infection or a 
peripheral immune stimulus microglia and astrocytes of aged mice, 20 – 24 months of 
age, show a stronger and prolonged production of IL-1β and IL-6 and other 
proinflammatory mediators compared to young ones (Godbout et al., 2005; Barrientos et 
al., 2009a). And even more interestingly, this hyper reactive inflammatory response is 
restricted to the microglia/macrophages of the brain (Godbout et al., 2005; Barrientos et 
al., 2009a, 2015a). 
Further studies show that the difference in microglia and astrocyte phenotype of young 
and aged mice mediates the deleterious actions of a systemic immune activation on 
neurons. While older, 12 months old rats exhibit high numbers of scavenger receptor 
CD68+ and IL-1β+ microglia 3 weeks after immune activation this phenotype could not be 
detected in 2 months old rats (Liu et al. 2012). Additionally, the impairment in LTP seen in 
that study was prevented upon microglia inhibition by systemic minocycline administration 
10 days after the immune stimulation. Also injections of IL-1 receptor antagonist (IL-1RA) 
in the cisterna magna immediately prior to infection with E.coli abolished the significant 
lower theta burst induced L-LTP seen in aged mice, implying a critical role for cytokines 
such as IL-1β (Chapman et al. 2010). In aged rats, the production of IL-1β in response to 
E.coli infection was prolonged in comparison to younger animals. Interestingly, this effect 
was only observed in the hippocampus and led to disruption of hippocampus-dependent 
contextual fear conditioning (Barrientos et al. 2009) as long as IL-1β levels were elevated. 
Taken together, the results of this study are in agreement with others showing that the 
proinflammatory status in the brain of aged mice seems to mediate the detrimental effects 
of a systemic inflammation. 
Besides microglia and blood derived macrophages also astrocytes can contribute to an 
inflammatory environment in the brain. Astrocytes are the most abundant cell type in the 
CNS and alongside to their trophic support of neurons, they also are involved in protecting 
injured or infected areas of the brain by formation of a so called glial scar. Moreover, 
astrocytes are a prominent source of cytokines and chemokines. Especially after 
traumatic brain injury astrocytic production of proinflammatory mediators are associated 
with prolonged damage. After peripheral immune activation with E.coli LPS there is an 
increase in astrocytic NFκB activation with an activation peak 3 days after stimulation and 
a subsequent decline which was followed until day 16. Even though the astrocyte 
activation is still 1.5-fold increased and also apoptosis is still slightly elevated up to 2 
weeks after stimulation, a further decrease to control conditions cannot be excluded (Fan 
et al. 2014). Other papers report an increase in astrocytes numbers and activation in a 
GFAP-reporter mouse with a peak at 6 hours after systemic LPS application declining to 
control conditions already after another 42 hours (Biesmans et al. 2013).  
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In the present study, I could not detect an increase in astrocyte numbers either in adult or 
in aged mice after peripheral immune stimulation. However, also here an upregulation in 
astrocytic activation markers shortly after the immune activation cannot be excluded. 
Interestingly, also upon ageing the basal number of astrocytes is not altered in the study 
presented here, making these cells less likely to be involved in an age-dependent 
vulnerability towards infection or systemic immune activation. 
 
 
4.3. Long-term influences of a systemic immune activation on neuronal 
structure and signaling in the APP/PS1 mouse model of Alzheimer´s disease 
 
AD is the most common cause of dementia in elderly people. During the disease 
progression, the death of neurons as well as the loss of synapses is strongly correlated 
with cognitive impairments. Pathological hallmarks of AD are the aggregation of amyloid-β 
peptide as byproduct of the amyloidogenic cleavage of the amyloid precursor protein into 
senile plaques and the abnormal intracellular aggregates of hyperphosphorylated forms of 
the microtubule-associated and stabilizing protein tau (Mandelkow and Mandelkow 1998). 
Several mouse models were designed featuring one or more pathological hallmarks 
already present in the young mouse.  
In the present studies, I used the APP/PS1 mouse model reflecting the amyloid-portion of 
the AD pathology which is characterized by an increasing Aβ plaque load starting at about 
6 months of age (Borchelt et al. 1997, Jankowsky et al. 2001) and resulting in a 
substantial plaque load in the hippocampus and cortex by 9 months (Jankowski et al. 
2004) and a peak in plaque formation with 12 months of age (Garcia-Alloza et al. 2006). In 
addition, various studies show decreased numbers and altered morphology of dendritic 
spines in the hippocampus already in young adult APP/PS1 mice (Moolmann et al. 2004, 
Grutzendler et al. 2007, Kummer et al. 2011, Alonso-Nanclares et al. 2013, Heneka et al. 
2013, Šišková et al. 2014). Further studies elucidate that an elevation in aggregated Aβ 
causes impairment in LTP (Nalbantoglu et al. 1997, Chapman et al. 1999, Kummer et al. 
2011, Heneka et al. 2013). Deficits in hippocampus-dependent learning and memory start 
with 6 months of age and extent over the whole lifespan of the mice (Cao et al. 2007, Ding 
et al. 2008). 
Along with this neurodegenerative phenotype, also neuroinflammation and changes in the 
CNS immune response are part of the AD pathology. It has been shown that in the brain 
of AD mouse models as well as in post mortem tissue of AD patients activated microglia, 
cytokines, chemokines and their receptors and astrogliosis is elevated (Cartier et al. 2005; 
Wyss-Coray 2006, Heneka and O´Banion 2007). Especially microglia surrounding Aβ 
plaques are positive for activation markers and pro-inflammatory mediators such as MHC 
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class II, Cox-2, MCP-1, TNF-a, IL-1β, and IL-6 (Akiyama et al. 2000, Glass et al. 2010). 
Thereby, the M1 activation of microglia mediated by TLR-, NLR- and RAGE-signaling 
further amplifies neurotoxic properties of Aβ deposits. Indeed, impairment in spatial 
learning and LTP of adult APP/PS1 mice is paralleled by increased expression of IL-1β 
(Gallagher et al. 2013, Kelly et al. 2013). Also, the administration of Aβ leads to LTP 
deficits and increased hippocampal IL-1β (Lyons et al., 2007). Furthermore, blockade of 
the IL-1 receptor improves hippocampus-dependent learning and memory in an animal 
model of AD (Kitazawa et al. 2011). And also the treatment of aged transgenic APP mice 
with minocycline to inactivate microglia rescued spatial learning (Fan et al., 2007).  
But not only innate immunity of the brain contributes to AD pathology also systemic 
inflammation can drive neurodegeneration. Activation of the peripheral immune system 
caused by infection may be involved in the early stages of AD pathogenesis (Perry et al., 
2007). And also simply the overproduction of inflammatory immune mediators as 
described for obesity and type 2 diabetes act as risk factors for AD (Granic et al. 2009, 
Jones et al. 2009). The peripheral immune stimulation with E.coli LPS also demonstrates 
a worsening of Aβ accumulation, tau pathology and even cognitive function in AD models 
(Qiao et al. 2001, Lee et al. 2010, Valero et al. 2014). Sheng and colleagues report higher 
numbers of activated microglia and astrocytes and higher levels of intracellular APP and 
Aβ in aged APP transgenic mice after 3 months of weekly LPS injections (Sheng et al. 
2003).  
The data described here show a reduction in dendritic complexity and spine density of 
cortical and hippocampal pyramidal neurons and granule cells of aged APP/PS1 mice 3 
months after LPS E.coli or S.typhimurium treatment. Especially the phenotype seen in the 
dentate gyrus has not been observed in the aged WT mice. This is in agreement with a 
study by Valero and colleagues. Only 6 weeks after systemic LPS application, adult 3xTg 
AD mice show heavy impaired memory in the Morris water maze, decrease in synaptic 
markers and slight reduction in dendritic complexity of new born granule cells in the 
dentate gyrus (Valero et al. 2014). Of note, in the same study changes in granule cells 
complexity were not visible in WT controls. 
Of course the study by Valero et al. (2014) emphasizes the differences between adult WT 
and AD mice. While I indeed could not find any differences in adult WT mice upon 
peripheral immune stimulation to the controls, adult APP/PS1 mice show decreased spine 
densities of the dentate gyrus granule cells 3 months after immune stimulation. Therefore, 
a higher sensitivity towards a systemic immune activation is also displayed here. Besides 
the changes in neuronal structure, also synaptic plasticity in aged APP/PS1 mice is 
altered. Here, the immune stimulation with either E.coli or S.typhimurium LPS leads to 
inhibition of LTP. This again is in contrast to the data on aged WT mice, which show no 
appreciable differences in neuronal signaling upon E.coli treatment. The differences 
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observed between WT and AD mice are likely mediated by a higher Aβ plaque load seen 
after peripheral immune activation (Qiao et al. 2001, Sheng et al. 2003, Lee et al. 2010). It 
is also tempting to speculate that the stronger production of inflammatory molecules in 
response to the peripheral insult may account for the differences in WT and AD mice. The 
primed status of microglia even in younger APP/PS1 might mediate this exaggerated 
response (Akiyama et al. 2000, Glass et al. 2010). Here, it is likely that, due to the pre-
existing higher levels a threshold of pro-inflammatory mediators is even exceeded with the 
less potent E.coli LPS. However, also the involvement of peripheral immune cells cannot 
be excluded. Especially aged APP/PS1 mice show an enhanced pro-inflammatory profile 
of microglia and reduction of blood brain barrier integrity leading to enhanced immune cell 
recruitment into the CNS (Minogue et al. 2014). In this context, measuring the Aβ plaque 
load and the expression of inflammatory cytokines will be of extreme interest. 
 
 
4.4. Long-term detrimental effects of a peripheral immune stimulation with 
LPS of Salmonella typhimurium are mediated by the NLRP3 inflammasome 
 
The NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome is a 
multi protein complex catalyzing the maturation of the proinflammatory cytokines IL-1β 
and IL-18 in response to injury, infection or tissue damage. Components of the NLRP3 
inflammasome are the cytoplasmic innate receptor NLRP3, the adaptor apoptosis-
associated speck-like protein containing a CARD (ASC), and caspase-1. Both IL-1β and 
IL-18 are expressed as inactive precursor forms, pro-IL-1β and pro-IL-18 and require 
cleavage by activated caspase-1 for activation and secretion as mature cytokines. 
Besides in a scenario of infection or injury, also amyloid-β aggregates are able to activate 
the NLRP3 inflammasome (Halle et al. 2008). Direct brain injury or infection and also a 
peripheral immune stimulation with E.coli LPS can lead to high expression of all NLRP3 
components (Zhang et al. 2014). And of course, the up-regulation of IL-1β and IL-18 in 
response to peripheral immune activation gives indirect evidence for the involvement of 
NLRP3 inflammasome in the several detrimental effects on neuronal function (Gibertini et 
al. 1995, Soiampornkul et al. 2008, Tong et al. 2008). It was further shown that NLRP3 
deficiency can indeed prevent AD related pathology in the APP/PS1 model (Heneka et al. 
2013). Here, reduced spine density in CA1 apical dendrites, impaired LTP and learning 
and memory deficits in the Morris water maze task were rescued in the APP/PS1/Nlrp3-/- 
mice. Furthermore, the phagocytic capacity of microglia was enhanced while the burden 
of amyloid β plaques was reduced. These data show a rescue of the Aβ mediated 
neurodegeneration in the absence of the NLRP3 inflammasome. In this thesis, I examined 
whether NLRP3 deficiency is also beneficial in the context of a systemic immune 
  DISCUSSION | 99 
 
activation and whether Salmonella typhimurium LPS leads to reduced neuronal 
complexity and plasticity in an inflammasome dependent manner. Surprisingly, the initial 
response to S.typhimurium LPS injection of the aged NLRP3 KO mice is not different from 
aged WT mice. NLRP3 KO mice show a similar body weight loss and an equivalent 
mortality rate of about 17% after immune stimulation with S.typhimurium LPS. 
Nevertheless, like the WT also the NLRP3 KO mice recovered and showed no sickness 
behavior or differences in body weight compared to control mice 3 months after immune 
stimulation. This initial sickness behavior of NLRP3 KO similar to WT mice suggests that 
other pro-inflammatory cytokines such as TNF-α mediate the peripheral immune activation 
and that inhibition of IL-1β and IL-18 signaling does not prevent LPS S.typhimurium 
induced lethality and immune activation as claimed by Netea and colleagues described 
above (Netea et al. 2001). 
Nevertheless, the neuronal phenotype 3 months after immune stimulation indeed shows 
protection of NLRP3 KO mice against S.typhimurium LPS: The cortical as well as 
hippocampal excitatory neurons of NLRP3 KO show dendritic complexity similar to the 
control after the peripheral immune stimulation. In the CA1 basal compartment, even a 
slight increase is visible. Also the spine density in dentate gyrus and cortex layer II/III are 
comparable in NLRP3 KO controls and LPS stimulated mice. Solely the CA1 basal spine 
density is still decreased after peripheral immune activation. However, the absolute 
number of spines in the basal compartment is most likely not altered due to the increase 
in dendritic complexity. 
In addition to the neuronal structure also the synaptic plasticity is restored in NLRP3 KO 
mice. There are no alterations in basal synaptic transmission, paired pulse facilitation and 
LTP 3 months after peripheral administration of S.typhimurium LPS. In a way the immune 
response and the observations made in the CNS of the aged, 16 months old NLRP3 KO 
mice resemble those of adult, 4 months old mice. 
Although the activation of microglia and astrocytes as well as the production of pro-
inflammatory cytokines was not quantified in this study, the data suggest that indeed 
higher IL-1β or IL-18 levels and stronger pro-inflammatory activation of microglia in aged 
WT mice is responsible for decreased neuronal dendritic complexity and LTP upon LPS 
S.typhimurium treatment. Even though at first glance, the neurodegenerative pathology of 
APP/PS1 mice seems quite different from the effects of a systemic immune activation only 
with a bacterial cell wall component, the data in this thesis partially support the hypothesis 
of a generalized detrimental function to IL-1β and IL-18 signaling in the context of 
neuroinflammation. 
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4.5. Long-term detrimental effects of a peripheral immune stimulation with 
PGN/LTA  
 
Sepsis is a complex inflammatory response of the host’s immune system to virulence 
factors like endotoxins. Until two decades ago, sepsis and septic shock as a multi-step 
inflammatory reaction was considered to be specific for Gram negative bacteria (Parrillo et 
al. 1990). Today we know, that most cases of sepsis are actually caused by Gram positive 
bacteria with the most prominent representatives Stapylococcus aureus, Streptococcus 
pyogenes, Pseudomonas aeruginosa and Klebsiella spp. (Martin et al. 2003). Especially 
Staphylococcus aureus came into focus in the context of nosocomial infections. However, 
studies with Gram positive bacteria or Gram positive bacterial endotoxins in the context of 
sepsis induced encephalopathy and neuroinflammation are still the exception.  
Therefore, LPS is still the best described endotoxin and LPS injections serve as a model 
for systemic infections, sepsis and also neuroinflammation. Sepsis caused by Gram 
positive bacteria is mediated by the two major components of the gram-positive cell wall 
peptidoglycan (PGN) and lipoteichoic acid (LTA). In contrast to LPS, the recognition of 
LTA and PGN is mediated by TLR2, LBP, and CD14, whereas TLR-4 and MD-2 are not 
involved (Schröder et al. 2003). As major difference between TLR4 and TLR2 signaling, 
TLR2 binding leads to NFκB activation in the classical MyD88-dependent pathway and 
inhibits the TRIF-dependent signaling pathway (Akira and Takeda 2004). 
Whether purified LTA and PGN can cause LPS-comparable immune response is still a 
matter of debate. On the one hand, it has been shown that both LTA and PGN are able to 
induce expression of IL-1, IL-6, TNFα and production of nitric oxide when given to 
macrophages in vitro and in vivo (Kengatharan et al 1996). In contrast, 10 µg/ml of LTA or 
PGN are sufficient to induce TNF-α production but fail to activate iNOS in mouse 
macrophages (Paul-Clark et al. 2006). A different study shows that GFAP, CD11b, MHC 
class II but not CD68 are highly expressed 2 days after intravenous administration of 20 
µg/g LTA in the rat pineal gland (Jiang-Shieh et al. 2005). Furthermore, it has been 
hypothesized that only when acting together LTA and PGN can cause septic shock and 
organ toxicity already 6 hours after i.v. application in rats at doses of 10 µg/g and 3 µg/g, 
respectively (De Kimpe et al. 1995). Another study demonstrates that the magnitude of 
the inflammatory reaction towards Gram positive bacteria seems to be smaller than the 
LPS induced one (Abe et al. 2010). On the other hand, Hessle and colleagues found that 
Gram positive bacteria can induce expression of IL-1β, IL-6, IL-8 and TNF-α equally 
strong than Gram negative bacteria in human monocytes culture. However, the 
application of LTA and PGN alone failed to generate this strong response (Hessle et al. 
2005). Another study could not find any signs of TLR2 activation with either LTA or PGN 
or in combination (LaFlamme et al. 2001). Systemic PGN has even been reported to 
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abolish the neuroinflammatory microglia phenotype induced by LPS (LaFlamme et al. 
2003). Critical for the successful immune activation with PGN seems to be the purification 
method (Hanke and Kielian 2012). As PGN contains mainly sugars and amino acids which 
are also present or closely related to the ones found in mammals, possibly the structure of 
these cell wall component is of most relevance. 
The presented body weight data here demonstrate that indeed PGN/LTA application does 
not provoke sickness behavior comparable to LPS in adult or aged WT mice. Also in the 
brain, 3 months after the peripheral application of PGN/LTA there is no change in the 
number or morphology of astrocytes and microglia. Yet, data on CNS immune cell 
activation are missing for time points during or shortly after immune stimulation. And still a 
pro-inflammatory activation status of microglia and astrocytes cannot be excluded, as 
besides the number and morphology of microglia no other immune relevant marker was 
quantified here. In addition to that, also the correlation between microglia morphology and 
activation status and function has recently been questioned (Kettenmann 2011; Tremblay 
and Sierra 2014) and a subtle but chronic production of pro-inflammatory cytokines might 
not be associated with altered microglia morphology in the presented scenario. Therefore, 
the question of whether PGN and LTA are able to induce LPS-comparable 
neuroinflammation is still unanswered. 
Without doubt, in contrast to the wealth of experiments using LPS, not much is known 
about the influence of PGN/LTA or Gram positive bacteria mediated immune stimulation 
on neurons or glial cells of the CNS. More precisely, the influence of the application of 
Gram positive endotoxins on neuronal architecture or synaptic plasticity in rodents has not 
been addressed. Results from this study show that peripheral application of PGN/LTA 
does not cause long-term effects on neuronal morphology in adult mice. Neither in the 
cortex nor in the hippocampus a difference in dendritic complexity or spine density could 
be observed upon immune stimulation. In aged 19 months mice however, the neuronal 
phenotype 3 months after PGN/LTA treatment is comparable to the stimulation with LPS 
of Salmonella typhimurium. Especially in the cortex layer II/III, pyramidal neurons exhibit 
dramatic decrease in dendritic complexity and spine density. But also the apical CA1 
dendrites and the basal CA1 spine density is negatively affected. In the dentate gyrus, the 
absolute number of synapses is probably not changed as dendritic complexity is 
increased while spine density is decreased.  
LTP of the Schaffer collateral is mildly but significantly reduced upon PGN/LTA treatment. 
In contrast to the stimulation with S.typhimurium LPS there are no changes in the escape 
latency during the Morris water maze task. But indeed, also the use of hippocampus-
dependent strategies is heavily impaired. Therefore, the only difference between a 
systemic immune activation with S.typhimurium LPS and PGN/LTA is the absence of an 
obvious immune activation of microglia in the latter. 
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Interestingly, also the APP/PS1 mice show a stronger sensitivity towards this 
unconventional immune stimulation. Here, in particular the CA1 apical compartment and 
the dentate gyrus granule cells show a stronger decrease in spine density than the aged 
WT mice. This is associated with a more intense impairment in LTP, although basal 
synaptic transmission is enhanced in comparison to control APP/PS1 mice. The impact on 
hippocampus-dependent learning and microglial activation was not examined in this 
study. Therefore, one can only speculate whether the AD mice show an immune 
activation in the brain different from WT mice after immune stimulation. Also the 
involvement of peripheral immune cells is possible. It was shown, that an enhanced pro-
inflammatory profile of microglia of aged APP/PS1 mice along with disruption of blood 
brain barrier integrity promotes immune cell recruitment into the CNS diminishing 
neuroprotective and promoting neurodegenerative mechanisms (Minogue et al. 2014). 
Similar to the LPS model, also with PGN/LTA stimulation, even the adult APP/PS1 mice 
show slight alterations in neuronal morphology. Noteworthy, here again the spine density 
of the granule cells is remarkably decreased. But also in the adult APP/PS1 mice a 
quantification of the peripheral as well as the brain immune response will be necessary to 
understand the underlying mechanisms.  
In summary, here for the first time age-dependent alterations in neuronal structure and 
signaling were reported for a model of Gram positive induced immune activation. The 
effects were intensified in the APP/PS1 mouse model for Alzheimer´s disease.  
 
 
4.6. Chronic infection with Toxoplasma gondii causes changes in neuronal 
structure 
 
The protozoan parasite Toxoplasma gondii (T.gondii) can infect a wide range of warm-
blooded animals and based on seroprevalence data about 30 to 70% of the human 
population is infected showing a high geographical variety (Parlog et al. 2015). Infections 
with T.gondii can be asymptomatic as well as severe if it comes to eye and brain 
infections. Even after the acute phase, T.gondii remains within the host over its whole 
lifespan, thanks to adequate immune functions, usually unnoticed. In 
immunocompromised patients however, T.gondii infection can cause life-threatening 
encephalitis. 
Today we know, that even in immune competent people Toxoplasma gondii causes subtle 
neurological and behavioral changes promoting mental disorders including depression 
and schizophrenia (Flegr 2007, Webster 2007). Also in rodents, infection with T.gondii 
leads to elaborated behavioral changes manifesting in a more curios and active behavior 
(Hay et al. 1985, Webster et al. 1994) and infected animals lose their innate fear of feline 
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odors (Berdoy et al. 2000). Even though some studies already suggest a contribution of 
low-level inflammation (Hermes et al. 2008), neurotransmitter imbalance (Gatkowska et al. 
2012) or dopamine overproduction (Prandovszky et al. 2011), underlying mechanisms are 
still far from unraveled. In particular, the impact of chronic Toxoplasma gondii infection on 
neuronal architecture and signaling has not been explored yet.  
In this study, the architecture of excitatory neurons of cortex layer II/III, the CA1 area and 
dentate gyrus of the hippocampus as well as of inhibitory medium spiny neurons of the 
striatum were examined 8 weeks after infection with T.gondii. In the hippocampus, CA1 
pyramidal neurons and granule cells of the dentate gyrus show a significant reduction in 
dendritic complexity. Also the striatal medium spiny neurons exhibit a mild decrease in 
dendritic branches. In cortex layer II/III, pyramidal neurons display a significant reduction 
of intersections in the Sholl analysis of basal dendrites. The apical dendrites show only a 
slight reduction. Here, however additionally the spine density was dramatically reduced. It 
was further shown that the levels of synaptophysin and PSD95 are significantly reduced in 
cortex and hippocampus. But besides high numbers of astrocytes, activated microglia, T 
cells and scattered spots of apoptosis neurodegeneration was surprisingly low (Parlog 
2015). Therefore, activation of brain resident as well as peripheral immune cells 
contributes to the decreased neuronal complexity without promoting neuronal death. 
The distribution of T.gondii tissue cysts is usually very low in rodents and no preference 
for a specific brain area can be identified (Gulinello et al. 2010). In the same infection 
model as used for the analysis of neuronal morphology, likewise a random distribution of 
T. gondii cysts was observed with 6 to 10 parasite cysts within the cortex and 1 to 2 cysts 
within the hippocampus per 500 µm transversal brain slice (Parlog 2015). Even though 
this relatively low concentration of T.gondii tissue cysts was found in infected animals, a 
strong sickness behavior of the infected mice was noticeable 8 weeks after infection. This 
is line with other studies of C57Bl/6 mice chronically infected with T.gondii. In the 
genetically highly susceptible C57Bl/6 mice chronic type II T.gondii infections invariably 
cause lethal toxoplasmic encephalitis (Gigley et al. 2009). Therefore, it is not surprising 
that C57Bl/6 mice show other behavioral alterations besides the T.gondii specific loss of 
fear from cat odors. Gatkowska and colleagues report a decrease in locomotion, grooming 
and open field exploration associated with a progressive body weight loss in chronically 
T.gondii infected C57Bl/6 mice (Gatkowska et al. 2012). Interestingly, even though 
T.gondii tissue cysts are evenly distributed in brains of C57Bl/6 mice, the genetically 
resistant BALB/c mice show a twofold increase in tissue cysts in the amygdala (Vyas et al. 
2007), which is important for memory of fear and emotional events and which might 
explain behavioral differences between the two mice strains. Unfortunately, data regarding 
body weight loss, food intake, exploration and locomotion activity are not provided in this 
study. But indeed, the phenotype observed in C57Bl/6 chronically infected with T.gondii 
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might rather resemble the T.gondii infection of immunocompromised patients than the 
latent unnoticed infection of healthy individuals. Therefore, changes in synaptic markers 
and neuronal structure shown in this thesis are more likely consequence of the chronic 
immune activation inevitably leading to death rather than a direct effect of the pathogen on 
single neurons.  
The latent T.gondii infections of BALB/c mice would probably cause even smaller and less 
obvious changes within neuronal networks and provide a T.gondii specific mechanism 
besides the pro-inflammatory activation of brain resident immune cells. But most likely 
also there the immune response within the CNS and the recruitment of peripheral immune 
cells would play a pivotal role. 
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4.7. Conclusions and outlook 
 
In this thesis, I could show that neuronal structure and function can be modified by the 
CNS infection with T.gondii as well as by the systemic innate immunity activated by 
different bacterial endotoxins. In contrast to the majority of studies in the field of 
neuroinflammation and neurodegeneration, here influences of an immune stimulation or 
infection were examined long after the acute phase of immune activation was over come. 
Thereby, it became obvious that a peripheral immune activation with different bacterial 
endotoxins failed to induce long-term changes in adult mice. However, direct CNS 
infection as displayed by the parasite T.gondii is sufficient to influence neurons also in 
young adult mice. Here, the chronic infection of C57Bl/6 with T.gondii leads to a cell type 
and brain region unspecific reduction in neuronal complexity. Changes in neuronal 
structure are most likely caused by the pro-inflammatory activation of microglia and 
astrocytes as well as peripheral immune cells as shown by Parlog 2015. As C57Bl/6 mice 
resemble a genetically sensitive mouse strain for chronic T.gondii infection, the data 
obtained here most likely give insight into the situation seen in immunocompromised 
patients developing toxoplasmic encephalitis. It would be very interesting to examine the 
effects of a chronic T.gondii infection in a genetically resistant model as the BALB/c 
mouse which could provide insight into the mechanisms underlying the latent infection as 
seen in a great proportion of the human population. 
In contrast to the direct CNS infection, activation of the peripheral immune system alone 
shows detrimental effects on structure and function of hippocampal and cortical neurons 
only in aged, 16 months old WT mice. The reason for this might be a prolonged activation 
of microglia due to age-dependent priming of these brain macrophages. Furthermore, I 
could demonstrate that LPS of E.coli although it is the endotoxin used predominantly to 
establish neuroinflammation and investigate the connection between the peripheral 
immune system and CNS function, failed to induce appreciable long-term changes even in 
aged WT mice. 
Immune stimulation with Salmonella typhimurium LPS however leads to decreased 
neuronal complexity and spine density accompanied with impairment in Schaffer collateral 
LTP and spatial learning in the Morris water maze. An even stronger activation of 
microglia as displayed here and a stronger production of IL-1β and IL-18 (Netea et al. 
2001) might account for this phenomenon. This hypothesis could be partially confirmed by 
experiments with NLRP3 knockout animals. The genetic ablation of the NLRP3 
inflammasome and therefore the maturation of IL-1β and IL-18 prevented reduction in 
dendritic complexity and spine density as well as it rescued the impairment in LTP upon 
immune stimulation with S.typhimurium LPS in aged mice. However, further experiments 
are necessary to verify the important role of IL-1β in the described scenario. As obvious 
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step, it is needed to quantify the activation of microglia and astrocytes during the time 
course of immune stimulation. In addition, a more detailed description of the activation 
phenotype of the CNS immune cells is necessary to draw conclusions about their actual 
function. Immune activation markers as CD11b, CD68, MHC class II, Cox-2, MCP-1, TNF-
a, IL-1β, IL-6, IL-18 are only some to mention here. And of course, the upregulation of 
NLRP3 inflammasome components as caspase-1, NLRP3 and ASC has to be shown.  
As the immune activation paradigm used in this thesis resembles the situation of sepsis-
recovery, further long-term studies with prolonged but low doses of endotoxins could shed 
light on the mechanisms seen in patients with type 2 diabetes, severe obesity or 
atherosclerosis. The influence seen after chronic overproduction of proinflammatory 
mediators without life-threatening upregulation of the peripheral immune system could 
display a completely different danger for the CNS. In line with this, for a convincing role of 
solely the peripheral immune system, the integrity of the blood brain barrier in all 
genotypes and age groups needs proof. 
One important finding during my investigations was that also the immune stimulation with 
endotoxins of the Gram positive bacterial cell wall can lead to a neurodegenerative 
phenotype in aged WT mice. So far, neither the neuronal structure nor synaptic plasticity 
and hippocampus-dependent learning were investigated after peripheral application of 
PGN and LTA from Staphylococcus aureus. As the majority of sepsis cases are caused 
by Gram positive bacteria and as S.aureus gained notoriety in the context of nosocomial 
infections, the development of a suitable model for these diseases is more than overdue. 
In this study, I could demonstrate that the outcome of a peripheral immune activation with 
PGN/LTA shows remarkable similarity with the one of S.typhimurium LPS. First, it has to 
be confirmed, that PGN/LTA leads to peripheral immune activation and actually can cause 
neuroinflammation as studies are not in agreement concerning this question so far. 
Further, similarities in the mode of action between Salmonella typhimurium LPS and 
PGN/LTA of Staphylococcus aureus might provide information about how sepsis, severe 
bacteraemia, septic shock, type 2 diabetes, obesity or periodontitis can all promote 
neurodegeneration. 
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6. LIST OF ABBREVIATIONS 
 
Aβ amyloid beta 
AD Alzheimer’s disease 
ACSF artificial cerebrospinal fluid 
AIF-1 allograft inflammatory factor 1 
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazol propionic acid 
ASC apoptosis-associated-speck-like protein  
ATP adenosine triphosphate 
APP  amyloid precursor protein 
BBB blood-brain barrier 
BDNF brain-derived neurotrophic factor 
BSA bovine serum albumine 
CA cornu ammonis 
CamKII Ca
2+
/calmodulin-dependent protein kinase II  
CC  cytokine with C-C structure 
CD cluster of differentiation 
COX cyclooxygenase 
CNS central nervous system 
CREB cyclic AMP-responsive element-binding protein  
CX3C cytokine with CXXXC structure 
DAMP danger-associated molecular pattern 
DAPI 4´,6-diamidino-2-phenylindole 
DiI 1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine perchlorate 
DNA deoxyribonucleic acid 
EC entorhinal cortex 
fEPSP field excitatory post-synaptic potential 
GABA γ-aminobutyric acid 
GFAP glial fibrillar acidic protein  
HMGB1 high-mobility group box 1 protein 
IFN-γ interferon-gamma 
IBA-1 ionized calcium-binding adapter molecule 1  
IL interleukin  
IL-1R interleukin 1 receptor 
IL-1RA interleukin 1 receptor antagonist 
IRAK IL-1R-associated kinases  
iNOS inducible nitric oxide synthase  
ISI inter stimulus interval 
LBP lipopolysaccharide-binding protein 
LPS lipopolysaccharide 
LTA lipoteichoic acid 
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LTD long-term depression 
LTP long-term potentiation 
MAL MyD88-adaptor-like protein 
MAP  microtubule associated proteins 
MAPK mitogen-activated protein kinase 
MD-2 lymphocyte antigen 96 
MHC major histocompatibility complex 
MIP-1 macrophage inflammatory protein-1 
MWM Morris water maze 
MyD88 myeloid differentiation primary response gene (88) 
NF-κB nuclear factor-kappa B 
NLR NOD like receptor 
NLRP3 NOD-, LRR- and pyrin domain-containing 3 
NMDA N-methyl-D-aspartate 
NO nitric oxide 
NSAID non-steroidal anti-inflammatory drugs 
NT-3 neurotrophin 3 
p75
NTR
 
pan neurotrophin receptor 75 
PAMP pathogen associated molecular pattern 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PGN peptidoglycan 
PKA protein kinase A 
PPF paired pulse facilitation 
PRR pattern recognition receptors 
PS1 presenilin 1 
ROI region of interest 
RAGE receptor for advanced glycation end-products 
ROS reactive oxygen species 
RT room temperature 
TGF-β transforming growth factor-beta 
TIR toll/interleukin receptor 
TIRAP  TIR domain-containing adapter protein 
TLR toll-like receptor 
TNF-α tumor necrosis factor-alpha 
TNF-R tumor necrosis factor-receptor 
TRAF TNF receptor-associated factor 
TRAM  TRIF-related adaptor molecule 
TREM-2 triggering receptor expressed on myeloid cells 2 
TRIF  TIR domain-containing adaptor protein inducing IFN-β 
WT wildtype 
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